PT J
AU Ali, M
   Yusuf, HI
   Stahmer, J
   Rahlenbeck, SI
AF Ali, Mahdi
   Yusuf, Hassan Ismail
   Stahmer, Jens
   Rahlenbeck, Sibylle I.
TI Cardiovascular Risk Factors and Physical Activity Among University Students in Somaliland
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Cardiovascular risk factors; BMI; Somalia; Physical inactivity; Sedentary life style; Blood pressure; Overweight
ID young-adults; prevalence; inactivity
AB Physical inactivity is a well-known risk factor for the development of cardiovascular diseases and counts as fourth leading cause of death worldwide. The study aimed to elucidate to what extent cardiovascular risk factors exist in university students in Somaliland. In a cross-sectional survey, self-administered questionnaires were used to elucidate existence of cardiovascular risk factors in 173 university students (117 male, 56 female) in Hargeisa, Somaliland. Information elucidated included socio-economic and demographic data in addition to questions on coffee intake, on physical activity behavior, type of sport/activity and intensity and duration. Height and weight were taken, as was blood pressure (BP). Median age was 23 years in male and 20 years in female students. Mean BMI was 19.7 in male and 21.8 in female students. The prevalence rates of elevated BP and overweight (BMI a parts per thousand yen 25) in female and male students were, 0 versus 9 and 14 versus 7 %, respectively. Coffee consumption was reported by 39 % of students. None of the female students reported smoking cigarettes, while 5.1 % of the male students did. Physical inactivity was reported by 52 % of the female students and 27 % of the male students (p = 0.01). Overall, male students reported a higher degree and intensity of physical activity. The prevalence of cardiovascular risk factors is low in female and male university students in Somaliland. However, the results demonstrate a high degree of physical inactivity and overweight might become a problem in the future. This issue should be addressed by increasing the motivation and opportunities for physical activity in students.
C1 [Ali, Mahdi; Yusuf, Hassan Ismail] Univ Hargeisa, Fac Med, Hargeisa, Somalia.
   [Stahmer, Jens] Reinbek Hosp, Internal Med, D-21465 Reinbek, Germany.
   [Rahlenbeck, Sibylle I.] Afrika Akt eV, Epidemiol & Publ Hlth, Berlin, Germany.
RP Rahlenbeck, SI (corresponding author), Afrika Akt eV, Epidemiol & Publ Hlth, Berlin, Germany.
EM Rahlenbeck@hotmail.com
FU Afrika aktiv e.V.; Else-Kroener-Fresenius-Stiftung, Germany
CR Abdi IA, 2013, J COMMUN HEALTH, V38, P246, DOI 10.1007/s10900-012-9606-4
   Adegoke BOA, 2011, J PHYS ACT HEALTH, V8, P1135, DOI 10.1123/jpah.8.8.1135
   Baalwa J, 2010, AFR HEALTH SCI, V10, P367
   Belue R, 2009, GLOBALIZATION HEALTH, V5, P0, DOI 10.1186/1744-8603-5-10
   Ewane EM, 2012, PAN AFRICAN MED J, V11, P77
   Guha-Sapir D, 2009, PLOS MED, V6, P0, DOI 10.1371/journal.pmed.1000108
   Hassan IY, 2007, PREVALENCE SURVEY HY, V0, P0
   Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8
   Magutah K, 2013, AFR HEALTH SCI, V13, P10, DOI 10.4314/ahs.v13i1.2
   Oyeyemi AL, 2013, J EPIDEMIOL, V23, P169, DOI 10.2188/jea.JE20120116
   Peer N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19216
   Rahlenbeck SI, 1998, ANN BIOL CLIN-PARIS, V56, P705
   Rebacz-Maron E, 2013, BIOL TRACE ELEM RES, V151, P350, DOI 10.1007/s12011-012-9578-3
   Senbanjo IO, 2012, CARDIOVASC J AFR, V23, P260, DOI 10.5830/CVJA-2011-037
   Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, P0, DOI 10.1186/1471-2261-9-39
   UNICEF, 2011, SOM, V0, P0
   UNICEF, 2011, SOM MULT IND CLUST S, V0, P0
   World Health Organization, 2007, GLOB REC PHYS ACT HL, V0, P0
NR 18
TC 20
Z9 22
U1 0
U2 30
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD APR 15
PY 2015
VL 40
IS 2
BP 326
EP 330
DI 10.1007/s10900-014-9938-3
PG 5
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational Health
GA CD1GJ
UT WOS:000350822600019
PM 25179818
DA 2025-04-28
ER

PT J
AU Lee, LS
   Choi, JH
   Sung, MJ
   Hur, JY
   Hur, HJ
   Park, JD
   Kim, YC
   Gu, EJ
   Min, B
   Kim, HJ
AF Lee, Lan-Sook
   Choi, Ji Hea
   Sung, Mi Jeong
   Hur, Jin-Young
   Hur, Haeng Jeon
   Park, Jong-Dae
   Kim, Young-Chan
   Gu, Eun-Ji
   Min, Byungjin
   Kim, Hyun-Jin
TI Green tea changes serum and liver metabolomic profiles in mice with high-fat diet-induced obesity
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Acetyl-CoA acyltransferase 2; Fatty acid beta-oxidation; Green tea; Metabolomics; Obesity
ID mitochondrial beta-oxidation; weight maintenance; skeletal-muscle; lipid oxidation; catechins; polyphenols; metaanalysis; caffeine; acid; rats
AB Scope: Green tea (GT) consumption helps to prevent and control obesity by stimulating hepatic lipid metabolism. However, GT-induced changes in serum and liver metabolomes associated with the anti-obesity effects are not clearly understood. The aim of this study was to identify and validate metabolomic profiles in the livers and sera of GT-fed obese mice to elucidate the relationship between GT consumption and obesity prevention. Methods and results: Serum and liver metabolites were analyzed in mice fed normal diet, high-fat diet (HFD), HFD with GT, and HFD with crude catechins, using LC-quadrupole TOF MS. The addition of 1% GT to HFD reduced adipose tissue and the levels of blood triglycerides, glucose, insulin, and leptin elevated in HFD-fed mice. We proposed an HFD-induced obesity pathway and validated it by investigating the key regulatory enzymes of mitochondrial beta-oxidation: carnitine palmitoyltransferase-1 and -2, acyl-coenzyme A dehydrogenase, and acetylcoenzyme A acyltransferase. The results showed that HFD-induced abnormal mitochondrial beta-oxidation was moderated by the consumption of caffeine-and theanine-enriched GT. Conclusion: Results of LC/MS-based metabolomic analysis of obese mice showed changes associated with abnormal lipid and energy metabolism, which were alleviated by GT intake, indicating the mechanism underlying the anti-obesity effects of GT.
C1 [Lee, Lan-Sook; Choi, Ji Hea; Sung, Mi Jeong; Hur, Jin-Young; Hur, Haeng Jeon; Park, Jong-Dae; Kim, Young-Chan] Korea Food Res Inst, Songnam, Gyeonggi, South Korea.
   [Choi, Ji Hea] Univ Sci & Technol, Dept Food Biotechnol, Daejeon, South Korea.
   [Gu, Eun-Ji; Kim, Hyun-Jin] Gyeongsang Natl Univ, Dept Food Sci & Technol, Div Appl Life Sci Plus BK21, Jinju, Gyeongsang, South Korea.
   [Gu, Eun-Ji; Kim, Hyun-Jin] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, Gyeongsang, South Korea.
   [Min, Byungjin] Tuskegee Univ, Coll Agr Environm & Nutr Sci, Dept Food & Nutr Sci, Tuskegee, AL 36088 USA.
C3 Korea Food Research Institute (KFRI); University of Science & Technology (UST); Gyeongsang National University; Gyeongsang National University; Tuskegee University
RP Kim, HJ (corresponding author), Gyeongsang Natl Univ, 501 Jinjudaero, Jinju, Gyeongsang, South Korea.
EM hyunjkim@gnu.ac.kr
FU High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; Korea Food Research Institute; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [2014R1A2A2A01006774]; BK21 Plus Program, Ministry of Education, Republic of Korea
CR An YP, 2013, J PROTEOME RES, V12, P3755, DOI 10.1021/pr400398b
   Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104
   Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345
   Fu CW, 2011, J PHARMACEUT BIOMED, V55, P1067, DOI 10.1016/j.jpba.2011.03.011
   Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022
   Galili O, 2007, AM J PHYSIOL-HEART C, V292, PH904, DOI 10.1152/ajpheart.00628.2006
   Girillo P, 2006, J AM SOC NEPHROL, V17, PS165, DOI 10.1681/ASN.2006080909
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Khaodhiar L, 1999, CLIN CORNERSTONE, V2, P17, DOI 10.1016/S1098-3597(99)90002-9
   Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r
   Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p
   Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, PE1039, DOI 10.1152/ajpendo.2000.279.5.E1039
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lee LS, 2013, J AGR FOOD CHEM, V61, P332, DOI 10.1021/jf304161y
   Li TP, 2013, J AGR FOOD CHEM, V61, P7599, DOI 10.1021/jf400283w
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Lu KL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093135
   Magliano DC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064258
   McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Ogura R, 2008, FOOD CHEM TOXICOL, V46, P2190, DOI 10.1016/j.fct.2008.02.016
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Richard D, 2009, PHARMACOL RES, V59, P351, DOI 10.1016/j.phrs.2009.01.015
   Rogge MM, 2009, BIOL RES NURS, V10, P356, DOI 10.1177/1099800408329408
   Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Xie GX, 2012, J PROTEOME RES, V11, P3449, DOI 10.1021/pr300318m
   Xie GX, 2009, J AGR FOOD CHEM, V57, P3046, DOI 10.1021/jf804000y
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
NR 35
TC 55
Z9 59
U1 2
U2 113
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD APR 15
PY 2015
VL 59
IS 4
BP 784
EP 794
DI 10.1002/mnfr.201400470
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA CF8CK
UT WOS:000352782800016
PM 25631872
DA 2025-04-28
ER

PT J
AU Keast, RSJ
   Swinburn, BA
   Sayompark, D
   Whitelock, S
   Riddell, LJ
AF Keast, Russell S. J.
   Swinburn, Boyd A.
   Sayompark, Dhoungsiri
   Whitelock, Susie
   Riddell, Lynn J.
TI Caffeine increases sugar-sweetened beverage consumption in a free-living population: a randomised controlled trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Sugar-sweetened beverages; Caffeine; Free-living populations
ID body-weight; flavor; liking; reinforcement; adolescents; preference; children; energy
AB Excessive sugar-sweetened beverage (SSB) consumption has been associated with overweight and obesity. Caffeine is a common additive to SSB, and through dependence effects, it has the potential to promote the consumption of caffeine-containing foods. The objective of the present study was to assess the influence that caffeine has on the consumption of SSB. Participants (n 99) were blindly assigned to either a caffeinated SSB (C-SSB) or a non-caffeinated SSB (NC-SSB) group. Following randomisation, all participants completed a 9 d flavour-conditioning paradigm. They then completed a 28 d ad libitum intake intervention where they consumed as much or as little of C-SSB or NC-SSB as desired. The amount consumed (ml) was recorded daily, 4 d diet diaries were collected and liking of SSB was assessed at the start and end of the intervention. Participants (n 50) consuming the C-SSB had a daily SSB intake of 419 (SD 298) ml (785 (SD 559) kJ/d) over the 28 d intervention, significantly more than participants (n 49) consuming the NC-SSB (273 (SD 278) ml/d, 512 (SD 521) kJ/d) (P<0.001). A trained flavour panel (n 30) found no difference in flavour between the C-SSB and NC-SSB (P>0.05). However, participants who consumed the C-SSB liked the SSB more than those who consumed the NC-SSB (6.3 v. 6.0 on a nine-point hedonic scale, P<0.022). The addition of low concentrations of caffeine to the SSB significantly increases the consumption of the SSB. Regulating caffeine as a food additive may be an effective strategy to decrease the consumption of nutrient-poor high-energy foods and beverages.
C1 [Keast, Russell S. J.; Sayompark, Dhoungsiri; Whitelock, Susie; Riddell, Lynn J.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia.
   [Swinburn, Boyd A.] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Burwood, Vic 3125, Australia.
   [Swinburn, Boyd A.] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand.
   [Sayompark, Dhoungsiri] Rajamangala Univ Technol Tawan Ok, Fac Sci & Technol, Chon Buri, Thailand.
C3 Deakin University; Deakin University; World Health Organization; University of Auckland; Rajamangala University of Technology Tawan-ok
RP Riddell, LJ (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM lynn.riddell@deakin.edu.au
FU Diabetes Australia Research Trust
CR Datamonitor, 2007, CARB SOFT DRINKS US, V0, P0
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Garrett BE, 1998, PSYCHOPHARMACOLOGY, V139, P195, DOI 10.1007/s002130050704
   Griffiths R R, 2000, NIHON SHINKEI SEISHIN YAKURIGAKU ZASSHI, V20, P223
   Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727
   Hughes J, 1993, PROBLEMS DRUG DEPEND, V0, P0
   Keast RSJ, 2011, EUR J CLIN NUTR, V65, P1338, DOI 10.1038/ejcn.2011.123
   Keast RSJ, 2008, FOOD QUAL PREFER, V19, P465, DOI 10.1016/j.foodqual.2008.02.002
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Krachler B, 2006, NUTR J, V5, P0, DOI 10.1186/1475-2891-5-34
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Nehlig A, 1999, NEUROSCI BIOBEHAV R, V23, P563, DOI 10.1016/S0149-7634(98)00050-5
   Riddell L, 2007, MED J AUSTRALIA, V187, P655, DOI 10.5694/j.1326-5377.2007.tb01463.x
   ROGERS PJ, 1995, PSYCHOPHARMACOLOGY, V120, P457, DOI 10.1007/BF02245818
   Schuh KJ, 1997, PSYCHOPHARMACOLOGY, V130, P320, DOI 10.1007/s002130050246
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Temple JL, 2012, PSYCHOPHARMACOLOGY, V223, P37, DOI 10.1007/s00213-012-2684-2
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Troiano RP, 2000, AM J CLIN NUTR, V72, P1343S, DOI 10.1093/ajcn/72.5.1343s
   Yeomans MR, 2007, PHYSIOL BEHAV, V92, P831, DOI 10.1016/j.physbeh.2007.06.006
   Yeomans MR, 2002, APPETITE, V39, P35, DOI 10.1006/appe.2001.0480
   Yeomans MR, 1998, PSYCHOPHARMACOLOGY, V137, P401, DOI 10.1007/s002130050636
   Yeomans MR, 2000, APPETITE, V35, P131, DOI 10.1006/appe.2000.0339
NR 24
TC 26
Z9 29
U1 0
U2 27
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JAN 28
PY 2015
VL 113
IS 2
BP 366
EP 371
DI 10.1017/S000711451400378X
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CC3EW
UT WOS:000350229700018
PM 25567475
DA 2025-04-28
ER

PT J
AU Ghadieh, HE
   Smiley, ZN
   Kopfman, MW
   Najjar, MG
   Hake, MJ
   Najjar, SM
AF Ghadieh, Hilda E.
   Smiley, Zachary N.
   Kopfman, Melissa W.
   Najjar, Mona G.
   Hake, Michael J.
   Najjar, Sonia M.
TI Chlorogenic acid/chromium supplement rescues diet-induced insulin resistance and obesity in mice
SO NUTRITION & METABOLISM
LA English
DT Article
ID high-fat diet; chromium dinicocysteinate supplementation; continuous moderate exercise; nf-kappa-b; metabolic syndrome; antioxidant property; acid; coffee; fructose; glucose
AB Abdominal obesity is a major risk factor for insulin resistance, type 2 diabetes and cardiovascular diseases. Dietary fat induces insulin resistance in humans and rodents. The current study investigates whether a Chlorogenic acid/Chromium III supplement rescues obesity and insulin resistance caused by high-fat feeding of male C57BL/6 J mice for 7 weeks. Administering an oral daily dose of this supplement in the last 3 weeks of feeding reversed diet-induced body weight gain and insulin resistance, assessed by hyperglycemia, glucose intolerance and insulin intolerance. Indirect calorimetry analysis revealed that this effect is mediated at least partly, by increasing energy expenditure and spontaneous locomoter activity. These findings underscore the important role that chlorogenic acid and chromium play in maintaining glucose metabolism and insulin response in mice fed a high-fat diet.
C1 [Ghadieh, Hilda E.; Smiley, Zachary N.; Kopfman, Melissa W.; Najjar, Mona G.; Hake, Michael J.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, Toledo, OH 43614 USA.
   [Ghadieh, Hilda E.; Smiley, Zachary N.; Kopfman, Melissa W.; Najjar, Mona G.; Hake, Michael J.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Toledo, OH 43614 USA.
   [Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Toledo, OH 43614 USA.
C3 University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo
RP Najjar, SM (corresponding author), Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, Toledo, OH 43614 USA.
EM sonia.najjar@utoledo.edu
FU NIH [R01 DK054254, R01 DK083850, R01 HL112248]; Middle-East Diabetes Research Center (MEDRC)
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Al-Share QY, 2015, DIABETES, V0, P0
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Bakker LEH, 2014, DIABETES, V63, P248, DOI 10.2337/db13-0696
   Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649
   Bermúndez-Soto MJ, 2007, J NUTR BIOCHEM, V18, P259, DOI 10.1016/j.jnutbio.2006.05.003
   Bowman TA, 2010, ENDOCRINOLOGY, V151, P5157, DOI 10.1210/en.2010-0176
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035
   Dragan S, 2015, CURR MED CHEM, V22, P14
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Haram PM, 2009, CARDIOVASC RES, V81, P723, DOI 10.1093/cvr/cvn332
   Heinrich G, 2010, GASTROENTEROLOGY, V139, P644, DOI 10.1053/j.gastro.2010.03.056
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Iqbal N, 2009, METAB SYNDR RELAT D, V7, P143, DOI 10.1089/met.2008.0048
   Jain SK, 2012, MOL NUTR FOOD RES, V56, P1333, DOI 10.1002/mnfr.201100719
   Jain SK, 2010, MOL NUTR FOOD RES, V54, P1371, DOI 10.1002/mnfr.200900177
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Król E, 2014, BIOL TRACE ELEM RES, V157, P147, DOI 10.1007/s12011-013-9877-3
   LeRoith D, 2008, NAT CLIN PRACT ENDOC, V4, P164, DOI 10.1038/ncpendmet0729
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mesarwi O, 2013, ENDOCRIN METAB CLIN, V42, P617, DOI 10.1016/j.ecl.2013.05.001
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Najjar SM, 2014, SEMIN IMMUNOPATHOL, V36, P55, DOI 10.1007/s00281-013-0407-3
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975
   Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530
   Patel PR, 2012, DIABETOLOGIA, V55, P763, DOI 10.1007/s00125-011-2388-x
   Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840
   Rippe JM, 2013, ADV NUTR, V4, P236, DOI 10.3945/an.112.002824
   Ruhl Constance E, 2004, CLIN LIVER DIS, V8, P501, DOI 10.1016/j.cld.2004.04.008
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Selcuk MY, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-30
   Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8
   Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855
   Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   Wang ZQ, 2014, FRONT ENDOCRINOL, V5, P0, DOI 10.3389/fendo.2014.00099
   Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001
NR 44
TC 27
Z9 29
U1 1
U2 36
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD MAY 22
PY 2015
VL 12
IS 
BP 
EP 
DI 10.1186/s12986-015-0014-5
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CK0PY
UT WOS:000355908300001
PM 26045713
DA 2025-04-28
ER

PT J
AU O'Connor, L
   Imamura, F
   Lentjes, MAH
   Khaw, KT
   Wareham, NJ
   Forouhi, NG
AF O'Connor, Laura
   Imamura, Fumiaki
   Lentjes, Marleen A. H.
   Khaw, Kay-Tee
   Wareham, Nicholas J.
   Forouhi, Nita G.
TI Prospective associations and population impact of sweet beverage intake and type 2 diabetes, and effects of substitutions with alternative beverages
SO DIABETOLOGIA
LA English
DT Article
DE Adiposity; Coffee; Fruit juice; Population impact; Sweet beverages; Tea; Type 2 diabetes; Water
ID weight-loss maintenance; low-protein content; metabolic syndrome; glycemic index; epic-norfolk; risk; consumption; cancer; cohort; mellitus
AB Aims/hypothesis This study aimed to evaluate the association of types of sugar-sweetened beverages (SSB) (soft drinks, sweetened-milk beverages, sweetened tea/coffee), artificially sweetened beverages (ASB) and fruit juice with incident type 2 diabetes and determine the effects of substituting non-SSB for SSB and the population-attributable fraction of type 2 diabetes due to total sweet beverages. Methods Beverage consumption of 25,639 UK-resident adults without diabetes at baseline (1993-1997) in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study was assessed using 7-day food diaries. During 10.8 years of follow-up 847 incident type 2 diabetes cases were verified. Results In adjusted Cox regression analyses there were positive associations (HR [95% CI] per serving/day]) for soft drinks 1.21 (1.05, 1.39), sweetened-milk beverages 1.22 (1.05, 1.43) and ASB 1.22 (1.11, 1.33), but not for sweetened tea/coffee 0.98 (0.94, 1.02) or fruit juice 1.01 (0.88, 1.15). Further adjustment for adiposity attenuated the association of ASB, HR 1.06 (0.93, 1.20). There was a positive dose-response relationship with total sweet beverages: HR per 5% energy 1.18 (1.11, 1.26). Substituting ASB for any SSB did not reduce the incidence in analyses accounting for energy intake and adiposity. Substituting one serving/day of water or unsweetened tea/coffee for soft drinks and for sweetened-milk beverages reduced the incidence by 14%-25%. If sweet beverage consumers reduced intake to below 2% energy, 15% of incident diabetes might be prevented. Conclusions/interpretation The consumption of soft drinks, sweetened-milk beverages and energy from total sweet beverages was associated with higher type 2 diabetes risk independently of adiposity. Water or unsweetened tea/coffee appear to be suitable alternatives to SSB for diabetes prevention. These findings support the implementation of population-based interventions to reduce SSB consumption and increase the consumption of suitable alternatives.
C1 [O'Connor, Laura; Imamura, Fumiaki; Wareham, Nicholas J.; Forouhi, Nita G.] Univ Cambridge, Epidemiol Unit, Inst Metab Sci, Sch Clin Med,MRC, Cambridge CB2 0QQ, England.
   [Lentjes, Marleen A. H.; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0QQ, England.
C3 University of Cambridge; University of Cambridge
RP O'Connor, L (corresponding author), Univ Cambridge, Epidemiol Unit, Inst Metab Sci, Sch Clin Med,MRC, Cambridge Biomed Campus,POB 285, Cambridge CB2 0QQ, England.
EM laura.oconnor@mrc-epid.cam.ac.uk; nita.forouhi@mrc-epid.cam.ac.uk
FU Medical Research Council (MRC) UK; Cancer Research UK; MRC Epidemiology Unit [MC_UU_12015/5]; MRC [MC_UU_12015/1, MC_UU_12015/5, MC_UP_A100_1003] Funding Source: UKRI
CR Aller EEJG, 2014, INT J OBESITY, V38, P1511, DOI 10.1038/ijo.2014.52
   Unknown -, 2002, MCCANCE WIDD COMP FO, V0, P0
   Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102
   Briggs ADM, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f6189
   British Nutrition Foundation, 2013, HLTH HYDR GUID, V0, P0
   Day N, 1999, BRIT J CANCER, V80, P95
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-1072
   Eshak ES, 2013, CLIN NUTR, V32, P300, DOI 10.1016/j.clnu.2012.08.003
   Faculty of Public Health, 2013, DUT SUG SWEET BEV PO, V0, P0
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137
   Lentjes MAH, 2014, BRIT J NUTR, V111, P516, DOI 10.1017/S0007114513002754
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Miller PE, 2013, AM J PREV MED, V45, P416, DOI 10.1016/j.amepre.2013.05.014
   Muraki I, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5001
   National Cancer Institute, 2014, SOURC EN US POP 2005, V0, P0
   National Health Service, 2011, NHS LIV WELL 5 DAY W, V0, P0
   National Health Service, 2013, NHS CHOIC FACTS SUG, V0, P0
   Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799
   Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402
   Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439
   Welch AA, 2001, PUBLIC HEALTH NUTR, V4, P1253, DOI 10.1079/PHN2001196
   World Health Organization (WHO), 2015, GUIDELINE: SUGARS INTAKE FOR ADULTS AND CHILDREN, V0, P0
   Xi B, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093471
   Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563
NR 34
TC 118
Z9 131
U1 4
U2 41
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD JUL 15
PY 2015
VL 58
IS 7
BP 1474
EP 1483
DI 10.1007/s00125-015-3572-1
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CK8ZL
UT WOS:000356528900012
PM 25944371
DA 2025-04-28
ER

PT J
AU Klebanoff, MA
   Keim, SA
AF Klebanoff, Mark A.
   Keim, Sarah A.
TI Maternal Serum Paraxanthine During Pregnancy and Offspring Body Mass Index at Ages 4 and 7 Years
SO EPIDEMIOLOGY
LA English
DT Article
ID caffeine consumption; united-states; risk; metabolites; exposure; smoking; obesity; trends; women
AB Background: Obesity affects 18% of U. S. children. In a recent report, maternal consumption of >= 150 mg of caffeine per day during pregnancy was associated with increased odds for obesity in the offspring (odds ratio = 2.1 [95% confidence interval = 1.2-3.5]). If this association was causal, a considerable fraction of childhood obesity might be prevented by reduction of caffeine intake in pregnancy. Methods: We studied 1986 mother-child pairs who were controls from a case-control study of caffeine metabolites and spontaneous abortion nested within the Collaborative Perinatal Project. Women were pregnant during 1959-1966, and children were followed with visits at 48 and/or 84 months of age, when height and weight were measured according to a standardized protocol. Serum was drawn at <20 and >= 26 weeks' gestation and assayed for paraxanthine (caffeine's primary metabolite) by high-performance liquid chromatography. Relative risks of obesity (body mass index >= 95th percentile for age and sex) were estimated by log-binomial or Poisson regression and adjusted for maternal age, race, education, smoking, prepregnant weight, diabetes in pregnancy, and gestational age at blood draw. Results: Obesity prevalence was 11.7% at 48 months and 6.5% at 84 months. Associations of maternal serum paraxanthine and child obesity were nonlinear, and adjustment reduced the magnitude of all associations. The maximum relative risk (approximately 1.4) was for the association of paraxanthine drawn at <20 weeks with obesity at ages 48 and 84 months. Conclusion: This study does not support an increased risk of childhood obesity with increasing maternal caffeine consumption during pregnancy.
C1 Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA.
   Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University
RP Klebanoff, MA (corresponding author), Nationwide Childrens Hosp, Res Bldg 3,WB 5231,700 Childrens Dr, Columbus, OH 43215 USA.
EM mark.klebanoff@nationwidechildrens.org
CR ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310
   Unknown -, 1985, MALFORMATIONS CHILDR, V0, P0
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Branum AM, 2011, AM J EPIDEMIOL, V174, P1159, DOI 10.1093/aje/kwr250
   Buscariollo DL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087547
   Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841
   Diggle P, 1995, OXFORD STAT SCI SERI, V0, P0
   Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005
   Grosso LM, 2006, AM J EPIDEMIOL, V163, P1035, DOI 10.1093/aje/kwj125
   Hediger ML, 1998, PEDIATRICS, V102, P0, DOI 10.1542/peds.102.5.e60
   Hinkle S, 2014, BJOG, V0, P0, DOI DOI 10.111/1471-0528.12930
   Hoyt AT, 2014, MATERN CHILD HLTH J, V18, P1540, DOI 10.1007/s10995-013-1397-4
   Klebanoff MA, 1999, NEW ENGL J MED, V341, P1639, DOI 10.1056/NEJM199911253412202
   Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32
   Klebanoff MA, 1998, ANN EPIDEMIOL, V8, P107, DOI 10.1016/S1047-2797(97)00125-7
   Lassmann FM, 1980, EARLY CORRELATES SPE, V0, P0
   LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10
   Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3
   Li D-K, 2014, SOC PED PER EP RES S, V0, P0
   Martin Joyce A, 2007, NATL VITAL STAT REP, V56, P1
   McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074
   Niswander KR, 1972, DHEW PUBLICATION, V0, P0
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   PARSONS WD, 1978, CLIN PHARMACOL THER, V24, P40
   Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019
   Ribas-Fitó N, 2006, INT J EPIDEMIOL, V35, P853, DOI 10.1093/ije/dyl067
   Signorello LB, 2004, EPIDEMIOLOGY, V15, P229, DOI 10.1097/01.ede.0000112221.24237.0c
   Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 32
TC 10
Z9 12
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1044-3983
EI 1531-5487
J9 EPIDEMIOLOGY
JI Epidemiology
PD MAR 15
PY 2015
VL 26
IS 2
BP 185
EP 191
DI 10.1097/EDE.0000000000000220
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CB1PO
UT WOS:000349400300024
PM 25643099
DA 2025-04-28
ER

PT J
AU Ziegler, AM
   Temple, JL
AF Ziegler, Amanda M.
   Temple, Jennifer L.
TI Soda Consumption is Associated with Risk-Taking Behaviors in Adolescents
SO AMERICAN JOURNAL OF HEALTH BEHAVIOR
LA English
DT Article
DE risk taking; adolescents; caffeine; sugar sweetened beverages; soda
ID energy drink consumption; sweetened beverage consumption; united-states; substance use; reinforcement sensitivity; sensation seeking; brain-development; caffeine intake; alcohol-use; trajectory
AB Objectives: Soda consumption is on the rise among children and adolescents. The purpose of this study was to test the hypothesis that increased soda consumption predicts risk-taking behavior among high school students. Methods: To test this hypothesis, we used data from the 2011 Youth Risk Behavior Surveillance System to compare the odds of engaging in a series of risk-taking behaviors among students who reported no soda consumption, occasional soda consumption (1 - 6 times per week), and daily soda consumption (>= 7 times per week). Results: Daily soda consumption was associated with increased odds of engaging in 90% of the risk behaviors analyzed. In addition, there were sex differences in the magnitude of the relationships for many of these behaviors. Conclusions: These data suggest that in addition to increased risk of obesity, dental caries, and reduced sleep quality, soda consumption is associated with increased risk-taking behavior.
C1 [Ziegler, Amanda M.; Temple, Jennifer L.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.
   [Temple, Jennifer L.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA.
C3 State University of New York (SUNY) System; University at Buffalo, SUNY; State University of New York (SUNY) System; University at Buffalo, SUNY
RP Temple, JL (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.
EM jltemple@buffalo.edu
FU [RO1 DA030386]
CR Ahluwalia N, 2015, ADV NUTR, V6, P102, DOI 10.3945/an.114.007401
   Ahluwalia N, 2014, AM J CLIN NUTR, V100, P1124, DOI 10.3945/ajcn.113.082172
   Arcan C, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-263
   Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019
   Balconi M, 2014, J ADDICT MED, V8, P399, DOI 10.1097/ADM.0000000000000065
   Brener Nancy D, 2004, MORBIDITY AND MORTALITY WEEKLY REPORT, V53, P1
   Burrows T, 2013, NUTR REV, V71, P135, DOI 10.1111/nure.12005
   Chen TJH, 2005, MED HYPOTHESES, V65, P703, DOI 10.1016/j.mehy.2005.04.037
   Colder CR, 2002, J CONSULT CLIN PSYCH, V70, P976, DOI 10.1037/0022-006X.70.4.976
   Colder CR, 2001, HEALTH PSYCHOL, V20, P127, DOI 10.1037/0278-6133.20.2.127
   Colder CR, 2013, J RES ADOLESCENCE, V23, P345, DOI 10.1111/jora.12001
   Collado A, 2014, ADDICT BEHAV, V39, P1580, DOI 10.1016/j.addbeh.2014.01.024
   Dayan J, 2010, J PHYSIOL-PARIS, V104, P279, DOI 10.1016/j.jphysparis.2010.08.007
   Dickin KL, 2014, J ACAD NUTR DIET, V114, P945, DOI 10.1016/j.jand.2013.09.029
   Eaton DK, 2013, J ACAD NUTR DIET, V113, P1165, DOI 10.1016/j.jand.2013.05.013
   Emond JA, 2014, J PEDIATR-US, V165, P1194, DOI 10.1016/j.jpeds.2014.08.050
   Fagan AA, 2013, J QUANT CRIMINOL, V29, P347, DOI 10.1007/s10940-012-9183-9
   Fite PJ, 2006, ADDICT BEHAV, V31, P1454, DOI 10.1016/j.addbeh.2005.09.015
   Gage Julia C, 2005, J ADOLESC HEALTH, V37, P517, DOI 10.1016/j.jadohealth.2004.12.012
   Galvan A, 2010, FRONT HUM NEUROSCI, V4, P0, DOI 10.3389/neuro.09.006.2010
   Ginsburg KR, 2009, PEDIATRICS, V124, P1040, DOI 10.1542/peds.2008-3037
   Hamilton HA, 2013, CAN J PUBLIC HEALTH, V104, PE496, DOI 10.17269/cjph.104.3998
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Harrington S, 2008, J SCH NURS, V24, P3, DOI 10.1622/1059-8405(2008)024[0003:TROSBC]2.0.CO;2
   Haszard JJ, 2015, PUBLIC HEALTH NUTR, V18, P1036, DOI 10.1017/S1368980014001256
   Kann L, 2014, MMWR SURVEILL SUMM, V63, P1
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425
   Kuznetsova VB, 2015, PERSONAL MENT HEALTH, V9, P44, DOI 10.1002/pmh.1280
   Laghi F, 2015, EAT BEHAV, V17, P119, DOI 10.1016/j.eatbeh.2015.01.011
   Larson N, 2015, PUBLIC HEALTH NUTR, V0, P1
   Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008
   Lopez NV, 2012, J ACAD NUTR DIET, V112, P541, DOI 10.1016/j.jand.2011.11.013
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Marczinski CA, 2015, ADV NUTR, V6, P96, DOI 10.3945/an.114.007393
   Marczinski CA, 2013, ALCOHOL CLIN EXP RES, V37, P276, DOI 10.1111/j.1530-0277.2012.01868.x
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490
   Moreno-López L, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0049185
   Park S, 2013, AM J HEALTH BEHAV, V37, P414, DOI 10.5993/AJHB.37.3.14
   Scalese Marco, 2014, J ADDICT, V2014, P962178, DOI 10.1155/2014/962178
   Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616
   Snipes DJ, 2015, ADDICT BEHAV, V41, P136, DOI 10.1016/j.addbeh.2014.10.010
   Temple JL, 2014, PEDIATRICS, V134, PE112, DOI 10.1542/peds.2013-3962
   Temple Jennifer L, 2011, J CAFFEINE RES, V1, P41, DOI 10.1089/jcr.2011.0005
   Temple JL, 2009, BEHAV PHARMACOL, V20, P731, DOI 10.1097/FBP.0b013e328333b27c
   Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53
   Trapp GSA, 2014, DRUG ALCOHOL DEPEN, V134, P30, DOI 10.1016/j.drugalcdep.2013.09.006
   Trucco EM, 2011, ADDICT BEHAV, V36, P729, DOI 10.1016/j.addbeh.2011.02.008
   Vara AS, 2014, DEV COGN NEUROS-NETH, V10, P129, DOI 10.1016/j.dcn.2014.08.009
   Wang B, 2013, SOC SCI MED, V97, P161, DOI 10.1016/j.socscimed.2013.08.013
NR 51
TC 8
Z9 11
U1 0
U2 22
PU PNG PUBLICATIONS
PI OAK RIDGE
PA 2205-K OAK RIDGE RD, #115, OAK RIDGE, NC 27310 USA
SN 1945-7359
EI 
J9 AM J HEALTH BEHAV
JI Am. J. Health Behav.
PD NOV 15
PY 2015
VL 39
IS 6
BP 761
EP 771
DI 10.5993/AJHB.39.6.3
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DB1JN
UT WOS:000368264600003
PM 26450543
DA 2025-04-28
ER

PT J
AU Miller, J
   Lee, A
   Obersky, N
   Edwards, R
AF Miller, Jane
   Lee, Amanda
   Obersky, Natalie
   Edwards, Rachael
TI Implementation of A Better Choice Healthy Food and Drink Supply Strategy for staff and visitors in government-owned health facilities in Queensland, Australia
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Food supply; Hospitals; Health centres; Health facilities; Obesity; Australia
ID obesity prevention; interventions; environment; promotion; nutrition; program; schools
AB Objective: The present paper reports on a quality improvement activity examining implementation of A Better Choice Healthy Food and Drink Supply Strategy for Queensland Health Facilities (A Better Choice). A Better Choice is a policy to increase supply and promotion of healthy foods and drinks and decrease supply and promotion of energy-dense, nutrient-poor choices in all food supply areas including food outlets, staff dining rooms, vending machines, tea trolleys, coffee carts, leased premises, catering, fundraising, promotion and advertising. Design: An online survey targeted 278 facility managers to collect self-reported quantitative and qualitative data. Telephone interviews were sought concurrently with the twenty-five A Better Choice district contact officers to gather qualitative information. Setting: Public sector-owned and -operated health facilities in Queensland, Australia. Subjects:One hundred and thirty-four facility managers and twenty-four district contact officers participated with response rates of 48.2 % and 96.0 %, respectively. Results: Of facility managers, 78.4 % reported implementation of more than half of the A Better Choice requirements including 24.6 % who reported full strategy implementation. Reported implementation was highest in food outlets, staff dining rooms, tea trolleys, coffee carts, internal catering and drink vending machines. Reported implementation was more problematic in snack vending machines, external catering, leased premises and fundraising. Conclusions: Despite methodological challenges, the study suggests that policy approaches to improve the food and drink supply can be implemented successfully in public-sector health facilities, although results can be limited in some areas. A Better Choice may provide a model for improving food supply in other health and workplace settings.
C1 [Miller, Jane; Obersky, Natalie; Edwards, Rachael] Queensland Hlth, Prevent Hlth Unit, Fortitude Valley Bc, Qld 4006, Australia.
   [Lee, Amanda] Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia.
   [Lee, Amanda] Queensland Univ Technol, Sch Exercise & Nutr Sci, Kelvin Grove, Qld, Australia.
C3 Queensland Health; Queensland University of Technology (QUT); Queensland University of Technology (QUT)
RP Miller, J (corresponding author), Queensland Hlth, Prevent Hlth Unit, POB 2368, Fortitude Valley Bc, Qld 4006, Australia.
EM janemiller.au@gmail.com
FU Queensland Health
CR Anderson LM, 2009, AM J PREV MED, V37, P340, DOI 10.1016/j.amepre.2009.07.003
   Australian Bureau of Statistics, 2012, 2011 CENS QUICKST QU, V0, P0
   Devine CM, 2007, OBESITY, V15, P57S, DOI 10.1038/oby.2007.388
   Dick M, 2012, EUR J CLIN NUTR, V66, P1124, DOI 10.1038/ejcn.2012.108
   Engbers LH, 2005, AM J PREV MED, V29, P61, DOI 10.1016/j.amepre.2005.03.001
   Franco L, 2005, AUST NZ J PUBL HEAL, V29, P189, DOI 10.1111/j.1467-842X.2005.tb00074.x
   Goetzel RZ, 2009, J OCCUP ENVIRON MED, V51, P125, DOI 10.1097/JOM.0b013e3181954b03
   Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5
   Healthy Fundraising Australia, 2012, SCH FUNDR ID, V0, P0
   Heinen L, 2009, MILBANK Q, V87, P101, DOI 10.1111/j.1468-0009.2009.00549.x
   Kelly B, 2012, HEALTH PROMOT J AUST, V23, P73, DOI 10.1071/HE12073
   Kelly B, 2011, HEALTH PROMOT INT, V26, P188, DOI 10.1093/heapro/daq061
   Kelly B, 2010, AUST NZ J PUBL HEAL, V34, P583, DOI 10.1111/j.1753-6405.2010.00619.x
   Lawrence S, 2009, PEDIATRICS, V123, PS287, DOI 10.1542/peds.2008-2780G
   Living Fundraisers, 2012, SMART HEALTH MOR PRO, V0, P0
   Nutrition Australia, 2011, FUNDR ID HLTH KIDS, V0, P0
   Pratt CA, 2007, OBESITY, V15, P2171, DOI 10.1038/oby.2007.258
   Public Service Commission, 2011, QUEENSL PUBL SERV WO, V0, P0
   Queensland Association of School Tuckshops Inc, 2005, FRESH ID FUNDR, V0, P0
   Queensland Government, 2011, INT FACTS QUEENSL, V0, P0
   Queensland Government, 2010, HLTH CHOIC CAT, V0, P0
   Queensland Health, 2011, A BETT CHOIC, V0, P0
   Queensland Health, 2007, BETT CHOIC HLTH FOOD, V0, P0
   Queensland Health, 2011, QUEENSL HLTH STRAT P, V0, P0
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Wharton CM, 2008, J SCHOOL HEALTH, V78, P245, DOI 10.1111/j.1746-1561.2008.00296.x
   Whitehead D, 2004, HEALTH PROMOT INT, V19, P259, DOI 10.1093/heapro/dah213
NR 29
TC 20
Z9 20
U1 2
U2 18
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUN 15
PY 2015
VL 18
IS 9
BP 1602
EP 1609
DI 10.1017/S1368980013003455
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA CJ1UZ
UT WOS:000355271400013
PM 24476797
DA 2025-04-28
ER

PT J
AU Ma, YJ
   Gao, MM
   Liu, DX
AF Ma, Yongjie
   Gao, Mingming
   Liu, Dexi
TI Chlorogenic Acid Improves High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Chlorogenic acid (CGA); Hepatic steatosis; Inflammation; Insulin resistance; Obesity
ID ppar-gamma; induced obesity; coffee consumption; oxidative stress; gene-expression; caffeic acid; liver; inflammation; rats; overexpression
AB Purpose Chlorogenic acid (CGA), the most abundant component in coffee, has exhibited many biological activities. The objective of this study is to assess preventive and therapeutic effects of CGA on obesity and obesity-related liver steatosis and insulin resistance. Methods Two sets of experiments were conducted. In set I, 6-week old C57BL/6 mice were fed a regular chow or high-fat diet (HFD) for 15 weeks with twice intra-peritoneal (IP) injection of CGA (100 mg/kg) or DMSO (carrier solution) per week. In set 2, obese mice (average 50 g) were treated by CGA (100 mg/kg, IP, twice weekly) or DMSO for 6 weeks. Body weight, body composition and food intake were monitored. Blood glucose, insulin and lipid levels were measured at end of the study. Hepatic lipid accumulation and glucose homeostasis were evaluated. Additionally, genes involved in lipid metabolism and inflammation were analyzed by real time PCR. Results CGA significantly blocked the development of diet-induced obesity but did not affect body weight in obese mice. CGA treatment curbed HFD-induced hepatic steatosis and insulin resistance. Quantitative PCR analysis shows that CGA treatment suppressed hepatic expression of Ppar gamma, Cd36, Fabp4, and Mgot I gene. CGA treatment also attenuated inflammation in the liver and white adipose tissue accompanied by a decrease in mRNA levels of macrophage marker genes including F4/80, Cd68, Cd11b, Cd11c, and Tnf alpha, Mcp-1 and Ccr2 encoding inflammatory proteins. Conclusion Our study provides direct evidence in support of CGA as a potent compound in preventing diet-induced obesity and obesity-related metabolic syndrome. Our results suggest that drinking coffee is beneficial in maintaining metabolic homeostasis when on a high fat diet.
C1 [Ma, Yongjie; Gao, Mingming; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.
C3 University System of Georgia; University of Georgia
RP Liu, DX (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Room 450 Pharm South,250 West Green St, Athens, GA 30602 USA.
EM dliu@uga.edu
FU National Institute of Health [RO1EB007357, RO1HL098295]
CR Ahrens MJ, 2013, J MED FOOD, V16, P211, DOI 10.1089/jmf.2012.0069
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bu L, 2013, AAPS J, V15, P1001, DOI 10.1208/s12248-013-9501-7
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cortés VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002
   Cui R, 2014, GENE THER, V21, P840, DOI 10.1038/gt.2014.64
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gao MM, 2014, J CONTROL RELEASE, V185, P1, DOI 10.1016/j.jconrel.2014.03.047
   Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1
   Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Karthikesan K, 2010, J FUNCT FOODS, V2, P134, DOI 10.1016/j.jff.2010.04.001
   Kim Y, 2010, BIOTECHNOL J, V5, P99, DOI 10.1002/biot.200900228
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109
   Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7
   Ma YJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038734
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Monteiro R, 2010, MEDIAT INFLAMM, V2010, P0, DOI 10.1155/2010/289645
   Morán-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505
   Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
   Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037
NR 40
TC 163
Z9 172
U1 3
U2 57
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD APR 15
PY 2015
VL 32
IS 4
BP 1200
EP 1209
DI 10.1007/s11095-014-1526-9
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA CD6AG
UT WOS:000351169800003
PM 25248334
DA 2025-04-28
ER

PT J
AU Deliens, T
   Clarys, P
   De Bourdeaudhuij, I
   Deforche, B
AF Deliens, Tom
   Clarys, Peter
   De Bourdeaudhuij, Ilse
   Deforche, Benedicte
TI Correlates of University Students' Soft and Energy Drink Consumption According to Gender and Residency
SO NUTRIENTS
LA English
DT Article
ID sugar-sweetened beverage; type-2 diabetes-mellitus; weight-gain; determinants; obesity; metaanalysis; patterns; caffeine; fructose; behavior
AB This study assessed personal and environmental correlates of Belgian university students' soft and energy drink consumption and investigated whether these associations were moderated by gender or residency. Four hundred twenty-five university students completed a self-reported on-line questionnaire assessing socio-demographics, health status, soft and energy drink consumption, as well as personal and environmental factors related to soft and energy drink consumption. Multiple linear regression analyses were conducted. Students believing soft drink intake should be minimized (individual subjective norm), finding it less difficult to avoid soft drinks (perceived behavioral control), being convinced they could avoid soft drinks in different situations (self-efficacy), having family and friends who rarely consume soft drinks (modelling), and having stricter family rules about soft drink intake were less likely to consume soft drinks. Students showing stronger behavioral control, having stricter family rules about energy drink intake, and reporting lower energy drink availability were less likely to consume energy drinks. Gender and residency moderated several associations between psychosocial constructs and consumption. Future research should investigate whether interventions focusing on the above personal and environmental correlates can indeed improve university students' beverage choices.
C1 [Deliens, Tom; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Dept Human Biometry & Biomech, B-1050 Brussels, Belgium.
   [De Bourdeaudhuij, Ilse; Deforche, Benedicte] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.
C3 Vrije Universiteit Brussel; Ghent University
RP Deliens, T (corresponding author), Vrije Univ Brussel, Dept Human Biometry & Biomech, Pl Laan 2, B-1050 Brussels, Belgium.
EM Tom.Deliens@vub.ac.be; pclarys@vub.ac.be; ilse.debourdeaudhuij@ugent.be; Benedicte.Deforche@vub.ac.be
CR Aguinis H, 2005, J APPL PSYCHOL, V90, P94, DOI 10.1037/0021-9010.90.1.94
   Aiken LS, 1991, MULTIPLE REGRESSION: TESTING AND INTERPRETING INTERACTIONS, V0, P0
   Ajzen I, 1985, ACTION CONTROL COGNI, V0, PP11, DOI 10.1007/978-3-642-69746-32
   Unknown -, 1986, SOCIAL FOUNDATIONS OF THOUGHT AND ACTION, V0, P0, DOI DOI 10.5465/AMR.1987.4306538
   Aranda M, 2006, J CHROMATOGR A, V1131, P253, DOI 10.1016/j.chroma.2006.07.018
   Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008
   Bere E, 2008, PUBLIC HEALTH NUTR, V11, P49, DOI 10.1017/S1368980007000122
   Block JP, 2013, J ADOLESCENT HEALTH, V52, P702, DOI 10.1016/j.jadohealth.2012.11.017
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Brunt AR, 2008, APPETITE, V51, P615, DOI 10.1016/j.appet.2008.04.019
   Burrows T, 2013, NUTR REV, V71, P135, DOI 10.1111/nure.12005
   Campbell B, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-1
   Crombie AP, 2009, NUTR REV, V67, P83, DOI 10.1111/j.1753-4887.2008.00143.x
   Deliens T, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-53
   Deliens T, 2013, APPETITE, V65, P111, DOI 10.1016/j.appet.2013.01.024
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   El Ansari W, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-28
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   Ezendam NPM, 2010, BRIT J NUTR, V103, P768, DOI 10.1017/S0007114509992297
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Hattersley L, 2009, PUBLIC HEALTH NUTR, V12, P1816, DOI 10.1017/S136898000800462X
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Hoge Gezondheidsraad, 2021, STAND VAN OMICS-TECHNOLOGIEEN EN HUN KLINISCHE TOEPASSING (ADVIES VAN DE HOGE GEZONDHEIDSRAAD NO. 9477), V0, P0
   Kelly NR, 2013, J NUTR EDUC BEHAV, V45, P304, DOI 10.1016/j.jneb.2012.10.012
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Malinauskas BM, 2007, NUTR J, V6, P0, DOI 10.1186/1475-2891-6-35
   Mullie P, 2009, MIL MED, V174, P852, DOI 10.7205/MILMED-D-00-1409
   Nelson MC, 2009, J NUTR EDUC BEHAV, V41, P287, DOI 10.1016/j.jneb.2008.05.005
   Pereira MA, 2013, CURR ATHEROSCLER REP, V15, P0, DOI 10.1007/s11883-013-0375-z
   Pettit ML, 2011, J AM COLL HEALTH, V59, P335, DOI 10.1080/07448481.2010.510163
   Prestwich A, 2014, HEALTH PSYCHOL REV, V8, P270, DOI 10.1080/17437199.2013.813729
   Reid SD, 2015, J EPIDEMIOL GLOB HEA, V5, P103, DOI 10.1016/j.jegh.2014.05.004
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Renner B, 2012, HEALTH PSYCHOL, V31, P306, DOI 10.1037/a0025302
   Rush E, 2006, ASIA PAC J CLIN NUTR, V15, P242
   Sakurai M, 2014, EUR J NUTR, V53, P251, DOI 10.1007/s00394-013-0523-9
   Sallis JF, 2002, ECOLOGICAL MODELS OF HEALTH BEHAVIOR, V3rd, P0
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Tak NI, 2011, APPETITE, V56, P503, DOI 10.1016/j.appet.2011.01.013
   Vandelanotte C, 2004, HEALTH PROMOT INT, V19, P463, DOI 10.1093/heapro/dah408
   Vella-Zarb RA, 2009, J AM COLL HEALTH, V58, P161, DOI 10.1080/07448480903221392
   Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x
   West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210
   Yang CC, 2010, APPETITE, V54, P512, DOI 10.1016/j.appet.2010.02.004
NR 44
TC 16
Z9 23
U1 1
U2 42
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG 15
PY 2015
VL 7
IS 8
BP 6550
EP 6566
DI 10.3390/nu7085298
PG 17
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CQ4PQ
UT WOS:000360587500030
PM 26258790
DA 2025-04-28
ER

PT J
AU Nowak, D
   Jasionowski, A
AF Nowak, Dariusz
   Jasionowski, Artur
TI Analysis of the Consumption of Caffeinated Energy Drinks among Polish Adolescents
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article; Proceedings Paper
DE adolescents; caffeine; dependence; energy drink; overdose
ID alcohol-consumption; patterns; risk; associations; children
AB Background: Energy drinks (EDs) are extremely popular among adults and adolescents. Regular intake of EDs may lead to an overdose of caffeine, loss of bone mass, overweight, hypertension and, in older age, osteoporosis and cardiovascular diseases. Some people mix EDs with alcohol, which adversely affects their health. The objective of this study was to analyze the consumption of EDs by adolescents. Methods: The study consisted of a questionnaire surveying amounts of drinks, preferences and product awareness among younger consumers. The study was carried out in junior and senior high schools in Poland (n = 2629). Results: EDs were consumed by 67% of students (quite frequently by 16%). Students who practiced sports were more willing to drink EDs. Also, boys drank them more often than girls. When selecting a particular ED, young people looked at the taste, price and effect. Most respondents consumed one ED (250 mL) daily, although there were individuals consuming two or more drinks daily. Most respondents knew the ingredients of EDs, and 24% admitted to mixing EDs with alcohol. Conclusions: EDs are extremely popular among adolescents. Young people drinking EDs every day are potentially at risk of taking an overdose of caffeine.
C1 [Nowak, Dariusz] Nicolaus Copernicus Univ Torun, Dept Nutr & Dietet, Fac Hlth Sci, Ludwik Rydygier Collegium Medicum Bydgoszcz, PL-85626 Bydgoszcz, Poland.
   [Jasionowski, Artur] Nicolaus Copernicus Univ Torun, Dept Theoret Fdn Biomed Sci & Med Informat, Fac Pharm, Ludwik Rydygier Collegium Medicum Bydgoszcz, PL-85626 Bydgoszcz, Poland.
C3 Nicolaus Copernicus University; Nicolaus Copernicus University
RP Nowak, D (corresponding author), Nicolaus Copernicus Univ Torun, Dept Nutr & Dietet, Fac Hlth Sci, Ludwik Rydygier Collegium Medicum Bydgoszcz, Debowa 3, PL-85626 Bydgoszcz, Poland.
EM d.nowak@cm.umk.pl
CR Aguilar F, 2009, EFSA J, V7, P0, DOI 10.2903/j.efsa.2009.1327
   Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x
   Azagba Sunday, 2013, CMAJ OPEN, V1, PE19, DOI 10.9778/cmajo.20120017
   Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019
   Azsagba S, 2014, PREV MED, V61, P26, DOI 10.1016/j.ypmed.2014.01.013
   Banda C, 2010, J AM DENT ASSOC S, V110, P0, DOI 10.1016/j.jada.2010.06.407
   Bigard AX, 2010, ARCH PEDIATRIE, V17, P1625, DOI 10.1016/j.arcped.2010.08.001
   Bonar EE, 2015, ADDICT BEHAV, V43, P11, DOI 10.1016/j.addbeh.2014.11.023
   Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, P0, DOI 10.3389/fpubh.2014.00134
   Ferreira SE, 2006, ALCOHOL CLIN EXP RES, V30, P598, DOI 10.1111/j.1530-0277.2006.00070.x
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Kapner Ari, 2004, EPHEDRA ENERGY DRINK, V0, P0
   Lau-Barraco C, 2014, ADDICT BEHAV, V39, P308, DOI 10.1016/j.addbeh.2013.10.017
   Malinauskas BM, 2007, NUTR J, V6, P0, DOI 10.1186/1475-2891-6-35
   Martz ME, 2015, J ADOLESCENT HEALTH, V56, P557, DOI 10.1016/j.jadohealth.2015.01.019
   Miller Kathleen E, 2012, J CAFFEINE RES, V2, P62, DOI 10.1089/jcr.2012.0015
   Morgan K J, 1982, REGUL TOXICOL PHARMACOL, V2, P296, DOI 10.1016/0273-2300(82)90003-4
   OBrien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Poulos NS, 2016, HEALTH EDUC J, V75, P318, DOI 10.1177/0017896915578299
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Snipes DJ, 2015, ADDICT BEHAV, V41, P136, DOI 10.1016/j.addbeh.2014.10.010
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Walsh MJ, 2006, CLIN TOXICOL, V44, P642
   Weldy DL, 2010, J AM BOARD FAM MED, V23, P555, DOI 10.3122/jabfm.2010.04.090261
NR 26
TC 68
Z9 73
U1 1
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL 15
PY 2015
VL 12
IS 7
BP 7910
EP 7921
DI 10.3390/ijerph120707910
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health
GA CO7MB
UT WOS:000359342300056
PM 26184263
DA 2025-04-28
ER

PT J
AU Kempf, K
   Kolb, H
   Gärtner, B
   Bytof, G
   Stiebitz, H
   Lantz, I
   Lang, R
   Hofmann, T
   Martin, S
AF Kempf, Kerstin
   Kolb, Hubert
   Gaertner, Babette
   Bytof, Gerhard
   Stiebitz, Herbert
   Lantz, Ingo
   Lang, Roman
   Hofmann, Thomas
   Martin, Stephan
TI Cardiometabolic effects of two coffee blends differing in content for major constituents in overweight adults: a randomized controlled trial
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; N-methylpyridinium; Coffee and health; Coffee and body weight
ID pathway in-vitro; chlorogenic acid; blood-pressure; weight-loss; n-methylpyridinium; glucose-tolerance; adipose-tissue; risk; consumption; metaanalysis
AB Purpose The hypothesis was tested that coffee types differing in content of major constituents also differ with regard to cardiometabolic effects. Methods Overweight persons (n = 118) were randomized to consume a dark roast [rich in N-methylpyridinium (NMP)] or medium roast (rich in caffeoylquinic acids, trigonelline) coffee blend for 3 months, after a washout period of 4 weeks. Before and after the intervention period, body weight and 15 further general and biochemical parameters were determined. Results Participants consumed an average of 4-5 cups per day. Mean body weight, body mass index and waist circumference did not change during the coffee consumption phase in either of the study groups. Systolic blood pressure decreased in the dark roast coffee group only (p < 0.05). High-density lipoprotein cholesterol levels increased in the medium roast coffee group only, and triglyceride levels increased in the dark roast coffee group only. Glucoregulation and insulin levels were not affected, although there was a small increase of hemoglobin A1c values in both groups. An increase of adiponectin levels occurred in the medium roast coffee group only and was negatively associated with NMP concentrations. Differences did not remain statistically significant after correction for multiple testing. Conclusion Medium and dark roast coffee blends exert small but possibly relevant different cardiometabolic effects. Further studies of health outcomes in relation to coffee constituents seem warranted.
C1 [Kempf, Kerstin; Kolb, Hubert; Gaertner, Babette; Martin, Stephan] West German Ctr Diabet & Hlth, Dusseldorf Cathol Hosp Grp, D-40591 Dusseldorf, Germany.
   [Bytof, Gerhard; Stiebitz, Herbert; Lantz, Ingo] Tchibo GmbH, Hamburg, Germany.
   [Lang, Roman; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, D-85354 Freising Weihenstephan, Germany.
C3 Technical University of Munich
RP Kempf, K (corresponding author), West German Ctr Diabet & Hlth, Dusseldorf Cathol Hosp Grp, Hohensandweg 37, D-40591 Dusseldorf, Germany.
EM kerstin.kempf@wdgz.de
FU Tchibo GmbH, Germany
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Boekschoten M V, 2006, NED TIJDSCHR GENEESKD, V150, P2873
   Boettler U, 2012, MOL BIOL REP, V39, P7155, DOI 10.1007/s11033-012-1547-6
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Chikama A, 2008, J HEALTH SCI, V54, P162, DOI 10.1248/jhs.54.162
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Gómez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080
   Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Lang R, 2012, ACS S SERIES, V0, P0
   Lang R, 2011, MOL NUTR FOOD RES, V55, P1613, DOI 10.1002/mnfr.201000656
   Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k
   Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226
   Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976
   Liu J, 2013, MAYO CLIN P, V0, P0
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Moisey LL, 2010, BRIT J NUTR, V103, P833, DOI 10.1017/S0007114509992406
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ohnaka K, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/207426
   Perrone D, 2010, J AGR FOOD CHEM, V58, P12238, DOI 10.1021/jf102110u
   RATNAYAKE WMN, 1993, FOOD CHEM TOXICOL, V31, P263, DOI 10.1016/0278-6915(93)90076-B
   Rebello SA, 2013, CURR CARDIOL REP, V15, P0, DOI 10.1007/s11886-013-0403-1
   Smrke S, 2013, FOOD FUNCT, V4, P1082, DOI 10.1039/c3fo30377b
   Speer Karl, 2006, BRAZ. J. PLANT PHYSIOL., V18, P201, DOI 10.1590/S1677-04202006000100014
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Weiss C, 2010, J AGR FOOD CHEM, V58, P1976, DOI 10.1021/jf903614d
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
NR 47
TC 37
Z9 39
U1 0
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD AUG 15
PY 2015
VL 54
IS 5
BP 845
EP 854
DI 10.1007/s00394-014-0763-3
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CN1PG
UT WOS:000358191500017
PM 25204719
DA 2025-04-28
ER

PT J
AU Cicero, AFG
   Rosticci, M
   Parini, A
   Morbini, M
   Urso, R
   Grandi, E
   Borghi, C
AF Cicero, Arrigo F. G.
   Rosticci, Martina
   Parini, Angelo
   Morbini, Martino
   Urso, Riccardo
   Grandi, Elisa
   Borghi, Claudio
TI Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial
SO NUTRITION JOURNAL
LA English
DT Article
DE Berberine; Chlorogenic acid; Nutraceutical; Insulin-sensitivity; Lipoproteins; Liver steatosis
ID metabolic syndrome; chlorogenic acid; preclinical evidences; cardiovascular risk; coffee consumption; disease; overweight; berberine; obesity; diet
AB Background: Overweight subjects easily develop alterations of the glucose and lipid metabolism and are exposed to an increased cardiometabolic risk. This condition is potentially reversible through the improvement of dietary and behavioural habits. However, a well-assembled nutraceutical would be a useful tool to better improve the metabolic parameters associated to overweight and insulin resistance. Methods: To evaluate the effect of a combined nutraceutical containing berberine, chlorogenic acid and tocotrienols, we performed a double blind, cross-over designed trial versus placebo, in 40 overweight subjects with mixed hyperlipidaemia. After the first 8 weeks of treatment (or placebo), patients were asked to observe a 2-week washout period, and they were then assigned to the alternative treatment for a further period of 8 weeks. Clinical and laboratory data associated to hyperlipidaemia and insulin resistance have been obtained at the baseline, at the end of the first treatment period, after the washout, and again after the second treatment period. Results: Both groups experienced a significant improvement of anthropometric and biochemical parameters versus baseline. However, total cholesterol, LDL cholesterol, triglycerides, non-HDL cholesterol, fasting insulin, HOMA-IR, GOT and Lipid Accumulation Product decreased more significantly in the nutraceutical group versus placebo. Conclusions: This combination seems to improve a large number of metabolic and liver parameters on the short-term in overweight subjects. Further studies are needed to confirm these observations on the middle-and long-term.
C1 [Cicero, Arrigo F. G.; Rosticci, Martina; Parini, Angelo; Morbini, Martino; Urso, Riccardo; Grandi, Elisa; Borghi, Claudio] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
   [Cicero, Arrigo F. G.] Hypertens Res Ctr, I-40138 Bologna, Italy.
C3 University of Bologna
RP Cicero, AFG (corresponding author), Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
EM afgcicero@cardionet.it
CR Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6
   BORNER K, 1977, J CLIN CHEM CLIN BIO, V15, P121
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Cicero AFG, 2013, CURR TOP NUTRACEUT R, V11, P41
   Cicero AF, 2014, CURR VASC PHARMACOL, V12, P565, DOI 10.2174/15701611113119990120
   Cicero AF, 2009, CLIN LIPIDOL, V4, P553, DOI 10.2217/CLP.09.41
   Cicero AFG, 2013, INTERN EMERG MED, V8, P265, DOI 10.1007/s11739-012-0875-9
   Cicero AFG, 2010, J WOMENS HEALTH, V19, P133, DOI 10.1089/jwh.2008.1268
   Conroy KP, 2011, P NUTR SOC, V70, P426, DOI 10.1017/S0029665111001662
   Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014
   Ebbert JO, 2014, CURR ATHEROSCLER REP, V16, P0, DOI 10.1007/s11883-014-0445-x
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gruben N, 2014, BBA-MOL BASIS DIS, V1842, P2329, DOI 10.1016/j.bbadis.2014.08.004
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   Kaur J, 2014, CARDIOL RES PRACT, V2014, P0, DOI 10.1155/2014/943162
   Kones Richard, 2014, HOSP PRACT (1995), V42, P92, DOI 10.3810/hp.2014.02.1096
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Magrone T, 2013, CAN J PHYSIOL PHARM, V91, P387, DOI 10.1139/cjpp-2012-0307
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nseir W, 2014, WORLD J GASTROENTERO, V20, P9338, DOI 10.3748/wjg.v20.i28.9338
   Oboh Ganiyu, 2015, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V26, P165, DOI 10.1515/jbcpp-2013-0141
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Rueda-Clausen CF, 2014, BMJ-BRIT MED J, V348, P0, DOI 10.1136/bmj.g3526
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Wahlefeld AW, 1974, METHODS ENZYMATIC AN, V2nd, P18
   Yang Z, 2014, MED CARE, V52, P658, DOI 10.1097/MLR.0000000000000154
NR 28
TC 27
Z9 26
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2891
EI 
J9 NUTR J
JI Nutr. J.
PD MAR 28
PY 2015
VL 14
IS 
BP 
EP 
DI 10.1186/s12937-015-0019-y
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CG8CF
UT WOS:000353534100001
PM 25886384
DA 2025-04-28
ER

PT J
AU Beam, JR
   Gibson, AL
   Kerksick, CM
   Conn, CA
   White, AC
   Mermier, CM
AF Beam, Jason R.
   Gibson, Ann L.
   Kerksick, Chad M.
   Conn, Carole A.
   White, Ailish C.
   Mermier, Christine M.
TI Effect of post-exercise caffeine and green coffee bean extract consumption on blood glucose and insulin concentrations
SO NUTRITION
LA English
DT Article
DE Chlorogenic acid; Oral glucose tolerance test; Cycling, glycogen; Carbohydrate; Insulin sensitivity index
ID chlorogenic acid; carbohydrate; muscle; ingestion; exercise; resynthesis; metabolism; overweight
AB Objective: The aim of this study was to investigate the effects of ingesting caffeine and green coffee bean extract on blood glucose and insulin concentrations during a post-exercise oral glucose tolerance test. Methods: Ten male cyclists (age: 26 +/- 5 y; height: 179.9 +/- 5.4 cm; weight: 77.6 +/- 13.3 kg; body mass index: 24 +/- 4.3 kg/m(2); VO2 peak: 55.9 +/- 8.4 mL.kg.min(-1)) participated in this study. In a randomized order, each participant completed three 30-min bouts of cycling at 60% of peak power output. Immediately after exercise, each participant consumed 75 g of dextrose with either 5 mg/kg body weight of caffeine, 10 mg/kg of green coffee bean extract (5 mg/kg chlorogenic acid), or placebo. Venous blood samples were collected immediately before and after exercise during completion of the oral glucose tolerance test. Results: No significant time x treatment effects for blood glucose and insulin were found. Two-h glucose and insulin area under the curve values, respectively, for the caffeine (658 +/- 74 mmol/L and 30,005 +/- 13,304 pmol/L), green coffee bean extract (637 +/- 100 mmol/L and 31,965 +/- 23,586 pmol/L), and placebo (661 +/- 77 mmol/L and 27,020 +/- 12,339 pmol/L) trials were not significantly different (P > 0.05). Conclusion: Caffeine and green coffee bean extract did not significantly alter postexercise blood glucose and insulin concentrations when compared with a placebo. More human research is needed to determine the impact of these combined nutritional treatments and exercise on changes in blood glucose and insulin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Beam, Jason R.; Gibson, Ann L.; White, Ailish C.; Mermier, Christine M.] Univ New Mexico, Dept Hlth Exercise & Sports Sci, Albuquerque, NM 87131 USA.
   [Kerksick, Chad M.] Lindenwood Univ, Sch Sport Recreat & Exercise Sci, Dept Exercise Sci, St Charles, MO USA.
   [Conn, Carole A.] Univ New Mexico, Dept Individual Family & Commun Educ, Albuquerque, NM 87131 USA.
C3 University of New Mexico; University of New Mexico
RP Beam, JR (corresponding author), Univ New Mexico, Dept Hlth Exercise & Sports Sci, Albuquerque, NM 87131 USA.
EM Jason.beam@sfcc.edu
FU university Academic Provost, College of Education, Graduate and Professional Student Association; university Graduate School, and Department of Health, Exercise & Sports Sciences
CR Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Battram DS, 2004, J APPL PHYSIOL, V96, P943, DOI 10.1152/japplphysiol.00745.2003
   Beelen M, 2012, MED SCI SPORT EXER, V44, P692, DOI 10.1249/MSS.0b013e31823a40ef
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130
   Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000
   Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Pedersen DJ, 2008, J APPL PHYSIOL, V105, P7, DOI 10.1152/japplphysiol.01121.2007
   Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P1284, DOI 10.1139/H08-121
   Taylor C, 2011, INT J SPORT NUTR EXE, V21, P410, DOI 10.1123/ijsnem.21.5.410
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Thong FSL, 2002, DIABETES, V51, P583, DOI 10.2337/diabetes.51.3.583
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
NR 22
TC 16
Z9 19
U1 0
U2 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB 15
PY 2015
VL 31
IS 2
BP 292
EP 297
DI 10.1016/j.nut.2014.07.012
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CA0WD
UT WOS:000348633400004
PM 25592006
DA 2025-04-28
ER

PT J
AU Tsiga, E
   Panagopoulou, E
   Niakas, D
AF Tsiga, E.
   Panagopoulou, E.
   Niakas, D.
TI Health promotion across occupational groups: one size does not fit all
SO OCCUPATIONAL MEDICINE-OXFORD
LA English
DT Article
DE Health behaviours; health promotion; lifestyles; physical activity; smoking
ID body-mass index; working-conditions; physical-activity; job stress; nurses; risk; men; behaviors; obesity; sample
AB Background Although several studies have examined the link between specific working conditions and health behaviours, very few have comparatively assessed the health behaviours of different occupational groups. Aims To compare protective and risky health behaviours among police officers, ambulance workers, hospital staff (doctors and nurses) and office workers, prompted by the need to identify key areas for interventions tailored to the needs of different occupational groups. Methods A cross-sectional postal survey using the Health Behaviours Inventory, assessing health behaviours which are risky (alcohol intake, smoking, coffee consumption, fast food meals and painkiller consumption) and protective (physical activity, eating breakfast and hours of sleep). Results The sample consisted of 1451 employees. Ambulance workers smoked the most cigarettes per day (F-(4,F-1405) = 8.63, P < 0.01), while doctors consumed twice as many fast food meals as any other occupational group (F-(4,F-1415) = 78.45, P < 0.01) and had the highest daily caffeine consumption (F-(4,F-1440) = 11.17, P < 0.01). Ambulance workers and doctors reported the highest frequency of alcohol consumption per week (F-(4,F-1421) = 10.13, P < 0.01). In regard to protective health behaviours, office workers reported the highest number of breakfast meals per week (F-(4,F-1431) = 5.7, P < 0.01) and sleeping hours per night (F-(4,F-1438) = 170.34, P < 0.01), while police officers and ambulance workers exercised more frequently (F-(4,F-1420) = 5.764, P < 0.01). Conclusions The results of the study highlight key priorities for health promotion for different occupational groups which need to be taken into consideration in policy making and developing workplace interventions.
C1 [Tsiga, E.; Panagopoulou, E.] Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, GR-4124 Thessaloniki, Greece.
   [Niakas, D.] Hellenic Open Univ, Sch Social Sci, GR-4124 Thessaloniki, Greece.
C3 Aristotle University of Thessaloniki
RP Panagopoulou, E (corresponding author), Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, Hyg Lab, 4th Floor, GR-4124 Thessaloniki, Greece.
EM efharis@the.forthnet.gr
CR Atkinson G, 2008, SPORTS MED, V38, P671, DOI 10.2165/00007256-200838080-00005
   Callaghan P, 1999, J ADV NURS, V29, P28
   Cares A, 2015, SUBST ABUS, V36, P59, DOI 10.1080/08897077.2014.933725
   Croezen S, 2009, EUR J CLIN NUTR, V63, P405, DOI 10.1038/sj.ejcn.1602950
   Dobson M, 2013, AM J IND MED, V56, P776, DOI 10.1002/ajim.22151
   Frank E, 2009, CAN FAM PHYSICIAN, V55, P810
   Hemmingsson T, 1997, INT J EPIDEMIOL, V26, P584, DOI 10.1093/ije/26.3.584
   IBM Corp, 2011, IBM SPSS STATISTICS, V0, P0
   JARVIS MJ, 1993, PSYCHOPHARMACOLOGY, V110, P45, DOI 10.1007/BF02246949
   Kageyama T, 1998, IND HEALTH, V36, P263, DOI 10.2486/indhealth.36.263
   Kirkcaldy BD, 1997, INT J STRESS MANAGE, V4, P79
   Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, P0, DOI 10.1186/1471-2458-6-24
   Kumlin L, 2001, J INTERN MED, V249, P315, DOI 10.1046/j.1365-2796.2001.00817.x
   Lallukka T, 2004, PREV MED, V38, P48, DOI 10.1016/j.ypmed.2003.09.027
   Mekary RA, 2012, AM J CLIN NUTR, V95, P1182, DOI 10.3945/ajcn.111.028209
   Morikawa Y, 2007, SCAND J WORK ENV HEA, V33, P45, DOI 10.5271/sjweh.1063
   Moustou I, 2010, OPEN OCCUP HLTH SAF, V2, P16, DOI 10.2174/1876216601002010016
   Mummery WK, 2005, AM J PREV MED, V29, P91, DOI 10.1016/j.amepre.2005.04.003
   NELSON DE, 1994, JAMA-J AM MED ASSOC, V271, P1273, DOI 10.1001/jama.271.16.1273
   Oreskovich MR, 2012, ARCH SURG-CHICAGO, V147, P168, DOI 10.1001/archsurg.2011.1481
   Ostry AS, 2006, BMC PUBLIC HEALTH, V6, P0, DOI 10.1186/1471-2458-6-53
   Pappas NA, 2005, BMC NURS, V4, P0, DOI 10.1186/1472-6955-4-8
   Pratt JP, 1970, HEALTH VALUES, V18, P41
   Proctor SP, 1996, SCAND J WORK ENV HEA, V22, P124, DOI 10.5271/sjweh.120
   Pyörälä M, 2000, DIABETES CARE, V23, P1097, DOI 10.2337/diacare.23.8.1097
   Richardson C, 2006, J CLIN NURS, V15, P1196, DOI 10.1111/j.1365-2702.2006.01456.x
   RICHMAN JA, 1992, ALCOHOL CLIN EXP RES, V16, P166, DOI 10.1111/j.1530-0277.1992.tb01360.x
   Sörensen L, 2005, OCCUP MED-OXFORD, V55, P136, DOI 10.1093/occmed/kqi036
   Wandel M, 2005, APPETITE, V44, P93, DOI 10.1016/j.appet.2004.08.002
   Winston James, 2008, BMC RES NOTES, V1, P69, DOI 10.1186/1756-0500-1-69
NR 30
TC 15
Z9 15
U1 0
U2 47
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0962-7480
EI 1471-8405
J9 OCCUP MED-OXFORD
JI Occup. Med.-Oxf.
PD OCT 15
PY 2015
VL 65
IS 7
BP 552
EP 557
DI 10.1093/occmed/kqv097
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CU0CZ
UT WOS:000363184800009
PM 26209792
DA 2025-04-28
ER

PT J
AU Zheng, XC
   Dai, WC
   Chen, XH
   Wang, KY
   Zhang, WQ
   Liu, L
   Hou, JL
AF Zheng, Xinchun
   Dai, Wencong
   Chen, Xiaohui
   Wang, Kunyuan
   Zhang, Wenqing
   Liu, Li
   Hou, Jinlin
TI Caffeine reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebrafish larvae
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE Caffeine; Zebrafish; Fatty liver; ER stress; Lipogenesis
ID fatty liver-disease; endoplasmic-reticulum stress; type-2 diabetes-mellitus; diet-induced obesity; b-virus x; nonalcoholic steatohepatitis; coffee consumption; hepatocellular-carcinoma; gene-expression; tea consumption
AB Background: Caffeine, the main component of coffee, has showed its protective effect on non-alcoholic fatty liver disease (NAFLD) in many studies. However, the hepatoprotection of caffeine and its mechanisms in zebrafish were unexplored. Thus, this study's intentions are to establish a NAFLD model of zebrafish larvae and to examine the role of caffeine on fatty liver with the model. Results: Growth and the incidence of fatty liver of zebrafish larvae increased with the increased amount of feeding in a dose-dependent manner. The degree of hepatic steatosis of larvae also gradually aggravated with the increased quantity and duration of feeding. Triglyceride contents of zebrafish fed for 20 days significantly increased in model group (180 mg/d) compared with control group (30 mg/d) (P < 0.001). Significant decreases in body weight and hepatic steatosis rate were observed in 2.5, 5, 8 % caffeine treatment group compared with model group (P < 0.05). Hepatic lipid accumulation was also significantly reduced in caffeine treatment larvae. Moreover, caffeine treatment was associated with upregulation of lipid beta-oxidation gene ACO and downregulation of lipogenesis-associated genes (SREBP1, ACC1, CD36 and UCP2), ER stress-associated genes (PERK, IRE1, ATF6 and BIP), the inflammatory cytokine genes (IL-1beta and TNF alpha) and autophagy associated genes (ATG12 and Beclin 1). Protein expression of CHOP, BIP and IL-1beta remarkably reduced in caffeine treatment group compared with model group. Conclusions: We induced hepatoteatosis in zebrafish by overfeeding regimen and demonstrated caffeine have a role in suppression of hepatosteatosis by downregulation of genes associated with lipogenesis, ER stress, inflammatory response and enhancement of lipid oxidation, indicating zebrafish model may be used to identify putative pharmacological targets and to test novel drugs for human NAFLD treatment.
C1 [Zheng, Xinchun; Dai, Wencong; Wang, Kunyuan; Liu, Li; Hou, Jinlin] Southern Med Univ, Guangdong Prov Key Lab Viral Hepatitis Res, Dept Infect Dis, Nanfang Hosp,State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.
   [Chen, Xiaohui; Zhang, Wenqing] Southern Med Univ, Dept Cell Biol, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Guangzhou 510515, Guangdong, Peoples R China.
C3 Southern Medical University - China; Southern Medical University - China
RP Liu, L (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Viral Hepatitis Res, Dept Infect Dis, Nanfang Hosp,State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China.
EM liliu.fimmu@gmail.com; jlhousmu@163.com
FU Major Science and Technology Special Project of China [2012ZX10002-003]
CR Amali AA, 2006, J BIOMED SCI, V13, P225, DOI 10.1007/s11373-005-9055-5
   Arauz J, 2013, J APPL TOXICOL, V33, P970, DOI 10.1002/jat.2788
   Asaoka Y, 2013, DIS MODEL MECH, V6, P905, DOI 10.1242/dmm.011981
   Baek JS, 2012, CHOLESTEROL, V0, P0, DOI DOI 10.1155/2012/564705
   Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, PG27, DOI 10.1152/ajpgi.00296.2007
   Birerdinc A, 2012, ALIMENT PHARM THER, V35, P76, DOI 10.1111/j.1365-2036.2011.04916.x
   Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032
   Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   Della Corte C, 2013, PAEDIAT CHILD HLTH, V23, P529
   Dranoff JA, 2014, HEPATOLOGY, V0, P0
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gutiérrez-Grobe Y, 2012, ANN HEPATOL, V11, P350, DOI 10.1016/S1665-2681(19)30931-7
   Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002
   Her GM, 2011, BBA-MOL CELL BIOL L, V1811, P536, DOI 10.1016/j.bbalip.2011.06.011
   Hiramitsu M, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03708
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jang MH, 2002, J KOREAN MED SCI, V17, P674, DOI 10.3346/jkms.2002.17.5.674
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Johnson S, 2011, CANCER CAUSE CONTROL, V22, P503, DOI 10.1007/s10552-010-9725-0
   Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048
   Katayama M, 2014, CLIN NUTR, V33, P302, DOI 10.1016/j.clnu.2013.05.006
   KLATSKY AL, 1992, AM J EPIDEMIOL, V136, P1248, DOI 10.1093/oxfordjournals.aje.a116433
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Leung WWM, 2011, J EPIDEMIOL COMMUN H, V65, P556, DOI 10.1136/jech.2009.104125
   Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914
   Lu J-W, 2013, ACTA HISTOCHEM, V0, P0
   Matsumoto T, 2010, DIS MODEL MECH, V3, P431, DOI 10.1242/dmm.002311
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001
   Oka Takehiko, 2010, BMC PHYSIOL, V10, P21, DOI 10.1186/1472-6793-10-21
   Pai WY, 2013, TRANSGENIC RES, V22, P823, DOI 10.1007/s11248-012-9685-0
   Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667
   POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114
   Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074
   Sapp V, 2014, HEPATOLOGY, V60, P1581, DOI 10.1002/hep.27284
   Schlegel A, 2012, CELL MOL LIFE SCI, V69, P3953, DOI 10.1007/s00018-012-1037-y
   Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008
   Sinha RA, 2013, HEPATOLOGY, V0, P0
   Sterling RK, 2003, GASTROENTEROLOGY, V124, PA705, DOI 10.1016/S0016-5085(03)83563-1
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Tainaka T, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-88
   Thakur PC, 2011, HEPATOLOGY, V54, P452, DOI 10.1002/hep.24349
   Torres DM, 2013, GASTROENTEROLOGY, V144, P670, DOI 10.1053/j.gastro.2013.02.015
   Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026
   Watanabe S, 2007, J GASTROEN HEPATOL, V22, PS96, DOI 10.1111/j.1440-1746.2006.04665.x
   Yin HQ, 2006, TOXICOL SCI, V94, P206, DOI 10.1093/toxsci/kfl078
   YOSHIOKA K, 1990, J NUTR SCI VITAMINOL, V36, P173, DOI 10.3177/jnsv.36.173
   Zheng GD, 2004, IN VIVO, V18, P55
   Zou YH, 2006, LIFE SCI, V79, P1100, DOI 10.1016/j.lfs.2006.03.021
NR 58
TC 76
Z9 80
U1 7
U2 91
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD NOV 17
PY 2015
VL 22
IS 
BP 
EP 
DI 10.1186/s12929-015-0206-3
PG 12
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA CW8UH
UT WOS:000365274300004
PM 26572131
DA 2025-04-28
ER

PT J
AU Xu, Y
   Zhang, M
   Wu, T
   Dai, SD
   Xu, JL
   Zhou, ZK
AF Xu, Yan
   Zhang, Min
   Wu, Tao
   Dai, ShengDong
   Xu, Jinling
   Zhou, Zhongkai
TI The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet
SO FOOD & FUNCTION
LA English
DT Article
ID epigallocatechin gallate; antioxidant property; lipid-metabolism; body-fat; obesity; catechins; extract; supplementation; oxidation; theanine
AB Beneficial effects of green tea (Camellia sinensis, Theaceae) extracts against obesity have been reported; however, the anti-obesity ability of the major components of green tea, polysaccharides, polyphenols and caffeine is not clear. Therefore, experiments with total green tea extracts, polyphenols, polysaccharides, caffeine, and a complex of polysaccharide and polyphenol at a dose of 400 or 800 mg kg(-1) were conducted on high-fat diet fed rats for 6 weeks to investigate their anti-obesity effects. The results indicated that polyphenols and polysaccharides were responsible for the suppressive effect of green tea extracts on body weight increase and fat accumulation. Moreover, polyphenols, polysaccharides, or caffeine can improve blood lipid and antioxidant levels, and effectively reduce rat serum leptin levels, inhibit the absorption of fatty acids, and markedly reduce the expression levels of the IL-6 and TNF-alpha gene. Furthermore, it was shown that polysaccharides and polyphenols were synergistic in reduction of serum leptin levels and in anti-inflammatory activity. These results suggest that the polysaccharide combination with polyphenols might be a potential therapy against obesity.
C1 [Xu, Yan; Zhang, Min; Wu, Tao; Dai, ShengDong; Xu, Jinling; Zhou, Zhongkai] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
C3 Tianjin University Science & Technology
RP Zhang, M (corresponding author), Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
EM zm0102@tust.edu.cn
FU Ministry of Science and Technology of the People's Republic of China [2012BAD33B08]
CR Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Colman E, 2012, NEW ENGL J MED, V367, P1577, DOI 10.1056/NEJMp1211277
   Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Huvaere K, 2011, J AGR FOOD CHEM, V59, P8718, DOI 10.1021/jf201139e
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   Imayama I, 2012, CANCER RES, V72, P2314, DOI 10.1158/0008-5472.CAN-11-3092
   Jordan MA, 2013, DRUG DISCOV TODAY, V0, PP107, DOI 10.5772/51145
   Jurgens TM, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008650.pub2
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Lu C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0034833
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Matsubara Y, 2009, ANN NUTR METAB, V54, P258, DOI 10.1159/000229506
   Mohamed GA, 2014, BULLETIN OF THE FACULTY OF PHARMACY, V0, P0
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.39
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Polotsky M, 2012, J APPL PHYSIOL, V112, P1637, DOI 10.1152/japplphysiol.01222.2011
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sayama K, 2000, IN VIVO, V14, P481
   Senanayake SPJN, 2013, J FUNCT FOODS, V5, P1529, DOI 10.1016/j.jff.2013.08.011
   Shen CL, 2011, FASEB J, V0, P25
   Stimpson E, 2013, J HEART LUNG TRANSPL, V32, PS212, DOI 10.1016/j.healun.2013.01.531
   Tian C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0053796
   Wang L, 2012, FOOD CHEM, V131, P1539, DOI 10.1016/j.foodchem.2011.09.129
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wu T, 2013, FOOD FUNCT, V4, P1654, DOI 10.1039/c3fo60251f
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
   Zheng GD, 2004, IN VIVO, V18, P55
NR 39
TC 163
Z9 180
U1 16
U2 376
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUN 15
PY 2015
VL 6
IS 1
BP 297
EP 304
DI 10.1039/c4fo00970c
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA AX9QB
UT WOS:000347235900029
PM 25431018
DA 2025-04-28
ER

PT J
AU Beckford, K
   Grimes, CA
   Riddell, LJ
AF Beckford, Kelsey
   Grimes, Carley A.
   Riddell, Lynn J.
TI Australian children's consumption of caffeinated, formulated beverages: a cross-sectional analysis
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Caffeine; Dietary; Beverages; Dietary; Soft drink; Child; Adolescent; Australia
ID sugar-sweetened beverages; body-weight; international survey; obesity; trial; adolescents; drinks; diets
AB Background: Caffeine is a common additive in formulated beverages, including sugar-sweetened beverages. Currently there are no data on the consumption of caffeinated formulated beverages in Australian children and adolescents. This study aimed to determine total intake and consumption patterns of CFBs in a nationally representative sample of Australian children aged 2-16 years and to determine contribution of CFBs to total caffeine intake. Consumption by day type, mealtime and location was also examined. Methods: Dietary data from one 24-hour recall collected in the 2007 Australian National Children's Nutrition and Physical Activity Survey were analysed. CFBs were defined as beverages to which caffeine has been added as an additive, including cola-type beverages and energy drinks. Socioeconomic status was based on the highest level of education attained by the participant's primary caregiver. Time of day of consumption was classified based on traditional mealtimes and type of day of consumption as either a school or non-school day. Location of consumption was defined by the participant during the survey. Results: On the day of the survey 15% (n = 642) of participants consumed CFBs. Older children and those of low socioeconomic background were more likely to consume CFBs (both P < 0.001). Amongst the 642 consumers mean (95% CI) intakes were 151 (115-187) g/day, 287 (252-321) g/day, 442 (400-484) g/day, and 555 (507-602) g/day for 2-3, 4-8, 9-13 and 14-16 year olds respectively. Consumers of CFBs had higher intakes of caffeine (mean (95% CI) 61 (55-67) mg vs. 11 (10-12) mg) and energy (mean (95% CI) 9,612 (9,247-9978) kJ vs. 8,186 (8,040-8,335) kJ) than non-consumers (both P < 0.001). CFBs contributed 69% of total daily caffeine intake. CFB intake was higher on non-school days compared with school days (P < 0.005) and consumption occurred predominantly at the place of residence (56%), within the "dinner" time bracket (17: 00-20: 30, 44%). Conclusions: The consumption of CFBs by all age groups within Australian children is of concern. Modifications to the permissibility of caffeine as a food additive may be an appropriate strategy to reduce the intake of caffeine in this age group. Additional areas for intervention include targeting parental influences over mealtime beverage choices.
C1 [Beckford, Kelsey; Grimes, Carley A.; Riddell, Lynn J.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Melbourne, Vic 3125, Australia.
C3 Deakin University
RP Riddell, LJ (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, 221 Burwood Highway, Melbourne, Vic 3125, Australia.
EM lynn.riddell@deakin.edu.au
CR Unknown -, 2005, PRINCIPLES OF NUTRITIONAL ASSESSMENT, V0, P0
   Unknown -, 2010, 2007 AUSTR NAT CHILD, V0, P0
   Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889
   Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Fitt E, 2013, FOOD CHEM, V140, P421, DOI 10.1016/j.foodchem.2012.07.092
   Food Standards Australia New Zealand, 2008, AUSNUT 2007 AUSTR FO, V0, P0
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   GRIFFITHS RR, 1988, PSYCHOPHARMACOLOGY, V94, P437, DOI 10.1007/BF00212836
   Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628
   Grimes CA, 2011, BRIT J NUTR, V105, P468, DOI 10.1017/S0007114510003673
   Hafekost K, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-950
   Heatherley SV, 2005, PSYCHOPHARMACOLOGY, V178, P461, DOI 10.1007/s00213-005-2159-9
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   Keast RSJ, 2011, EUR J CLIN NUTR, V65, P1338, DOI 10.1038/ejcn.2011.123
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Keast RSJ, 2015, BRIT J NUTR, V113, P366, DOI 10.1017/S000711451400378X
   Knight CA, 2006, CAN J DIET PRACT RES, V67, P96, DOI 10.3148/67.2.2006.96
   Mitchell GL, 2013, APPETITE, V60, P85, DOI 10.1016/j.appet.2012.09.014
   Riddell LJ, 2012, FOOD NUTR COMPON FOC, V2, P22, DOI 10.1039/9781849734752-00022
   Spurrier NJ, 2008, INT J BEHAV NUTR PHY, V5, P0, DOI 10.1186/1479-5868-5-31
   Whiting SJ, 2004, J NUTR, V134, P696S, DOI 10.1093/jn/134.3.696S
NR 27
TC 17
Z9 19
U1 0
U2 25
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
EI 
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 31
PY 2015
VL 15
IS 
BP 
EP 
DI 10.1186/s12889-015-1443-9
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CB1WN
UT WOS:000349418800035
PM 25636490
DA 2025-04-28
ER

PT J
AU Mullin, GE
AF Mullin, Gerard E.
TI Supplements for Weight Loss: Hype or Help for Obesity? Part II. The Inside Scoop on Green Coffee Bean Extract
SO NUTRITION IN CLINICAL PRACTICE
LA English
DT Article
ID long-term; overweight; men
C1 Johns Hopkins Univ Hosp, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins Medicine
RP Mullin, GE (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Carnegie 464, Baltimore, MD 21205 USA.
EM gmullin1@jhmi.edu
CR Anese M, 2014, FOOD CHEM, V145, P168, DOI 10.1016/j.foodchem.2013.08.047
   Dellalibera O, 2006, PHYTOTHERAPIE (PARIS), V4, P194, DOI 10.1007/s10298-006-0181-7
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hausenblas H, 2014, NAT MED J, V6, P0
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Mullin GE, 2014, NUTR CLIN PRACT, V29, P842, DOI 10.1177/0884533614552852
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Phillip A, 2014, THE WASHINGTON POST, V0, P0
   Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   St-Onge MP, 2012, OBESITY, V20, P343, DOI 10.1038/oby.2011.289
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
NR 15
TC 1
Z9 1
U1 0
U2 62
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-5336
EI 1941-2452
J9 NUTR CLIN PRACT
JI Nutr. Clin. Pract.
PD APR 15
PY 2015
VL 30
IS 2
BP 311
EP 312
DI 10.1177/0884533615572655
PG 2
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CF3ZM
UT WOS:000352487800019
PM 25757951
DA 2025-04-28
ER

PT J
AU Di Pietro, G
   Cardoso, DS
   da Silva, HMBS
   Santos, JC
   dos Santos, JR
   Simoes, RA
AF Di Pietro, Giuliano
   Cardoso, Damaris Santana
   Bernini Soares da Silva, Heloisa Mendonca
   Santos, Jessyca Costa
   dos Santos, Jordana Rosa
   Simoes, Rodrigo Almeida
TI Profile Development of Noncommunicable Chronic Diseases in a Brazilian Rural Town
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE nutritional epidemiological transition; lifestyle; chronic diseases
ID body-mass index; risk-factors; nutrition transition; women; cancer; diet; hypertension; obesity; health
AB Objective: To assess the relationship between socioeconomic and anthropometric data, frequency of food consumption, and the development of noncommunicable diseases (NCDs) in patients from a small rural town in northeastern Brazil. Methods: A cross-sectional questionnaire study was performed on patients from the Lagarto City Hospital (n = 50) and from family health units (n = 370). Results: The 420patients in the study had one or more NCDs such as hypertension, type 2 diabetes mellitus, and dyslipidemia. The mean age was 63.1 +/- 8.7years for both sexes. The typical patient was of mixed or black descent (66%), a farmer, and of low socioeconomic status and education; 100% of men and 84% of women were illiterate or had less than 4years of schooling. Approximately 50% of women and 89% of men were married and most had never used tobacco or were ex-smokers. The body mass index (BMI) of the study population was 29.4 +/- 5.5 kg/m(2), where 70% of the patients were type 2 diabetic with waist circumferences of 99.8 +/- 21.2 cm for men and 98.1 +/- 13.9 cm for women. The correlation between BMI and waist circumference was r = 0.88. Even with the use of medication, total cholesterol levels of above 240mg/dL were recorded in 10% of women and about 5% of men. Likewise, 10% of women and 100% of men had triglyceride levels above 200mg/dL; glucose levels were 133.6 +/- 47.4mg/dL in men and 110.8 +/- 38.8mg/dL in women. Blood pressure values were high, even in patients using one or more antihypertensive drugs for at least 2years (systolic pressure = 128.5 +/- 18.2; diastolic pressure = 86.3 +/- 8.9mmHg). Indices considered above the limit recommended by the World Health Organization (WHO) were obtained for 60% of women and 100% of men. Our research revealed that this population is characterized by a relatively low intake of fats and oils. Nevertheless, 100% of patients consumed meat every day, 57.6% never consumed processed foods such as candy or soft drinks, and 89% consumed coffee daily. Furthermore, the consumption of fruits was very low: 46.6% of respondents never ate fruit and 7.8% rarely consumed fruit. Likewise, 68.2% reported never eating milk and dairy products. Vegetables were consumed by only 51.4% of the population and 38.5% rarely or never consumed green vegetables. Products made from wheat, maize, cassava, beans, and rice were often consumed by 59.2% of the population. Conclusions: Our results indicate that the studied population is affected by nutritional transition, in which the greater access to carbohydrates and animal proteins is associated with high BMI, with the vast majority overweight and suffering from uncontrolled hypertension despite the use of medications. The high consumption of carbohydrates and animal protein, rapid urbanization, and sedentary lifestyle are the main factors responsible for the epidemic of noncommunicable diseases, especially among people with low income and education. Men are particularly affected, with increased visceral fat characterized by an increased waist circumference.
C1 [Di Pietro, Giuliano; Cardoso, Damaris Santana; Simoes, Rodrigo Almeida] Univ Fed Sergipe, Dept Farm, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Bernini Soares da Silva, Heloisa Mendonca] Univ Fed Sergipe, Dept Nutr, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Santos, Jessyca Costa; dos Santos, Jordana Rosa] Univ Fed Sergipe, Dept Nursing, BR-49100000 Sao Cristovao, Sergipe, Brazil.
C3 Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe
RP Di Pietro, G (corresponding author), Univ Fed Sergipe, Dept Farm, Ave Marechal Rondon,S-N Jardim Roza Elze, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM dipietrobr@yahoo.com.br
FU National Council for Research (Conselho Nacional de Pesquisa-CNPq, Brazil)
CR Batista Filho Malaquias, 2003, CAD. SAÚDE PÚBLICA, V19, PS181, DOI 10.1590/S0102-311X2003000700019
   Belahsen R, 2006, PUBLIC HEALTH NUTR, V9, P1130, DOI 10.1017/S1368980007668517
   Bertrand KA, 2013, CANCER PREV RES, V6, P864, DOI 10.1158/1940-6207.CAPR-3-0132
   Bolormaa Norov, 2008, ASIA PAC J PUBLIC HEALTH, V20 Suppl, P23
   BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725
   Brazilian Ministry of Health, 2010, VIGITEL TEL SURV SUR, V0, P0
   Brazilian Ministry of Planning Budget and Management, 2011, CENS 2010 CHAR POP H, V0, P0
   Burr JF, 2010, PHYSICIAN SPORTSMED, V38, P72, DOI 10.3810/psm.2010.04.1764
   Carvalho GQ, 2008, REV NUTR, V21, P577, DOI 10.1590/S1415-52732008000500010
   Cervato AM, 1999, THESIS USP SAO PAULO, V0, P0
   Cortez-Dias N, 2013, J HYPERTENS, V31, P1991, DOI 10.1097/HJH.0b013e32836342f7
   Castro Simone Henriques de, 2006, ARQ BRAS ENDOCRINOL METAB, V50, P450, DOI 10.1590/S0004-27302006000300007
   Decker SL, 2013, JAMA-J AM MED ASSOC, V309, P2579, DOI 10.1001/jama.2013.7106
   Di Pietro RF, 2007, NUTR HOSP, V22, P565
   Duarte ACG, 2007, AV NUTR ASP CLIN LAB, V0, P0
   Goon D, 2013, IRAN J PUBLIC HEALTH, V42, P489
   Jaime PC, 2011, J URBAN HEALTH, V88, P567, DOI 10.1007/s11524-010-9537-2
   Kitsantas P, 2013, J OBSTET GYNAECOL RE, V39, P1330, DOI 10.1111/jog.12065
   Kruger HS, 2001, BRIT J NUTR, V86, P733, DOI 10.1079/BJN2001469
   Laamiri FZ, 2013, INT J GEN MED, V6, P439, DOI 10.2147/IJGM.S40826
   Lee Hye Ah, 2013, J PREV MED PUBLIC HEALTH, V46, P173, DOI 10.3961/jpmph.2013.46.4.173
   Magno LAV, 2009, PHARMACOLOGY, V83, P231, DOI 10.1159/000205823
   Meetoo Danny, 2008, BR J NURS, V17, P1320
   Miller ER, 2005, ATHEROSCLEROSIS, V183, P175, DOI 10.1016/j.atherosclerosis.2005.04.001
   Millett C, 2013, PLOS MED, V10, P0, DOI 10.1371/journal.pmed.1001459
   Misra A, 2011, J DIABETES, V3, P278, DOI 10.1111/j.1753-0407.2011.00139.x
   Musaiger AO, 2012, INT J GEN MED, V5, P199, DOI 10.2147/IJGM.S29663
   Nagao H, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-88
   Navarro AM, 2001, REVISTA DE NUTRICAO, V14, P37, DOI 10.1590/S1415-52732001000100006
   Niinikoski H, 2012, NUTR METAB CARDIOVAS, V22, P770, DOI 10.1016/j.numecd.2012.05.002
   Pena SDJ, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017063
   Popkin BM, 2009, NESTLE NUTR WORKS SE, V63, P1, DOI 10.1159/000209967
   Popkin BM, 2004, INT J OBESITY, V28, PS2, DOI 10.1038/sj.ijo.0802804
   Sarno F, 2007, REV SAUDE PUBL, V41, P788, DOI 10.1590/S0034-89102007000500013
   Thawornchaisit P, 2013, BMJ OPEN, V3, P0, DOI 10.1136/bmjopen-2013-002826
NR 36
TC 4
Z9 4
U1 0
U2 22
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD MAY 4
PY 2015
VL 34
IS 3
BP 191
EP 198
DI 10.1080/07315724.2014.926162
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CI1ZE
UT WOS:000354543100002
PM 25751416
DA 2025-04-28
ER

PT J
AU Lee, CG
   Koo, JH
   Kim, SG
AF Lee, Chan Gyu
   Koo, Ja Hyun
   Kim, Sang Geon
TI Phytochemical regulation of Fyn and AMPK signaling circuitry
SO ARCHIVES OF PHARMACAL RESEARCH
LA English
DT Review
DE Fyn; AMPK; Phytochemical; Antioxidant; Metabolic disease
ID activated protein-kinase; tyrosine kinase; coffee consumption; epigallocatechin-3-gallate egcg; energy-expenditure; oxidative-stress; nuclear export; acts upstream; sirt1; inhibition
AB During the past decades, phytochemical terpenoids, polyphenols, lignans, flavonoids, and alkaloids have been identified as antioxidative and cytoprotective agents. Adenosine monophosphate-activated protein kinase (AMPK) is a kinase that controls redox-state and oxidative stress in the cell, and serves as a key molecule regulating energy metabolism. Many phytochemicals directly or indirectly alter the AMPK pathway in distinct manners, exerting catabolic metabolism. Some of them are considered promising in the treatment of metabolic diseases such as type II diabetes, obesity, and hyperlipidemia. Another important kinase that regulates energy metabolism is Fyn kinase, a member of the Src family kinases that plays a role in various cellular responses such as insulin signaling, cell growth, oxidative stress and apoptosis. Phytochemical inhibition of Fyn leads to AMPK-mediated protection of the cell in association with increased antioxidative capacity and mitochondrial biogenesis. The kinases may work together to form a signaling circuitry for the homeostasis of energy conservation and expenditure, and may serve as targets of phytochemicals. This review is intended as a compilation of recent advancements in the pharmacological research of phytochemicals targeting Fyn and AMPK circuitry, providing information for the prevention and treatment of metabolic diseases and the accompanying tissue injuries.
C1 [Lee, Chan Gyu; Koo, Ja Hyun; Kim, Sang Geon] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea.
C3 Seoul National University (SNU)
RP Kim, SG (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 151742, South Korea.
EM leeck7@snu.ac.kr; jhkoo@snu.ac.kr; sgk@snu.ac.kr
FU Ministry of Health Welfare [A111641]; National Research Foundation of Korea grant - Korea government (MSIP) [2007-0056817]
CR Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003
   Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004
   Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010
   AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
   Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702
   Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008
   Unknown -, 2008, THE FEDERAL REGISTER / FIND, V73, P47828
   Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312
   Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292
   Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081
   Boney CM, 2001, CELL GROWTH DIFFER, V12, P379
   Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241
   Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079
   Bulzomi P, 2012, J CELL PHYSIOL, V227, P1891, DOI 10.1002/jcp.22917
   Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   CHEADLE C, 1994, J BIOL CHEM, V269, P24034
   Choi SH, 2010, BIOCHEM PHARMACOL, V79, P1352, DOI 10.1016/j.bcp.2009.12.011
   Choi SH, 2010, EXPERT OPIN DRUG MET, V6, P213, DOI 10.1517/17425250903427972
   Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003
   Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667
   Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012
   Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45
   Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104
   Eberl G, 1999, J IMMUNOL, V163, P4091
   Fujiwara H, 2008, DIABETES RES CLIN PR, V80, P185, DOI 10.1016/j.diabres.2007.12.004
   Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004
   Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164
   Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189
   Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698
   Han CY, 2011, ANTIOXID REDOX SIGN, V14, P187, DOI 10.1089/ars.2010.3190
   Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527
   He ZW, 2008, MOL CARCINOGEN, V47, P172, DOI 10.1002/mc.20299
   HIRANO T, 1989, LIFE SCI, V45, P1111, DOI 10.1016/0024-3205(89)90168-9
   Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Hwang JT, 2009, PHYTOTHER RES, V23, P262, DOI 10.1002/ptr.2606
   Hwang MK, 2009, BIOCHEM PHARMACOL, V77, P1213, DOI 10.1016/j.bcp.2008.12.021
   Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200
   Janssen PLTMK, 1998, AM J CLIN NUTR, V67, P255, DOI 10.1093/ajcn/67.2.255
   Jelic D, 2007, J MED CHEM, V50, P1090, DOI 10.1021/jm0607202
   Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2
   Joo MS, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.427
   Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899
   Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282
   Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553
   Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009
   Kim AY, 2012, FREE RADICAL BIO MED, V53, P1198, DOI 10.1016/j.freeradbiomed.2012.06.039
   Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505
   Kim YW, 2009, FREE RADICAL BIO MED, V47, P1082, DOI 10.1016/j.freeradbiomed.2009.07.018
   Ko HH, 1999, J NAT PROD, V62, P164, DOI 10.1021/np980281c
   Koo JH, 2012, MOL PHARMACOL, V82, P27, DOI 10.1124/mol.111.077149
   Kook D, 2008, INVEST OPHTH VIS SCI, V49, P1712, DOI 10.1167/iovs.07-0477
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200
   Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779
   LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4
   Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007
   Lee DY, 2010, BIOORG MED CHEM LETT, V20, P3764, DOI 10.1016/j.bmcl.2010.04.064
   Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006
   Li B, 2011, BIOL PHARM BULL, V34, P1566, DOI 10.1248/bpb.34.1566
   Li CY, 2010, CURR OPIN PHARMACOL, V10, P111, DOI 10.1016/j.coph.2009.11.009
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   Liu G, 2007, J ENDOCRINOL, V194, P569, DOI 10.1677/joe-07-0200
   LIU YL, 1988, TOXICOL APPL PHARM, V93, P442, DOI 10.1016/0041-008X(88)90047-6
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   Lu J, 2010, J PATHOL, V222, P199, DOI 10.1002/path.2754
   Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162
   Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706
   McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394
   McKenna E, 1996, J BIOL CHEM, V271, P24517, DOI 10.1074/jbc.271.40.24517
   Mokhber-Dezfuli Najmeh, 2014, PHARMACOGN REV, V8, P8, DOI 10.4103/0973-7847.125517
   Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042
   Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1
   Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209
   Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Roebuck BD, 2003, CARCINOGENESIS, V24, P1919, DOI 10.1093/carcin/bgg173
   Rosenzweig T, 2004, CELL SIGNAL, V16, P1299, DOI 10.1016/j.cellsig.2004.03.015
   Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957
   Sánchez-Wandelmer J, 2009, BBA-BIOMEMBRANES, V1788, P1731, DOI 10.1016/j.bbamem.2009.05.002
   Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479
   Shin SM, 2009, MOL PHARMACOL, V75, P242, DOI 10.1124/mol.108.051128
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0
   Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611
   Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583
   Sung SH, 2000, J NAT PROD, V63, P1019, DOI 10.1021/np990499e
   Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022
   Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013
   Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005
   Tse MCL, 2013, MOL CELL BIOL, V33, P1797, DOI 10.1128/MCB.01410-12
   Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552
   Umemori H, 1999, J NEUROSCI, V19, P1393
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vatish Manu, 2009, ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, V115, P191, DOI 10.1080/13813450903164348
   Wang TTY, 1996, CARCINOGENESIS, V17, P271, DOI 10.1093/carcin/17.2.271
   Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031
   Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005
   Wu LX, 2006, ACTA PHARMACOL SIN, V27, P694, DOI 10.1111/j.1745-7254.2006.00326.x
   Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103
   Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028
   Yamada E, 2010, CELL METAB, V11, P113, DOI 10.1016/j.cmet.2009.12.010
   Yan GR, 2010, PROTEOMICS, V10, P976, DOI 10.1002/pmic.200900662
   Yang YM, 2010, WORLD J GASTROENTERO, V16, P3731, DOI 10.3748/wjg.v16.i30.3731
   Zhang Q, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/924851
   Zhang YS, 2008, MOL CANCER THER, V7, P3470, DOI 10.1158/1535-7163.MCT-08-0625
   Zhou J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087161
   ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E
   Zhu H, 2009, EXP BIOL MED, V234, P418, DOI 10.3181/0811-RM-340
NR 120
TC 10
Z9 12
U1 0
U2 16
PU PHARMACEUTICAL SOC KOREA
PI SEOUL
PA 1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA
SN 0253-6269
EI 1976-3786
J9 ARCH PHARM RES
JI Arch. Pharm. Res.
PD DEC 15
PY 2015
VL 38
IS 12
BP 2093
EP 2105
DI 10.1007/s12272-015-0611-x
PG 13
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CX5RX
UT WOS:000365761300001
PM 25951818
DA 2025-04-28
ER

PT J
AU Etxeberria, U
   de la Garza, AL
   Martínez, JA
   Milagro, FI
AF Etxeberria, Usune
   Laura de la Garza, Ana
   Alfredo Martinez, J.
   Milagro, Fermin I.
TI Biocompounds Attenuating the Development of Obesity and Insulin Resistance Produced by a High-fat Sucrose Diet
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE Curcumin; Chlorogenic acid; Coumaric acid; Naringin; Leucine; Anti-obesity
ID phenolic-compounds; glucose-tolerance; rats; leucine; acid; management; mice
AB The use of biocompounds as agents with potential anti-obesity effects might be a feasible alternative to the prescription of traditional drugs in the near future. The goal of the present study was to screen five different compounds in relation to their ability to prevent body weight gain and ameliorate obesity-associated metabolic impairments, namely insulin resistance. For this purpose, seventy Wistar rats were randomly assigned into seven experimental groups. A standard diet-fed control group (control, n=10); a high-fat, high-sucrose diet-fed group (BPS, n=10) and five experimental groups which were fed the I-IFS diet supplemented with one of the following biocompounds; curcumin (100 mg/kg bw, n=10), chlorogenic acid (50 mg/kg bw, n=10), coumaric acid (100 mg/kg bw, n=10), naringin (100 mg/kg bw, n=10) and leucine (1 % of diet, n=10). These results confirm the effectiveness of all the compounds to reduce significantly food efficiency, despite the significant higher food intake. Moreover, visceral fat mass percentage was significantly decreased after naringin and coumaric acid supplementation. In fact, this finding might be related to the considerable amelioration of HOMA-IR index detected in naringin-treated animals. A significant reduction in serum insulin levels and an improvement in the intraperitoneal glucose tolerance test and AUC were found in leucine- and coumaric acid-treated rats, respectively. In summary, the tested biocompounds, particularly naringin, coumaric acid and leucine, showed potential benefits in the prevention of obesity-related complications in rats, at least at the proved doses.
C1 [Etxeberria, Usune; Laura de la Garza, Ana; Alfredo Martinez, J.; Milagro, Fermin I.] Univ Navarra, Dept Nutr Food Sci & Physiol, Ctr Nutr Res, Pamplona 31008, Spain.
   [Alfredo Martinez, J.; Milagro, Fermin I.] Carlos III Hlth Res Inst, CIBERobn Physiopathol Obes & Nutr, Madrid, Spain.
C3 University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN
RP Martínez, JA (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, Ctr Nutr Res, C Irunlarrea 1, Pamplona 31008, Spain.
EM jalfmtz@unav.es
FU Linea Especial about Nutrition, Obesity and Health (University of Navarra, Spain); CIBERobn Physiopathology of Obesity and Nutrition; University of Navarra; Department of Education, Language policy and Culture from the Government of the Basque Country
CR Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637
   Alves NEG, 2012, THE OPEN NUTRACEUTICALS JOURNAL, V5, P193, DOI 10.2174/1876396001205010193
   Unknown -, 2015, OB OV, V0, P0
   Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   González-Castejón M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004
   Hoey H, 2014, P NUTR SOC, V73, P519, DOI 10.1017/S0029665114000652
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI 10.1002/mnfr.200890019
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   de la Garza AL, 2014, FOOD FUNCT, V5, P2120, DOI 10.1039/C4FO00154K
   LECLERCQMEYER V, 1985, ENDOCRINOLOGY, V116, P1168, DOI 10.1210/endo-116-3-1168
   Lomba A, 2010, LIPIDS HEALTH DIS, V9, P0, DOI 10.1186/1476-511X-9-60
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Öner-Iyidogan Y, 2013, J PHYSIOL BIOCHEM, V69, P677, DOI 10.1007/s13105-013-0244-9
   Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026
   TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152
   Torres-Leal FL, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-62
   van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107
   Vasudeva N, 2012, CHIN J INTEGR MED, V18, P473, DOI 10.1007/s11655-012-1120-0
   Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x
   Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123
NR 26
TC 7
Z9 7
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD AUG 15
PY 2015
VL 10
IS 8
BP 1417
EP 1420
DI 
PG 4
WC Chemistry, Medicinal; Food Science & Technology
SC Pharmacology & Pharmacy; Food Science & Technology
GA CO3XY
UT WOS:000359095800026
PM 26434131
DA 2025-04-28
ER

PT J
AU Li, DK
   Ferber, JR
   Odouli, R
AF Li, D-K
   Ferber, J. R.
   Odouli, R.
TI Maternal caffeine intake during pregnancy and risk of obesity in offspring: a prospective cohort study
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
ID endocrine disruptors; spontaneous-abortion; energy-balance; fetal-death; consumption; exposure; childhood; phosphorylation; metabolism; overweight
AB BACKGROUND/OBJECTIVES: In-utero exposures through adverse fetal programming are emerging as an important contributing factor to the epidemic of childhood obesity. This study examines the impact of in-utero exposure to caffeine on the risk of childhood obesity in offspring. SUBJECTS/METHODS: A prospective study of pregnant women with 15 years follow-up of their offspring was conducted to examine the impact of in-utero exposure to caffeine on the risk of childhood obesity. Maternal caffeine intake was prospectively ascertained during pregnancy and outcome measures (body mass index (BMI)) were ascertained from medical charts, with 17 BMI measurements per child, on average, during the follow-up period. Potential confounders including known perinatal risk factors for childhood obesity were adjusted for using the generalized estimating equations model with repeated measurements. RESULTS: After controlling for potential confounders, compared with those without caffeine exposure, in-utero exposure to caffeine overall is associated with 87% increased risk of childhood obesity: odds ratio (OR) = 1.87, 95% confidence interval (CI): 1.12-3.12. This association demonstrated a dose-response relationship: OR = 1.77 (1.05-3.00) for maternal daily caffeine intake <150mg per day, OR = 2.37 (1.24-4.52) for caffeine intake >= 150 mg per day during pregnancy, respectively. We also observed a linear relationship: every one unit increase (log(10) scale) in the amount of maternal caffeine intake was associated with 23% increased risk of obesity in offspring. The dose-response relationship appears stronger for persistent obesity than for transitory obesity (occasional high BMI), and for girls than for boys. CONCLUSIONS: We observed an association of in-utero exposure to caffeine with increased risk of childhood obesity. If this observation is further replicated in other studies, the finding will contribute to the understanding of fetal programming of childhood diseases and development of intervention strategy to prevent childhood obesity.
C1 [Li, D-K; Ferber, J. R.; Odouli, R.] Kaiser Permanente, Div Res, Kaiser Fdn Res Inst, Oakland, CA 94612 USA.
   [Li, D-K] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA.
C3 Kaiser Permanente; Stanford University
RP Li, DK (corresponding author), Kaiser Permanente, Div Res, Kaiser Fdn Res Inst, 2000 Broadway, Oakland, CA 94612 USA.
EM de-kun.li@kp.org
FU California Public Health Foundation
CR ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447
   ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Barlow SE, 2007, PEDIATRICS, V120, PS164, DOI 10.1542/peds.2007-2329C
   Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317
   Bech BH, 2006, INT J EPIDEMIOL, V35, P948, DOI 10.1093/ije/dyl116
   Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335
   Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x
   Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503
   Crozier SR, 2009, PAEDIATR PERINAT EP, V23, P446, DOI 10.1111/j.1365-3016.2009.01036.x
   Dubois L, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0030153
   Egawa T, 2011, J APPL PHYSIOL, V111, P1629, DOI 10.1152/japplphysiol.00249.2011
   Ervin RB, 2013, CONSUMPTION OF ADDED SUGARS AMONG U.S. ADULTS, V0, P0
   FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763
   GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, PR711, DOI 10.1152/ajpregu.00310.2010
   Heindel JJ, 2003, TOXICOL SCI, V76, P247, DOI 10.1093/toxsci/kfg255
   Hosmer DW, 2000, LOGISTIC REGRESSION, Vsecond, P0
   Ibáñez L, 2009, J CLIN ENDOCR METAB, V94, P3696, DOI 10.1210/jc.2009-0789
   Infante-Rivard C, 2007, PAEDIATR PERINAT EP, V21, P300, DOI 10.1111/j.1365-3016.2007.00825.x
   Kennedy J, 2014, APPETITE, V75, P103, DOI 10.1016/j.appet.2013.12.017
   Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178
   KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8
   Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32
   Kolnes AJ, 2010, ACTA PHYSIOL, V200, P65, DOI 10.1111/j.1748-1716.2010.02103.x
   Kosti Rena I, 2006, CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, V14, P151
   Kuczmarski RJ, 2000, VITAL HLTH STAT, V0, PP1, DOI 10.1016/J.BBRC.2015.06.114
   Leduc L, 2010, EUR J OBSTET GYN R B, V149, P127, DOI 10.1016/j.ejogrb.2009.12.005
   Li DW, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063445
   Li DK, 2002, EPIDEMIOLOGY, V13, P9, DOI 10.1097/00001648-200201000-00004
   Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002
   Luo HW, 2014, TOXICOL APPL PHARM, V274, P383, DOI 10.1016/j.taap.2013.11.020
   Luo ZC, 2010, WORLD J DIABETES, V1, P89, DOI 10.4239/wjd.v1.i3.89
   Matijasevich A, 2006, PAEDIATR PERINAT EP, V20, P100, DOI 10.1111/j.1365-3016.2006.00706.x
   Matijasevich Alicia, 2005, CAD. SAÚDE PÚBLICA, V21, P1676, DOI 10.1590/S0102-311X2005000600014
   Grummer-Strawn Laurence M, 2010, MORBIDITY AND MORTALITY WEEKLY REPORT, V59, P1
   Moreno-López L, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0049185
   Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x
   Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047
   Parazzini F, 1998, HUM REPROD, V13, P2286, DOI 10.1093/humrep/13.8.2286
   Picard A, 2014, MOL METAB, V3, P167, DOI 10.1016/j.molmet.2013.11.002
   Sengpiel V, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-42
   Signorello LB, 2004, EPIDEMIOLOGY, V15, P229, DOI 10.1097/01.ede.0000112221.24237.0c
   Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7
   Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406
   Svensson V, 2011, INT J OBESITY, V35, P46, DOI 10.1038/ijo.2010.189
   Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007
   Taubes G, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.f1050
   Taubes G, 2012, NATURE, V492, P155, DOI 10.1038/492155a
   Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597
   Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x
   Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747
   WEATHERSBEE PS, 1977, J REPROD MED, V19, P55
   Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132
   Wen XZ, 2012, BMC MED RES METHODOL, V12, P0, DOI 10.1186/1471-2288-12-38
   Weng XP, 2008, AM J OBSTET GYNECOL, V198, P0, DOI 10.1016/j.ajog.2007.10.803
   Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044497
   YOSHINO S, 1994, PHYSIOL BEHAV, V56, P31, DOI 10.1016/0031-9384(94)90258-5
NR 61
TC 31
Z9 34
U1 1
U2 31
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD APR 15
PY 2015
VL 39
IS 4
BP 658
EP 664
DI 10.1038/ijo.2014.196
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA CF4XO
UT WOS:000352557500016
PM 25388405
DA 2025-04-28
ER

PT J
AU Park, HS
   Shim, SM
AF Park, Hee-Sook
   Shim, Soon-Mi
TI Preventive responses to a standardized extract of Houttuynia cordata supplemented diet in obesity induced by a high-fat diet in mice
SO JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Adipocyte; High-fat diet; Liver injury; Standardized extract of Houttuynia cordata
ID lipid-accumulation; chlorogenic acid; liver-injury; lipotoxicity; inhibition; flavonoids; components; diseases
AB The current study investigated preventive responses to Houttuynia cordata (HC) standardized extract in obesity induced by a high-fat diet (HFD) in mice. High-performance liquid chromatography was carried out to analyze bioactive components in HC. Mice were divided into HFD groups as a control and HFD groups fed with 1 and 4 % of HC supplementation diet. Changes of the body weight of mice, blood biological factors, and histopathological markers were measured. Bioactive components from HC were characterized to contain chlorogenic acid, caffeic acid, rutin, and quercitrin. HC supplementation reduced body weight, glucose, and total cholesterol levels, but it did not affect aspartic acid transaminase, alanine transaminase, or triglyceride amounts in plasma from mice induced by HFD. A 4 % HC supplementation showed a remarkable decrease in the number of large adipocyte in subcutaneous and abdominal adipose tissue. Histopathological evaluation of liver injury induced by HFD was observed to be improved by HC supplementation, leading to attenuated levels of cytoplasmic vacuolation of hepatocytes. From these results, we explored that standardized extract of HC could be a potential natural product to be directly associated with the control of weight.
C1 [Park, Hee-Sook] Korea Food Res Inst, Res Grp Nutraceut Metab Syndrome, Seoul 463736, Gyeonggi Do, South Korea.
   [Park, Hee-Sook; Shim, Soon-Mi] Sejong Univ, Dept Food Sci & Technol, Seoul 143747, South Korea.
C3 Korea Food Research Institute (KFRI); Sejong University
RP Shim, SM (corresponding author), Sejong Univ, Dept Food Sci & Technol, 98 Gunja Dong, Seoul 143747, South Korea.
EM soonmishim@sejong.ac.kr
FU Natl. Research Foundation of Korea (NRF) - Korea government Ministry of Education, Science, Technology [2014R1A2A2A01007627]
CR Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755
   Aronne Louis J, 2007, CLIN CORNERSTONE, V8, P29, DOI 10.1016/S1098-3597(07)80026-3
   Chen YY, 2003, J NUTR SCI VITAMINOL, V49, P327, DOI 10.3177/jnsv.49.327
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chou SC, 2009, CHEM PHARM BULL, V57, P1227, DOI 10.1248/cpb.57.1227
   Han EH, 2009, FOOD CHEM TOXICOL, V47, P1659, DOI 10.1016/j.fct.2009.04.025
   HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI 10.1002/mnfr.200890019
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Jang SY, 2011, NAT PROD RES, V25, P222, DOI 10.1080/14786410903339044
   Ji LL, 2013, J NUTR BIOCHEM, V24, P1911, DOI 10.1016/j.jnutbio.2013.05.007
   Kim SK, 2001, ARCH PHARM RES, V24, P518, DOI 10.1007/BF02975156
   Koriem KMM, 2014, J TOXICOL-US, V2014, P0, DOI 10.1155/2014/583494
   Kusirisin W, 2009, MED CHEM, V5, P139, DOI 10.2174/157340609787582918
   Lin MC, 2013, FOOD FUNCT, V4, P322, DOI 10.1039/c2fo30228d
   Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936
   Meng J, 2005, CHEM PHARM BULL, V53, P1604, DOI 10.1248/cpb.53.1604
   Meng J, 2009, FITOTERAPIA, V80, P468, DOI 10.1016/j.fitote.2009.06.013
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Negi AS, 2008, MED RES REV, V28, P746, DOI 10.1002/med.20115
   Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590
   Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006
   van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049
   Xu CJ, 2005, TALANTA, V68, P108, DOI 10.1016/j.talanta.2005.04.043
   Xu DM, 2014, ENVIRON TOXICOL PHAR, V37, P1212, DOI 10.1016/j.etap.2014.04.022
   Xu XQ, 2006, TALANTA, V68, P759, DOI 10.1016/j.talanta.2005.05.027
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yang UJ, 2014, J KOREAN SOC APPL BI, V57, P161, DOI 10.1007/s13765-013-4187-1
   Zhang Lan-tao, 2011, ZHONGGUO YI XUE KE XUE YUAN XUE BAO, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015
NR 31
TC 1
Z9 1
U1 0
U2 28
PU KOREAN SOC  APPLIED BIOLOGICAL CHEMISTRY
PI KANGNAM-GU
PA RM 803,  KOREA SCIENCE & TECHNOLOGY CENTER, 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1738-2203
EI 2234-344X
J9 J KOREAN SOC APPL BI
JI J. Korean Soc. Appl. Biol. Chem.
PD OCT 15
PY 2015
VL 58
IS 5
BP 643
EP 649
DI 10.1007/s13765-015-0087-x
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA CQ1QT
UT WOS:000360374100003
DA 2025-04-28
ER

PT J
AU Abdali, D
   Samson, SE
   Grover, AK
AF Abdali, Daniyal
   Samson, Sue E.
   Grover, Ashok Kumar
TI How Effective Are Antioxidant Supplements in Obesity and Diabetes?
SO MEDICAL PRINCIPLES AND PRACTICE
LA English
DT Review
DE Vitamin C; Green tea; Green coffee; Cinnamon; Lipoic acid; Carnitine
ID alpha-lipoic acid; impaired glucose-tolerance; oxidative stress; resveratrol supplementation; zinc supplementation; metabolic-disorders; cinnamon extract; glycemic control; controlled-trial; adipose-tissue
AB Obesity is a central health issue due to its epidemic prevalence and its association with type 2 diabetes and other comorbidities. Obesity is not just being overweight. It is a metabolic disorder due to the accumulation of excess dietary calories into visceral fat and the release of high concentrations of free fatty acids into various organs. It represents a state of chronic oxidative stress and low-grade inflammation whose intermediary molecules may include leptin, adiponectin and cytokines. It may progress to hyperglycemia, leading to type 2 diabetes. Whether or not dietary antioxidant supplements are useful in the management of obesity and type 2 diabetes is discussed in this review. Only the benefits for obesity and diabetes are examined here. Other health benefits of antioxidants are not considered. There are difficulties in comparing studies in this field because they differ in the time frame, participants' ethnicity, administration of antioxidant supplements, and even in how obesity was measured. However, the literature presents reasonable evidence for marginal benefits of supplementation with zinc, lipoic acid, carnitine, cinnamon, green tea, and possibly vitamin C plus E, although the evidence is much weaker for omega-3 polyunsaturated fatty acids, coenzyme Q10, green coffee, resveratrol, or lycopene. Overall, antioxidant supplements are not a panacea to compensate for a fast-food and video-game way of living, but antioxidant-rich foods are recommended as part of the lifestyle. Such antioxidant foods are commonly available. (C) 2015 S. Karger AG, Basel
C1 [Abdali, Daniyal; Samson, Sue E.; Grover, Ashok Kumar] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada.
C3 McMaster University
RP Grover, AK (corresponding author), McMaster Univ, Dept Med, HSC 4N41,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
EM groverak@mcmaster.ca
FU McMaster University
CR Al-Lawati JA, 2008, DIABETES VASC DIS RE, V5, P304, DOI 10.3132/dvdr.2008.044
   AMMON HPT, 1991, ARCH PHARM, V324, P261, DOI 10.1002/ardp.19913240502
   Unknown -, 2000, WHO TECHN REP SER, V0, P0
   Unknown -, 2014, ALL GREEN TEA MAJ CO, V0, P0
   Unknown -, 2012, CAN NUTR FIL, V0, P0
   Ansar H, 2011, SAUDI MED J, V32, P584
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Behbehani K, 2014, MED PRIN PRACT, V23, P32, DOI 10.1159/000358884
   Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003
   Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0
   Blevins SM, 2007, DIABETES CARE, V30, P2236, DOI 10.2337/dc07-0098
   Brasnyó P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316
   Brennan DD, 2005, AM J ROENTGENOL, V185, P418, DOI 10.2214/ajr.185.2.01850418
   Bruckert E, 2008, PRESSE MED, V37, P1407, DOI 10.1016/j.lpm.2008.01.021
   Carbonelli MG, 2010, CURR PHARM DESIGN, V16, P840, DOI 10.2174/138161210790883589
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685
   Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235
   Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063
   Crawford P, 2009, J AM BOARD FAM MED, V22, P507, DOI 10.3122/jabfm.2009.05.080093
   Derosa G, 2011, FUND CLIN PHARMACOL, V25, P642, DOI 10.1111/j.1472-8206.2010.00888.x
   Derosa G, 2010, INTERNAL MED, V49, P1717, DOI 10.2169/internalmedicine.49.3401
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006
   Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023
   Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356
   Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045
   Fridovich I, 2013, MED PRIN PRACT, V22, P131, DOI 10.1159/000339212
   Friedman M, 2013, J AGR FOOD CHEM, V61, P9534, DOI 10.1021/jf402654e
   Galvano F, 2009, EXPERT OPIN PHARMACO, V10, P1875, DOI 10.1517/14656560903081745
   Ghavipour M, 2013, BRIT J NUTR, V109, P2031, DOI 10.1017/S0007114512004278
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Gianturco V, 2009, ARCH GERONTOL GERIAT, V49, P129, DOI 10.1016/j.archger.2009.09.022
   Golbidi S, 2011, FRONT PHARMACOL, V2, P0, DOI 10.3389/fphar.2011.00069
   Gu LW, 2003, J MASS SPECTROM, V38, P1272, DOI 10.1002/jms.541
   Gunasekara P, 2011, DIABET METAB SYND OB, V4, P53, DOI 10.2147/DMSO.S16691
   Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736
   Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493
   Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hsu Chung-Hua, 2011, ALTERN MED REV, V16, P157
   Hussain SA, 2006, SAUDI MED J, V27, P1483
   Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, P0, DOI 10.1186/1758-5996-4-13
   Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865
   Kamenova Petya, 2006, HORMONES (ATHENS), V5, P251
   Kang C, 2012, FOOD CHEM, V135, P2350, DOI 10.1016/j.foodchem.2012.06.092
   Karasawa K, 2011, J AGR FOOD CHEM, V59, P11287, DOI 10.1021/jf2029225
   Kataja-Tuomola MK, 2011, EUR J CLIN NUTR, V65, P590, DOI 10.1038/ejcn.2010.283
   Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215
   Kitabchi AE, 2013, DIABETES CARE, V36, P1919, DOI 10.2337/dc12-1912
   Koh EH, 2011, AM J MED, V124, P0, DOI 10.1016/j.amjmed.2010.08.005
   Kolahdouz Mohammadi R, 2013, MINERVA GASTROENTEROL DIETOL, V59, P231
   Lands B, 2014, PROG LIPID RES, V55, P17, DOI 10.1016/j.plipres.2014.04.002
   Lee YJ, 2011, J MED FOOD, V14, P386, DOI 10.1089/jmf.2010.1202
   Liochev SI, 2014, MED PRIN PRACT, V23, P195, DOI 10.1159/000357120
   Lu T, 2012, NUTR RES, V32, P408, DOI 10.1016/j.nutres.2012.05.003
   Malaguarnera M, 2009, METABOLISM, V58, P1618, DOI 10.1016/j.metabol.2009.05.014
   Mancuso C, 2014, FOOD CHEM TOXICOL, V65, P185, DOI 10.1016/j.fct.2013.12.024
   Mang B, 2006, EUR J CLIN INVEST, V36, P340, DOI 10.1111/j.1365-2362.2006.01629.x
   McNeilly AM, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-217
   Munro IA, 2013, OBES RES CLIN PRACT, V7, PE173, DOI 10.1016/j.orcp.2011.11.001
   Munro IA, 2012, BRIT J NUTR, V108, P1466, DOI 10.1017/S0007114511006817
   Naziroglu M, 2004, CLIN CHIM ACTA, V344, P63, DOI 10.1016/j.cccn.2004.01.031
   Niki E, 2014, FREE RADICAL BIO MED, V66, P3, DOI 10.1016/j.freeradbiomed.2013.03.022
   NORMANN PT, 1978, BIOCHIM BIOPHYS ACTA, V530, P461, DOI 10.1016/0005-2760(78)90166-2
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Parham Mahmoud, 2008, REV DIABET STUD, V5, P102, DOI 10.1900/RDS.2008.5.102
   Partida-Hernández G, 2006, BIOMED PHARMACOTHER, V60, P161, DOI 10.1016/j.biopha.2006.02.004
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146
   Rafighi Zahra, 2013, GLOB J HEALTH SCI, V5, P183, DOI 10.5539/gjhs.v5n3p183
   Ranasinghe P, 2012, DIABETIC MED, V29, P1480, DOI 10.1111/j.1464-5491.2012.03718.x
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   ROTILIO G, 1972, BIOCHEMISTRY-US, V11, P2182, DOI 10.1021/bi00761a027
   Roussel AM, 2003, J AM COLL NUTR, V22, P316, DOI 10.1080/07315724.2003.10719310
   Roussel AM, 2009, J AM COLL NUTR, V28, P16, DOI 10.1080/07315724.2009.10719756
   Rudich A, 2007, TRENDS ENDOCRIN MET, V18, P291, DOI 10.1016/j.tem.2007.08.006
   Schelbert KB, 2009, PRIMARY CARE, V36, P271, DOI 10.1016/j.pop.2009.01.009
   Seet RCS, 2011, ATHEROSCLEROSIS, V219, P231, DOI 10.1016/j.atherosclerosis.2011.07.097
   Sohet FM, 2012, NUTR REV, V70, P631, DOI 10.1111/j.1753-4887.2012.00526.x
   Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3
   Timmers S, 2013, ANN NY ACAD SCI, V1290, P83, DOI 10.1111/nyas.12185
   Upritchard JE, 2000, DIABETES CARE, V23, P733, DOI 10.2337/diacare.23.6.733
   Vanschoonbeek K, 2006, J NUTR, V136, P977, DOI 10.1093/jn/136.4.977
   Vashum KP, 2013, BMC ENDOCR DISORD, V13, P0, DOI 10.1186/1472-6823-13-40
   Vidal-Casariego A, 2013, EXP CLIN ENDOCR DIAB, V121, P234, DOI 10.1055/s-0033-1333688
   Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   WAGENKNECHT T, 1984, BIOCHEMISTRY-US, V23, P3383, DOI 10.1021/bi00310a001
   Walia M, 2003, MED PRIN PRACT, V12, P1, DOI 10.1159/000068159
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21
   Woehrlin F, 2010, J AGR FOOD CHEM, V58, P10568, DOI 10.1021/jf102112p
   Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763
   Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, PE736, DOI 10.1152/ajpendo.00183.2011
   Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015
   Zhang YY, 2011, OBESITY, V19, P1647, DOI 10.1038/oby.2011.121
NR 97
TC 139
Z9 151
U1 1
U2 48
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1011-7571
EI 1423-0151
J9 MED PRIN PRACT
JI Med. Princ. Pract.
PD JUN 15
PY 2015
VL 24
IS 3
BP 201
EP 215
DI 10.1159/000375305
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA CJ0UZ
UT WOS:000355195400001
PM 25791371
DA 2025-04-28
ER

PT J
AU Vogel, RM
   Joy, JM
   Falcone, PH
   Mosman, MM
   Kim, MP
   Moon, JR
AF Vogel, Roxanne M.
   Joy, Jordan M.
   Falcone, Paul H.
   Mosman, Matt M.
   Kim, Michael P.
   Moon, Jordan R.
TI Consuming a multi-ingredient thermogenic supplement for 28 days is apparently safe in healthy adults
SO FOOD & NUTRITION RESEARCH
LA English
DT Article
DE weight loss supplement; safety; clinical; hematology; nutrition; fat burner
ID weight-loss; green tea; dietary-supplements; energy-expenditure; double-blind; us adults; efficacy; obesity; capsaicin; caffeine
AB Background: Thermogenic (TRM) supplements are often used by people seeking to decrease body weight. Many TRM supplements are formulated with multiple ingredients purported to increase energy expenditure and maximize fat loss. However, in the past some TRM ingredients have been deemed unsafe and removed from the market. Therefore, it is important to verify the safety of multi-ingredient TRM supplements with chronic consumption. Objective: To assess the safety of daily consumption of a multi-ingredient TRM supplement over a 28-day period in healthy adults. Design: Twenty-three recreationally active adults (11M, 12F; 27.1 +/- 5.4 years, 171.6 +/- 9.6 cm, 76.8 +/- 16.1 kg, 26 +/- 5 BMI) were randomly assigned either to consume a multi-ingredient TRM supplement (SUP; n = 9) or remain unsupplemented (CRL; n = 14) for 28 days. Participants maintained their habitual dietary and exercise routines for the duration of the study. Fasting blood samples, resting blood pressure, and heart rate were taken before and after the supplementation period. Samples were analyzed for complete blood counts, comprehensive metabolic, and lipid panels. Results: Significant (p<0.05) group by time interactions were present for diastolic BP, creatinine, estimated glomerular filtration rate (eGFR), chloride, CO2, globulin, albumin: globulin (A/G), and high-density lipoprotein (HDL). Dependent t-tests conducted on significant variables revealed significant (p<0.05) within-group differences in SUP for diastolic BP (+6.2 +/- 5.3 mmHG), creatinine (+0.09 +/- 0.05 mg/dL), eGFR (-11.2 +/- 5.8 mL/min/1.73), globulin (-0.29 +/- 0.24 g/dL), A/G (+0.27 +/- 0.23), and HDL (-5.0 +/- 5.5 mg/dL), and in CRL for CO2 (-1.9 +/- 1.5 mmol/L) between time points. Each variable remained within the accepted physiological range. Conclusion: Results of the present study support the clinical safety of a multi-ingredient TRM containing caffeine, green tea extract, and cayenne powder. Although there were statistically significant (p<0.05) intragroup differences in SUP from pre-to postsupplementation for diastolic BP, creatinine, eGFR, globulin, A/G, and HDL, all remained within accepted physiological ranges and were not clinically significant. In sum, it appears as though daily supplementation with a multi-ingredient TRM is safe for consumption by healthy adults for a 28-day period.
C1 [Vogel, Roxanne M.; Joy, Jordan M.; Falcone, Paul H.; Mosman, Matt M.; Kim, Michael P.; Moon, Jordan R.] MusclePharm Sports Sci Inst, Denver, CO USA.
   [Vogel, Roxanne M.; Joy, Jordan M.] Concordia Univ Chicago, Dept Human Performance, River Forest, IL USA.
   [Moon, Jordan R.] US Sports Acad, Dept Sports Exercise Sci, Daphne, AL USA.
RP Moon, JR (corresponding author), 4721 Ironton St,Bldg A, Denver, CO 80239 USA.
EM jordan@musclepharm.com
FU MusclePharm Corporation
CR ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Farney TM, 2012, NUTR METAB INSIGHTS, V5, P0, DOI 10.4137/NMI.S8568
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010
   Roberts MD, 2008, J INT SOC SPORT NUTR, V5, P0, DOI 10.1186/1550-2783-5-19
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Smeets AJ, 2013, J NUTR, V143, P442, DOI 10.3945/jn.112.170613
   *US FDA, 2004, FDA ISS REG PROH SAL, V0, P0
   US Food and Drug Administration, 2013, STIM POT DANG HLTH F, V0, P0
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
NR 18
TC 11
Z9 12
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PD JUN 15
PY 2015
VL 59
IS 
BP 
EP 
DI 10.3402/fnr.v59.27999
PG 6
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA CN3DC
UT WOS:000358303100001
PM 26205229
DA 2025-04-28
ER

PT J
AU Ohara, T
   Muroyama, K
   Yamamoto, Y
   Murosaki, S
AF Ohara, Tatsuya
   Muroyama, Koutarou
   Yamamoto, Yoshihiro
   Murosaki, Shinji
TI A Combination of Glucosyl Hesperidin and Caffeine Exhibits an Anti-obesity Effect by Inhibition of Hepatic Lipogenesis in Mice
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE glucosyl hesperidin; caffeine; anti-obesity effect; lipogenesis; liver
ID serum triglyceride level; metabolic syndrome; hepg2 cells; cardiovascular-disease; lipid-accumulation; citric-acid; kk mice; arginine; mixture; adiposity
AB To develop an anti-obesity agent, we examined the combination effect of glucosyl hesperidin (G-hesperidin) and caffeine on obesity in mice. High-fat diet-induced obese KK mice were fed a low-fat diet with or without G-hesperidin, caffeine, or their combination for 2weeks. Decreases in body weight and significantly lower adipose tissue weight were observed in the combination-fed mice but not in the G-hesperidin-fed or caffeine-fed mice. DNA microarray analysis of mouse liver suggested that the feeding of G-hesperidin+caffeine was associated with lower lipogenesis. Therefore, we examined the anti-lipogenic effect of G-hesperidin+caffeine in fasted-refed KK mice. Hepatic triglyceride levels were significantly lower in the mice fed G-hesperidin+caffeine during the refeeding period but not in the mice fed each alone. In addition, hepatic expressions of genes related to lipogenesis, such as sterol regulatory element-binding protein-1c or fatty acid synthase, were significantly lower in the mice fed G-hesperidin+caffeine compared with that in the control mice. These results suggested that G-hesperidin+caffeine is effective for controlling obesity partly by the inhibition of hepatic lipogenesis. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Ohara, Tatsuya; Muroyama, Koutarou; Yamamoto, Yoshihiro; Murosaki, Shinji] House Wellness Foods Corp, Inst Res & Dev, Itami, Hyogo 6640011, Japan.
RP Ohara, T (corresponding author), House Wellness Foods Corp, Inst Res & Dev, 3-20 Imoji, Itami, Hyogo 6640011, Japan.
EM Ohara_Tatsuya@house-wf.co.jp
CR Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   Castellani LW, 2008, J BIOL CHEM, V283, P11633, DOI 10.1074/jbc.M708995200
   Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074
   HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5
   Hijiya H, 1991, EUROPEAN PATENT, V0, Patent No. 0402049
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9
   HY-YA M, 2011, JPN PHARMACOL THER, V39, P727
   Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002
   Koutsari C, 2006, J LIPID RES, V47, P1643, DOI 10.1194/jlr.R600011-JLR200
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502
   McCarthy MF, 2004, MED HYPOTHESES, V63, P1065, DOI 10.1016/j.mehy.2002.11.002
   Miwa Y, 2005, J NUTR SCI VITAMINOL, V51, P460, DOI 10.3177/jnsv.51.460
   Miwa Y, 2004, J NUTR SCI VITAMINOL, V50, P211, DOI 10.3177/jnsv.50.211
   Miwa Y, 2006, J NUTR SCI VITAMINOL, V52, P223, DOI 10.3177/jnsv.52.223
   Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Muroyama K, 2003, J NUTR SCI VITAMINOL, V49, P56, DOI 10.3177/jnsv.49.56
   Muroyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P2325, DOI 10.1271/bbb.67.2325
   Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642
   Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342
   Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572
   Plump AS, 1997, J LIPID RES, V38, P1033
   Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153
   Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554
   Yamada M, 2006, BIOSCI BIOTECH BIOCH, V70, P1386, DOI 10.1271/bbb.50657
NR 30
TC 22
Z9 23
U1 1
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD FEB 15
PY 2015
VL 29
IS 2
BP 310
EP 316
DI 10.1002/ptr.5258
PG 7
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA CA7DB
UT WOS:000349076500016
PM 25409936
DA 2025-04-28
ER

PT J
AU Sung, YY
   Kim, DS
   Kim, HK
AF Sung, Yoon-Young
   Kim, Dong-Seon
   Kim, Ho Kyoung
TI Akebia quinata extract exerts anti-obesity and hypolipidemic effects in high-fat diet-fed mice and 3T3-L1 adipocytes
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Adipogenesis; Adipose tissue; Akebia quinata; AMP-activated protein kinase; Fatty acid oxidation
ID activated protein-kinase; induced obesity; adipose-tissue; energy-balance; white adipose; ppar-alpha; expression; adiponectin; metabolism; mass
AB Ethnopharmacological relevance: The dry ripe fruit of the Akebia quinata (A. quinata) plant is used as an analgesic, an antiphlogistic, and a diuretic in traditional medicine. A. quinata has also been used in Korea as a crude drug for treating obesity. The aim of the study was to determine the anti-obesity and hypolipidemic effects of A. quinata extract (AQE) in mice consuming a high-fat diet and in 3T3-L1 adipocytes. Materials and methods: We measured obesity-related physiological parameters, gene expression, and protein phosphorylation in mice consuming a high-fat diet supplemented with AQE (400 mg/kg/day) for 6.5 weeks. Results: AQE reduced gain in body weight, adipose tissue weight, and serum lipid levels in mice consuming a high-fat diet. AQE supplementation reduced expression of genes related to adipogenesis and increased expression of PPAR alpha, acetyl-CoA oxidase, and adiponectin in the epididymal adipose tissue. Furthermore, AQE increased phospholylation of adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA carboxylase, both of which are related to fatty acid oxidation, in vivo. HPLC analysis revealed that AQE contained chlorogenic acid, isochlorogenic acid A, and isochlorogenic acid C. AQE and all of these constituents inhibited differentiation of 3T3-L1 cells and enhanced AMPK phosphorylation. Conclusions: These results suggest the AQE exerted anti-obesity and hypolipidemic effects in mice consuming a high-fat diet by regulating adipogenesis and fatty acid oxidation via AMPK activation. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Sung, Yoon-Young; Kim, Ho Kyoung] Korea Inst Oriental Med, Mibyeong Res Ctr, Taejon 305811, South Korea.
   [Kim, Dong-Seon] Korea Inst Oriental Med, KM Convergence Res Div, Taejon 305811, South Korea.
C3 Korea Institute of Oriental Medicine (KIOM); Korea Institute of Oriental Medicine (KIOM)
RP Kim, HK (corresponding author), Korea Inst Oriental Med, Mibyeong Res Ctr, 1672 Yuseong Daero, Taejon 305811, South Korea.
EM yysung@kiom.re.kr; dskim@kiom.re.kr; hkkim@kiom.re.kr
FU Korea Institute of Oriental Medicine, South Korea [K15200]; National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, South Korea [NRF-2014M3A9D7034335]
CR Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Bray G A, 2001, REV ENDOCR METAB DISORD, V2, P403, DOI 10.1023/A:1011808701117
   Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi HJ, 2007, BIOCHEM BIOPH RES CO, V359, P419, DOI 10.1016/j.bbrc.2007.05.107
   Choi J, 2005, J MED FOOD, V8, P78, DOI 10.1089/jmf.2005.8.78
   Dulloo AG, 2004, PHYSIOL BEHAV, V83, P587, DOI 10.1016/j.physbeh.2004.07.028
   Fasshauer M, 2003, DIABETOLOGIA, V46, P1594, DOI 10.1007/s00125-003-1228-z
   Hardie DG, 2008, INT J OBESITY, V32, PS7, DOI 10.1038/ijo.2008.116
   전용섭, 2014, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION 한국식품영양과학회지, V43, P200
   Hsu CY, 2007, BIOL RES, V40, P13
   Hsu SC, 2006, J NUTR, V136, P1779, DOI 10.1093/jn/136.7.1779
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kawata Jyunichi, 2007, J OLEO SCI, V56, P59
   Kim SK, 2010, CHEM-BIOL INTERACT, V186, P24, DOI 10.1016/j.cbi.2010.04.003
   Kim SJ, 2008, BIOL PHARM BULL, V31, P1415, DOI 10.1248/bpb.31.1415
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899
   Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Rim A-Ram, 2006, PREVENTIVE NUTRITION AND FOOD SCIENCE, V11, P84
   Rohrer J, 2007, BMC HEALTH SERV RES, V7, P1
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Schnell MA, 2002, HUM GENE THER, V13, P155, DOI 10.1089/10430340152712700
   Song MY, 2009, J MED FOOD, V12, P304, DOI 10.1089/jmf.2008.1010
   Sung YY, 2011, MOL MED REP, V4, P431, DOI 10.3892/mmr.2011.451
   Tang W, 1992, CHINESE DRUGS PLANT, V0, P59
   Tzeng TF, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/781812
   Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355
   Yamamoto Y, 2002, CLIN SCI, V103, P137, DOI 10.1042/CS20010336
   Zhou Y, 2009, BIOL PHARM BULL, V32, P993, DOI 10.1248/bpb.32.993
NR 35
TC 41
Z9 44
U1 2
U2 49
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JUN 20
PY 2015
VL 168
IS 
BP 17
EP 24
DI 10.1016/j.jep.2015.03.051
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA CK9JG
UT WOS:000356555800002
PM 25835369
DA 2025-04-28
ER

PT J
AU Fogelholm, M
   Kanerva, N
   Männistö, S
AF Fogelholm, M.
   Kanerva, N.
   Mannisto, S.
TI Association between red and processed meat consumption and chronic diseases: the confounding role of other dietary factors
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID energy-intake; weight-gain; cardiovascular risk; unprocessed red; cancer; women; carbohydrate; mortality; patterns; cutoff
AB BACKGROUND/OBJECTIVES: High consumption of meat has been linked with the risk for obesity and chronic diseases. This could partly be explained by the association between meat and lower-quality diet. We studied whether high intake of red and processed meat was associated with lower-quality dietary habits, assessed against selected nutrients, other food groups and total diet. Moreover, we studied whether meat consumption was associated with obesity, after adjustment for all identified associations between meat and food consumption. SUBJECTS/METHODS: The nationally representative cross-sectional study population consisted of 2190 Finnish men and 2530 women, aged 25-74 years. Food consumption over the previous 12 months was assessed using a validated 131-item Food Frequency Questionnaire. Associations between nutrients, foods, a modified Baltic Sea Diet Score and meat consumption (quintile classification) were analysed using linear regression. The models were adjusted for age and energy intake and additionally for education, physical activity and smoking. RESULTS: High consumption of red and processed meat was inversely associated with fruits, whole grain and nuts, and positively with potatoes, oil and coffee in both sexes. Results separately for the two types of meat were essentially similar. In a linear regression analysis, high consumption of meat was positively associated with body mass index in both men and women, even when using a model adjusted for all foods with a significant association with meat consumption in both sexes identified in this study. CONCLUSIONS: The association between meat consumption and a lower-quality diet may complicate studies on meat and health.
C1 [Fogelholm, M.] Univ Helsinki, Dept Food & Environm Sci, FI-00014 Helsinki, Finland.
   [Kanerva, N.] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   [Kanerva, N.; Mannisto, S.] Natl Inst Hlth & Welf, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare
RP Fogelholm, M (corresponding author), Univ Helsinki, Dept Food & Environm Sci, POB 99, FI-00014 Helsinki, Finland.
EM mikael.fogelholm@helsinki.fi
FU Academy of Finland [136895, 263836]; Academy of Finland (AKA) [136895, 263836] Funding Source: Academy of Finland (AKA); European Research Council (ERC) [263836] Funding Source: European Research Council (ERC)
CR Aston LM, 2012, BMJ OPEN, V2, P0, DOI 10.1136/bmjopen-2012-001072
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Brennan IM, 2012, AM J PHYSIOL-GASTR L, V303, PG129, DOI 10.1152/ajpgi.00478.2011
   Chan DSM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020456
   FAO/WHO/UNU, 1985, EN PROT REQ, V0, P0
   Fogelholm M, 2012, FOOD NUTR RES, V56, P0, DOI 10.3402/fnr.v56i0.19103
   Fretts AM, 2012, AM J CLIN NUTR, V95, P752, DOI 10.3945/ajcn.111.029942
   Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   Halkjer J, 2009, J AM DIET ASSOC, V109, P1356, DOI 10.1016/j.jada.2009.05.015
   Kaartinen NE, 2012, BRIT J NUTR, V107, P1367, DOI 10.1017/S0007114511004296
   Kappeler R, 2013, EUR J CLIN NUTR, V67, P598, DOI 10.1038/ejcn.2013.59
   Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149
   Larsson SC, 2012, BRIT J CANCER, V106, P603, DOI 10.1038/bjc.2011.585
   Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X
   Männistö S, 2010, BRIT J NUTR, V103, P1817, DOI 10.1017/S0007114510000073
   Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x
   Micha R, 2012, CURR ATHEROSCLER REP, V14, P515, DOI 10.1007/s11883-012-0282-8
   Mikkilä V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978
   Reinivuo H, 2010, PUBLIC HEALTH NUTR, V13, P915, DOI 10.1017/S1368980010001096
   Rohrmann S, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-63
   Romaguera D, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023384
   Rosell M, 2006, INT J OBESITY, V30, P1389, DOI 10.1038/sj.ijo.0803305
   Sánchez-Villegas A, 2006, INT J OBESITY, V30, P350, DOI 10.1038/sj.ijo.0803118
   Tolonen H, 2008, RECOMMENDATIONS FOR THE HEALTH EXAMINATION SURVEYS IN EUROPE, V0, P0
   Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330
   Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
NR 32
TC 41
Z9 44
U1 0
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD SEP 15
PY 2015
VL 69
IS 9
BP 1060
EP 1065
DI 10.1038/ejcn.2015.63
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CQ7SX
UT WOS:000360805600011
PM 25969395
DA 2025-04-28
ER

PT J
AU Robertson, TM
   Clifford, MN
   Penson, S
   Chope, G
   Robertson, MD
AF Robertson, Tracey M.
   Clifford, Michael N.
   Penson, Simon
   Chope, Gemma
   Robertson, M. Denise
TI A single serving of caffeinated coffee impairs postprandial glucose metabolism in overweight men
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Human; Coffee; Caffeine; Glucose; Insulin; Metabolism; Postprandial metabolism
ID decaffeinated coffee; chlorogenic acid; insulin sensitivity; blood-glucose; energy-expenditure; body-mass; risk; consumption; tolerance; ingestion
AB Previous studies regarding the acute effects of coffee on glycaemic control have used a single large dose of coffee, typically containing the caffeine equivalent of 2-4 servings of coffee. This study investigates whether the acute effects of coffee are dose-dependent, starting with a single serving. A total of ten healthy overweight males participated in a two-part randomised double-blind cross-over study. In the first part, they ingested 2, 4 or 8 g instant decaffeinated coffee (DC) dissolved in 400 ml water with caffeine added in proportion to the DC (total 100, 200 or 400 mg caffeine) or control (400 ml water) all with 50 g glucose. In the second part, they ingested the same amounts of DC (2, 4, 8 g) or control, but with a standard 100 mg caffeine added to each. Capillary blood samples were taken every 15 min for 2 h after each drink and glucose and insulin levels were measured. Repeated measures ANOVA on glucose results found an effect when caffeine was varied in line with DC (P = 0.008). Post hoc analysis revealed that both 2 and 4 g DC with varied caffeine content increased the glycaemic response v. control. There was no effect of escalating doses of DC when caffeine remained constant at 100 mg. These results demonstrate that one standard serving of coffee (2 g) is sufficient to affect glucose metabolism. Furthermore, the amount of caffeine found in one serving (100 mg) is sufficient to mask any potential beneficial effects of increasing other components. No dose-dependent effect was found.
C1 [Robertson, Tracey M.; Clifford, Michael N.; Robertson, M. Denise] Univ Surrey, Dept Nutr Sci, Guildford GU2 7WG, Surrey, England.
   [Penson, Simon; Chope, Gemma] Campden BRI, Dept Primary Prod & Proc, Chipping Campden GL55 6LD, Glos, England.
C3 University of Surrey
RP Robertson, MD (corresponding author), Univ Surrey, Dept Nutr Sci, Guildford GU2 7WG, Surrey, England.
EM m.robertson@surrey.ac.uk
FU Biotechnology and Biological Sciences Research Council (BBSRC); Campden BRI, a BBSRC CASE Studentship
CR Unknown -, 1998, FAO FOOD NUTR PAP, V66, P1
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Beaudoin MS, 2013, APPL PHYSIOL NUTR ME, V38, P140, DOI 10.1139/apnm-2012-0201
   Beaudoin MS, 2011, J NUTR, V141, P574, DOI 10.3945/jn.110.132761
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   GILBERT RM, 1976, CAN MED ASSOC J, V114, P205
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kempf K, 2015, EUR J NUTR, V54, P845, DOI 10.1007/s00394-014-0763-3
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   LARSSONCOHN U, 1976, SCAND J CLIN LAB INV, V36, P805, DOI 10.3109/00365517609081941
   Ludwig IA, 2012, FOOD RES INT, V48, P57, DOI 10.1016/j.foodres.2012.02.023
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   McCusker RR, 2003, J ANAL TOXICOL, V27, P520, DOI 10.1093/jat/27.7.520
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Ohnaka K, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/207426
   Robertson MD, 2001, AM J CLIN NUTR, V73, P111
   Robinson LE, 2004, J NUTR, V134, P2528, DOI 10.1093/jn/134.10.2528
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Strazzullo P, 2008, METABOLISM, V57, P355, DOI 10.1016/j.metabol.2007.10.010
   The British Coffee Association, 2015, COFF FACTS, V0, P0
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1
NR 42
TC 23
Z9 26
U1 0
U2 35
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD OCT 28
PY 2015
VL 114
IS 8
BP 1218
EP 1225
DI 10.1017/S0007114515002640
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CT7DT
UT WOS:000362974700014
PM 26316273
DA 2025-04-28
ER

PT J
AU Park, S
   McGuire, LC
   Galuska, DA
AF Park, Sohyun
   McGuire, Lisa C.
   Galuska, Deborah A.
TI Regional Differences in Sugar-Sweetened Beverage Intake among US Adults
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Sugar-sweetened beverages; Soda; Fruit-flavored drinks; Sports and energy drinks; Geographic region
ID united-states; consumption; risk; questionnaire; obesity; weight
AB Background Higher consumption of sugar-sweetened beverages (SSBs) is associated with obesity and type 2 diabetes, and the prevalence of obesity varies by geographic region. Although information on whether SSB intake differs geographically could be valuable for designing targeted interventions, this information is limited. Objective This cross-sectional study examined associations between living in specific census regions and frequency of SSB consumption among US adults using 2010 National Health Interview Survey data (n=25,431). Methods SSB consumption was defined as the consumption of four types of beverages (regular sugar-sweetened carbonated beverages, fruit drinks, sports/energy drinks, and sweetened coffee/tea drinks). The exposure variable was census region of residence (Northeast, Midwest, South, and West). We used multivariable logistic regression to estimate adjusted odds ratios (aORs) and 95% CIs for drinking SSBs after controlling for sociodemographic characteristics. Results Approximately 64% of adults consumed SSBs >= 1 time/day. The odds of drinking SSBs >= 1 time/day were significantly higher among adults living in the Northeast (aOR=1.13; 95% CI=1.01, 1.26) but lower among adults living in the Midwest (aOR=0.70; 95% CI=0.64, 0.78) or West (aOR=0.78; 95% CI=0.71, 0.87) compared with those living in the South. By type of SSB, the odds of drinking regular soda >= 1 time/day was significantly lower among adults living in the Northeast (aOR=0.51; 95% CI=0.45, 0.57), Midwest (aOR=0.86; 95% CI=0.78, 0.96), or West (aOR=0.56; 95% CI=0.51, 0.62) than those living in the South. The odds of drinking sports/energy drinks >= 1 time/day were significantly lower among adults living in the West (aOR=0.77; 95% CI=0.64, 0.93) than those living in the South. The odds of drinking a sweetened coffee/tea drink >= 1 time/day were significantly higher among adults living in the Northeast (aOR=1.60; 95% CI=1.43, 1.78) but lower among adults living in the Midwest (aOR=0.70; 95% CI=0.62, 0.78) than those living in the South. Conclusions Total frequency of SSB consumption and types of SSB consumption differed by geographic region. Interventions to reduce SSB intake could consider regional variations in SSB intake, particularly when more local data are not available.
C1 [Park, Sohyun; McGuire, Lisa C.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
   [Galuska, Deborah A.] Ctr Dis Control & Prevent, Sci, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
C3 Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA
RP Park, S (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop F77, Atlanta, GA 30341 USA.
EM spark3@cdc.gov
FU Intramural CDC HHS [CC999999] Funding Source: Medline
CR Unknown -, 2014, NATIONAL DIABETES STATISTICS REPORT, V0, P0
   Unknown -, 2019, DAT STAT, V0, P0
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Centers for Disease Control and Prevention, 1900, AND OBESITY, V0, P0
   Centers for Disease Control and Prevention US Department of Health and Human Services, 2011, 2010 NAT HLTH INT SU, V0, P0
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Kumar GS, 2014, MMWR-MORBID MORTAL W, V63, P686
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Martin-Biggers J, 2013, APPETITE, V62, P160, DOI 10.1016/j.appet.2012.12.001
   Ogden Cynthia L, 2011, NCHS DATA BRIEF, V0, P1
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Park S, 2014, PREV CHRONIC DIS, V11, P0, DOI 10.5888/pcd11.130304
   Park S, 2014, J ACAD NUTR DIET, V114, P1059, DOI 10.1016/j.jand.2013.11.003
   Park S, 2013, J ACAD NUTR DIET, V113, P112, DOI 10.1016/j.jand.2012.09.019
   Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46
   Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, PE1596, DOI 10.1210/jc.2011-1251
   Tucker KL, 2005, PUBLIC HEALTH NUTR, V8, P87, DOI 10.1079/PHN2005663
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
NR 33
TC 43
Z9 49
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD DEC 15
PY 2015
VL 115
IS 12
BP 1996
EP 2002
DI 10.1016/j.jand.2015.06.010
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CX9DF
UT WOS:000366004400011
PM 26231057
DA 2025-04-28
ER

PT J
AU Alsunni, A
   Majeed, F
   Yar, T
   AlRahim, A
   Ajhawaj, AF
   Alzaki, M
AF Alsunni, Ahmed
   Majeed, Farrukh
   Yar, Talay
   AlRahim, Ahmed
   Ajhawaj, Ali Fuad
   Alzaki, Muneer
TI Effects of energy drink consumption on corrected QT interval and heart rate variability in young obese Saudi male university students
SO ANNALS OF SAUDI MEDICINE
LA English
DT Article
ID electrocardiographic parameters; atrial-fibrillation; caffeine; repolarization; overweight; dispersion; system
AB BACKGROUND AND OBJECTIVES: Consumption of energy drinks has adverse effects on the heart that might be potentiated in obese individuals. Since the incidence of obesity and use of energy drinks is high among Saudi youth, we used non-invasive tests to study hemodynamic changes produced by altered autonomic cardiac activity following consumption of energy drinks in obese male students. DESIGN AND SETTING: This cross-sectional study was carried out at Department of Physiology, College of Medicine, University of Dammam, Saudi Arabia, over a one-year period from December 2013 to December 2014. SUBJECTS AND METHODS: In Saudi male university students we measured continuous ECG recordings and a one-minute deep breathing maneuver to measure the expiratory-to-inspiratory ratio, the mean heart rate range (MHRR), the mean percentage variability. (M% VHR) and the corrected QT interval (QTc) at 0, 30 and 60 minutes after consumption of energy drink. RESULTS: We enrolled 31 students (18 overweight/obese and 13 normal weights. QTc was significantly increased at 60 min as compared with the resting state in overweight/obese subjects (P=.006). Heart rate variability was significantly less in obese as compared with normal weight subjects at 60 minutes as indicated by E:I ratio, (P=.037), MHRR (P=.012), M% VHR (P=.040) after energy drink consumption. Significant increases in diastolic (P=.020) and mean arterial blood pressure (P=.024) were observed at 30 minutes in the obese group. CONCLUSION: Hemodynamic changes after intake of energy drinks in obese subjects indicate that obesity and energy drinks could synergistically induce harmful effects. This finding warrants efforts to caution the obese on intake of energy drinks and timely intervention to motivate changes in life style.
C1 [Alsunni, Ahmed; Majeed, Farrukh; Yar, Talay; AlRahim, Ahmed; Ajhawaj, Ali Fuad; Alzaki, Muneer] Univ Dammam, Dept Physiol, Al Khobar 31441, Saudi Arabia.
C3 Imam Abdulrahman Bin Faisal University
RP Majeed, F (corresponding author), Univ Dammam, Dept Physiol, Al Khobar 31441, Saudi Arabia.
EM fmajeed@uod.edu.sa
FU Deanship of Scientific Research at the University of Dammam, KSA
CR Alsunni Ahmed A, 2011, J AYUB MED COLL ABBOTTABAD, V23, P3
   Ambhore A, 2014, SINGAP MED J, V55, P607, DOI 10.11622/smedj.2014172
   Unknown -, 2009, CLEVE CLIN J MED, V0, P0, DOI DOI 10.3949/CCJM.76.S2.08
   Unknown -, 2006, QTC PROL RISK SUDD C, V0, P0
   Barella LF, 2015, EXP PHYSIOL, V100, P57, DOI 10.1113/expphysiol.2014.082982
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Bhave PD, 2013, HEART, V99, P1377, DOI 10.1136/heartjnl-2013-304543
   Braschi A, 2011, OBESITY, V19, P875, DOI 10.1038/oby.2010.252
   Buscemi S, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-15
   Cavka A, 2015, INT J ENDOCRINOL, V2015, P0, DOI 10.1155/2015/751530
   Davey P, 2002, J PHARMACOL TOXICOL, V48, P3, DOI 10.1016/S1056-8719(03)00008-X
   Girola A, 2001, OBES RES, V9, P71, DOI 10.1038/oby.2001.9
   Hsu HS, 2011, EUR J CLIN INVEST, V41, P393, DOI 10.1111/j.1365-2362.2010.02421.x
   Ibrahim NK, 2014, PAK J MED SCI, V30, P1415, DOI 10.12669/pjms.306.5396
   Indumathy J, 2015, OBES RES CLIN PRACT, V9, P55, DOI 10.1016/j.orcp.2014.01.007
   Karapetian GK, 2012, INT J SPORTS MED, V33, P507, DOI 10.1055/s-0032-1301904
   Karim Nasim, 2011, J BASIC APPL SCI, V7, P71
   Kim WS, 2014, ANN REHABIL MED-ARM, V38, P775, DOI 10.5535/arm.2014.38.6.775
   Malinauskas BM, 2007, NUTR J, V6, P0, DOI 10.1186/1475-2891-6-35
   Mapanga RF, 2014, ACTA PHYSIOL, V210, P546, DOI 10.1111/apha.12184
   Maule S, 2008, HYPERTENS RES, V31, P2003, DOI 10.1291/hypres.31.2003
   Mukerji R, 2012, OBESITY, V20, P1950, DOI 10.1038/oby.2011.255
   Musat DL, 2013, AM J CARDIOL, V112, P1379, DOI 10.1016/j.amjcard.2013.06.027
   Nomura A, 2000, AM J CARDIOL, V85, P106, DOI 10.1016/S0002-9149(99)00617-7
   Norah M, 2010, J EGYPT PUBLIC HLTH, V85, P46
   OBrien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Olateju T, 2015, CAN J DIABETES, V39, P78, DOI 10.1016/j.jcjd.2014.07.220
   OPTHOF T, 1993, CARDIOVASC RES, V27, P753, DOI 10.1093/cvr/27.5.753
   Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021
   Seyfeli E, 2006, INT J OBESITY, V30, P957, DOI 10.1038/sj.ijo.0803233
   SMITH SE, 1981, CLIN SCI, V61, P379, DOI 10.1042/cs0610379
   Steinke L, 2009, ANN PHARMACOTHER, V43, P596, DOI 10.1345/aph.1L614
   Valtonen MK, 2012, SCAND J PUBLIC HEALT, V40, P674, DOI 10.1177/1403494812461730
   Vardar SA, 2008, ANATOL J CARDIOL, V8, P27
   Wójcik OP, 2013, EUR J NUTR, V52, P169, DOI 10.1007/s00394-011-0300-6
   Yoshinaga C, 2012, INTERNATIONAL SPORTMED JOURNAL, V13, P109
NR 36
TC 14
Z9 15
U1 0
U2 23
PU K FAISAL SPEC HOSP RES CENTRE
PI RIYADH
PA PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA
SN 0256-4947
EI 1319-9226
J9 ANN SAUDI MED
JI Ann. Saudi Med.
PD JUL-AUG 15
PY 2015
VL 35
IS 4
BP 282
EP 287
DI 10.5144/0256-4947.2015.282
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA CV5WO
UT WOS:000364342300002
PM 26497707
DA 2025-04-28
ER

PT J
AU Santhanam, P
   Solnes, L
   Hannukainen, JC
   Taïeb, D
AF Santhanam, Prasanna
   Solnes, Lilja
   Hannukainen, Jarna C.
   Taieb, David
TI ADIPOSITY-RELATED CANCER AND FUNCTIONAL IMAGING OF BROWN ADIPOSE TISSUE
SO ENDOCRINE PRACTICE
LA English
DT Review
ID adaptive thermogenesis; white adipocytes; beige adipocytes; f-18-fdg pet/ct; energy-balance; glucose-uptake; breast-cancer; in-vivo; fat; cold
AB Objective: Brown adipose tissue (BAT) is involved in energy dissipation and cytokine production and is potentially beneficial for the human body. The aim of the paper is to review the literature on adiposity-related cancer and functional imaging of BAT. Methods: We performed a review on adiposity-related cancer and functional imaging of BAT. We extensively researched papers for information on BAT molecular biology, as well as functional imaging modalities. Results: Adipose tissue is linked to the development of many cancers. Multiple drugs including fenofibrate, spironolactone, and other substances, as well as experimental agents like b-3 receptor agonists, caffeine, green tea extract, medium chain triglycerides (MCTs), and adenosine are known to stimulate and activate BAT. However, cold and nonshivering thermogenesis are the main activators of BAT. BAT has been detected on both magnetic resonance imaging (MRI) and 18F-fluorodexoxyglucose positron emission tomography (18F-FDG-PET)-based imaging in multiple studies. Different methods of cold stimulation and static and dynamic protocols have been used to detect and image BAT. Factors like sex, fasting or fed state, surface skin temperature, and/or body mass index (BMI) may influence PET-based BAT detection. BAT has also been detected using MRI, (99m)Technetium(Tc)-sestamibi, and 123I- metaiodobenzylguanidine single-photon emission computed tomography/computed tomography (MIBG SPECT/CT). Conclusions: Stimulation of BAT offers promise in the management of obesity-related conditions. Tracers like [O-15]-H2O, [C-11] acetate, and 18F-fluoro-6-thia-heptadecanoic acid (18F-FTHA) that measure BAT blood flow, oxygen utilization, and nonessential fatty acid (NEFA) uptake, respectively, have been studied in humans. Future studies should focus on BAT tissue generation by altering the genetic pathways of adiposity-linked genes.
C1 [Santhanam, Prasanna] Marshall Univ, Joan C Edwards Sch Med, Dept Internal Med, Sect Endocrinol, Huntington, WV 25701 USA.
   [Solnes, Lilja] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA.
   [Hannukainen, Jarna C.] Univ Turku, Turku PET Ctr, Turku, Finland.
   [Taieb, David] Aix Marseille Univ, CERIMED, La Timone Univ Hosp, Dept Nucl Med, Marseille, France.
   [Taieb, David] Inst J Paoli I Calmettes, Marseille Cancerol Res Ctr, Inserm UMR1068, Marseille, France.
C3 Marshall University; Johns Hopkins University; University of Turku; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); Aix-Marseille Universite
RP Santhanam, P (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Internal Med, Sect Endocrinol, Huntington, WV 25701 USA.
EM prasanna@marshall.edu
CR Admiraal WM, 2013, J NUCL MED, V54, P208, DOI 10.2967/jnumed.112.111849
   Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415
   Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715
   Bae HS, 2014, J OVARIAN RES, V7, P0, DOI 10.1186/1757-2215-7-41
   Bauwens M, 2014, EUR J NUCL MED MOL I, V41, P776, DOI 10.1007/s00259-013-2611-8
   Beiroa D, 2014, DIABETES, V63, P3346, DOI 10.2337/db14-0302
   Berstein LM, 2012, FUTURE ONCOL, V8, P1537, DOI 10.2217/FON.12.150
   Bielli A, 2014, SPRINGERPLUS, V3, P0, DOI 10.1186/2193-1801-3-345
   Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115
   Brown RS, 1999, J NUCL MED, V40, P556
   Cao Q, 2014, BMC CANCER, V14, P0, DOI 10.1186/1471-2407-14-126
   Cereijo R, 2015, ANN MED, V47, P169, DOI 10.3109/07853890.2014.952328
   Coe PO, 2014, BRIT J SURG, V101, P1518, DOI 10.1002/bjs.9623
   Cohade C, 2003, J NUCL MED, V44, P170
   Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Dallner OS, 2006, ENDOCRINOLOGY, V147, P5730, DOI 10.1210/en.2006-0242
   De Pergola G, 2013, J OBES, V2013, P0, DOI 10.1155/2013/291546
   de Vos-Geelen J, 2014, CURR OPIN CLIN NUTR, V17, P509, DOI 10.1097/MCO.0000000000000106
   Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194
   Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403
   Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816
   Goetze S, 2008, J NUCL MED, V49, P752, DOI 10.2967/jnumed.107.048074
   Goodwin PJ, 2015, ANNU REV MED, V66, P281, DOI 10.1146/annurev-med-051613-012328
   Hadi M, 2007, J NUCL MED, V48, P1077, DOI 10.2967/jnumed.106.035915
   Hanssen MJW, 2015, DIABETOLOGIA, V58, P586, DOI 10.1007/s00125-014-3465-8
   Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775
   Honek J, 2014, HORM MOL BIOL CLIN I, V19, P5, DOI 10.1515/hmbci-2014-0014
   Ioannides SJ, 2014, BREAST CANCER RES TR, V147, P237, DOI 10.1007/s10549-014-3091-7
   Jackson SE, 2014, BMC CANCER, V14, P0, DOI 10.1186/1471-2407-14-926
   Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262
   Kliewer KL, 2015, CANCER BIOL THER, V16, P886, DOI 10.4161/15384047.2014.987075
   Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035
   Kyparos D, 2006, PHYSIOL RES, V55, P653, DOI 10.33549/physiolres.930890
   Lahesmaa M, 2014, J CLIN ENDOCR METAB, V99, PE28, DOI 10.1210/jc.2013-2312
   Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513
   Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017
   Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009
   Li JS, 2014, TUMOR BIOL, V35, P6831, DOI 10.1007/s13277-014-1939-4
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Lin XJ, 2014, JPN J CLIN ONCOL, V44, P783, DOI 10.1093/jjco/hyu082
   Ma J, 2015, MED SCI MONITOR, V21, P283, DOI 10.12659/MSM.892035
   Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, PE769, DOI 10.1210/jc.2012-2749
   Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023
   Nakayama Akira, 2003, MOL IMAGING, V2, P37, DOI 10.1162/153535003765276273
   Nalabolu Mohan Reddy, 2014, INT J HEMATOL ONCOL STEM CELL RES, V8, P31
   Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, PE444, DOI 10.1152/ajpendo.00691.2006
   Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653
   Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019
   Olsen JM, 2014, J CELL BIOL, V207, P365, DOI 10.1083/jcb.201403080
   Orava J, 2013, OBESITY, V21, P2279, DOI 10.1002/oby.20456
   Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012
   OSCULATI F, 1989, EUR J RADIOL, V9, P112
   Oudart H, 1995, CAN J PHYSIOL PHARM, V73, P1625, DOI 10.1139/y95-724
   Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004
   Quarta C, 2013, MOL METAB, V2, P153, DOI 10.1016/j.molmet.2013.04.002
   Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027
   Rance NE, 2013, FRONT NEUROENDOCRIN, V34, P211, DOI 10.1016/j.yfrne.2013.07.003
   Ricquier Daniel, 2011, FRONT ENDOCRINOL (LAUSANNE), V2, P85, DOI 10.3389/fendo.2011.00085
   Roca-Rivada A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0060563
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005
   Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530
   Schwartz B, 2014, FRONT ONCOL, V4, P0, DOI 10.3389/fonc.2014.00164
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Smits A, 2015, GYNECOL ONCOL, V137, P180, DOI 10.1016/j.ygyno.2015.01.540
   van der Lans AAJJ, 2014, AM J PHYSIOL-REG I, V307, PR103, DOI 10.1152/ajpregu.00021.2014
   van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022
   Vrieze A, 2012, J NUCL MED, V53, P1407, DOI 10.2967/jnumed.111.100701
   Vybíral S, 2000, EXP PHYSIOL, V85, P321, DOI 10.1111/j.1469-445X.2000.01909.x
   Wagner M, 2015, EXPERT OPIN THER TAR, V19, P527, DOI 10.1517/14728222.2014.991311
   Wang CZ, 2014, MOL CELL BIOCHEM, V393, P247, DOI 10.1007/s11010-014-2067-6
   Wijers SLJ, 2010, OBESITY, V18, P1092, DOI 10.1038/oby.2010.74
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Yeung HWD, 2003, J NUCL MED, V44, P1789
   Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105
NR 80
TC 8
Z9 11
U1 0
U2 12
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1530-891X
EI 1934-2403
J9 ENDOCR PRACT
JI Endocr. Pract.
PD NOV 15
PY 2015
VL 21
IS 11
BP 1282
EP 1290
DI 10.4158/EP15870.RA
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DO7MF
UT WOS:000377966000011
PM 26280202
DA 2025-04-28
ER

PT J
AU Michimi, A
   Wimberly, MC
AF Michimi, Akihiko
   Wimberly, Michael C.
TI The food environment and adult obesity in US metropolitan areas
SO GEOSPATIAL HEALTH
LA English
DT Article
DE Food environments; Obesity; Urban; USA
ID dietary energy density; body-mass index; united-states; weight status; risk; neighborhood; consumption; availability; associations; prevalence
AB This research examines the larger-scale associations between obesity and food environments in metropolitan areas in the United States (US). The US Census County Business Patterns dataset for 2011 was used to construct various indices of food environments for selected metropolitan areas. The numbers of employees engaged in supermarkets, convenience stores, full service restaurants, fast food restaurants, and snack/coffee shops were standardised using the location quotients, and factor analysis was used to produce two uncorrelated factors measuring food environments. Data on obesity were obtained from the 2011 Behavioral Risk Factor Surveillance System. Individual level obesity measures were linked to the metropolitan area level food environment factors. Models were fitted using generalised estimating equations to control for metropolitan area level intra-correlation and individual level sociodemographic characteristics. It was found that adults residing in cities with a large share of supermarket and full-service restaurant workers were less likely to be obese, while adults residing in cities with a large share of convenience store and fast food restaurant workers were more likely to be obese. Supermarkets and full-service restaurant workers are concentrated in the Northeast and West of the US, where obesity prevalence is relatively lower, while convenience stores and fast-food restaurant workers are concentrated in the South and Midwest, where obesity prevalence is relatively higher. The food environment landscapes measured at the metropolitan area level explain the continental-scale patterns of obesity prevalence. The types of food that are readily available and widely served may translate into obesity disparities across metropolitan areas.
C1 [Michimi, Akihiko; Wimberly, Michael C.] S Dakota State Univ, Geospatial Sci Ctr Excellence, 1021 Medary Ave,Wecota Hall 115,506B, Brookings, SD 57007 USA.
C3 South Dakota State University
RP Michimi, A (corresponding author), S Dakota State Univ, Geospatial Sci Ctr Excellence, 1021 Medary Ave,Wecota Hall 115,506B, Brookings, SD 57007 USA.
EM akihiko.michimi@gmail.com
CR Unknown -, 2014, BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM SURVEY DATA, V0, P0
   Unknown -, 2013, GUIDANCE ON EXHIBITS 53 AND 300-INFORMATION TECHNOLOGY AND E-GOVERNMENT, V0, P0
   Bleich SN, 2010, J EPIDEMIOL COMMUN H, V64, P465, DOI 10.1136/jech.2009.096297
   Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Broda C, 2009, J ECON PERSPECT, V23, P77, DOI 10.1257/jep.23.2.77
   Burgoine T, 2014, BMJ-BRIT MED J, V348, P0, DOI 10.1136/bmj.g1464
   CDC, 2014, 2011 SMART BRFSS MMS, V0, P0
   Chaix B, 2012, PLOS ONE, V7, P0
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082
   Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31
   Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276
   Currie J, 2010, EFFECT FAST FOOD RES, V0, P0
   DiStefano C, 2009, PRACTICAL ASSESSMENT, V0, P0
   Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011
   Drewnowski A, 2005, AM J CLIN NUTR, V82, P265S, DOI 10.1093/ajcn/82.1.265S
   Drewnowski Adam, 2012, AM J PUBLIC HEALTH, V102, Pe74, DOI 10.2105/AJPH.2012.300660
   Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201
   Duncan DT, 2014, AM J EPIDEMIOL, V179, P373, DOI 10.1093/aje/kwt251
   Garcia G, 2012, OBES SURG, V22, P810, DOI 10.1007/s11695-012-0601-8
   Gase LN, 2014, FRONT PUBLIC HEALTH, V2, P0, DOI 10.3389/fpubh.2014.00229
   Glanz K, 2007, AM J PREV MED, V32, P383, DOI 10.1016/j.amepre.2007.01.003
   Hattori A, 2013, PREV CHRONIC DIS, V10, P0, DOI 10.5888/pcd10.120123
   Hill JL, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-1051
   Jekanowski MD, 2001, J AGR RESOUR ECON, V26, P58
   Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025
   Larsen K, 2015, INT J PUBLIC HEALTH, V60, P69, DOI 10.1007/s00038-014-0620-4
   Larson N, 2011, J AM DIET ASSOC, V111, P1696, DOI 10.1016/j.jada.2011.08.007
   Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025
   Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1031, DOI 10.1017/S1368980009992771
   Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085
   McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001
   Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031
   Michimi A, 2010, INT J HEALTH GEOGR, V9, P0, DOI 10.1186/1476-072X-9-49
   Michimi A, 2010, AM J PREV MED, V39, PE1, DOI 10.1016/j.amepre.2010.04.008
   Monsivais P, 2014, AM J PREV MED, V47, P796, DOI 10.1016/j.amepre.2014.07.033
   Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090
   Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003
   Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Ogden Cynthia L, 2010, NCHS DATA BRIEF, V0, P1
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Ogden Cynthia L, 2013, NCHS DATA BRIEF, V0, P1
   OMB, 2010, 2010 STANDARDS FOR DELINEATING METROPOLITAN AND MICROPOLITAN STATISTICAL AREAS, V0, P0
   Pitts SBJ, 2013, PREV CHRONIC DIS, V10, P0, DOI 10.5888/pcd10.120319
   Powell LA, 2007, AM J PREV MED, V33, PS240, DOI 10.1016/j.amepre.2007.07.005
   Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008
   Prentice A M, 2003, OBES REV, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x
   Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590
   Shortridge BG, 2003, GEOGR REV, V93, P507, DOI 10.1111/j.1931-0846.2003.tb00045.x
   Smith LP, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-45
   SOBAL J, 2001, SOCIAL AND CULTURAL INFLUENCES ON OBESITY. INTERNATIONAL TEXTBOOK OF OBESITY, V0, P0
   Stewart H, 2004, DEMAND FOOD AWAY HOM, V0, P0
   Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585
   Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x
   US Census Bureau, 2011, COUNT BUS PATT, V0, P0
   US Census Bureau, 2015, N AM IND CLASS SYST, V0, P0
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Wong David WS, 2004, WORLDMINDS: GEOGRAPHICAL PERSPECTIVES ON 100 PROBLEMS, V0, PP571, DOI 10.4135/9780857020130.n7
   Yun S, 2006, INT J OBESITY, V30, P164, DOI 10.1038/sj.ijo.0803125
   Zenk SN, 2009, AM J NURS, V109, P61, DOI 10.1097/01.NAJ.0000357175.86507.c8
   Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202
NR 63
TC 12
Z9 16
U1 1
U2 16
PU UNIV NAPLES FEDERICO II
PI NAPLES
PA FAC VET MED, DEP PATHOLOGY & ANIMAL HEALTH, VET PARASITOLOGY, VIA DELLA VETERINARIA 1, NAPLES, 80137, ITALY
SN 1827-1987
EI 1970-7096
J9 GEOSPATIAL HEALTH
JI Geospatial Health
PD JUN 15
PY 2015
VL 10
IS 2
BP 223
EP 231
DI 10.4081/gh.2015.368
PG 9
WC Health Care Sciences & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational Health
GA DG3YF
UT WOS:000372006400016
PM 26618317
DA 2025-04-28
ER

PT J
AU Hu, B
   Cui, FC
   Yin, FP
   Zeng, XX
   Sun, Y
   Li, YQ
AF Hu, Bing
   Cui, Fengchao
   Yin, Fangping
   Zeng, Xiaoxiong
   Sun, Yi
   Li, Yunqi
TI Caffeoylquinic acids competitively inhibit pancreatic lipase through binding to the catalytic triad
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chlorogenic acids; Pancreatic lipase; Ligand-protein complex
ID density-functional thermochemistry; autodock vina; green tea; coffee; polyphenols; obesity; enzymes
AB Caffeoylquinic acid and its isomers inhibited porcine Pancreatic Lipase (PL) activity according to a competitive mode where binding and interaction with the catalytic triad of Ser153, His264 and Asp177 simultaneously occurred. The IC50 values under which 3-caffeoylquinic acid (CQA) and its isomers 4-, 5-CQA, 3,4-, 3,5- and 4,5-diCQA inhibited half of the porcine PL activity were 1.10, 1.23, 1.24, 0.252, 0.591 and 0.502 mM, respectively. The binding affinities in the range from -8.4 to -9.5 kCal/mol were well predicted from docking, which showed a high linear correlation coefficient of 0.893 and Spearman correlation of 1.0 with log(IC50) values. Caffeoylquinic acid and its isomers were stabilized by hydrogen bond and hydrophobic interaction in the binding pocket. This finding provided molecular mechanism of coffee and other natural food or drink containing caffeoylquinic acid and its isomers against lipase activity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Hu, Bing; Yin, Fangping; Zeng, Xiaoxiong; Sun, Yi] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
   [Cui, Fengchao; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China.
   [Cui, Fengchao; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China.
C3 Nanjing Agricultural University; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS
RP Sun, Y (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
EM sunyi01@njau.edu.cn; yunqi@ciac.ac.cn
FU National Natural Science Foundation of China [31171666, 21374117]; Natural Science Foundation of Jiangsu Province, China [BK2012367]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120097120001]; Priority Academic Program Development of Jiangsu Higher Education Institutions
CR Bandyopadhyay P, 2012, FOOD FUNCT, V3, P592, DOI 10.1039/c2fo00006g
   BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397
   Becke AD, 1993, JOURNAL OF CHEMICAL PHYSICS, V98, P5648, DOI 10.1063/1.464913
   BECKE AD, 1992, J CHEM PHYS, V97, P9173, DOI 10.1063/1.463343
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Christian B, 2008, HYBRID METAHEURISTIC, V0, P0
   Cui FC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0125848
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Frisch J, 2009, GAUSSIAN 16 REVISION, V0, P0
   Gilham D, 2005, METHODS, V36, P139, DOI 10.1016/j.ymeth.2004.11.003
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Jöbstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110
   Kukol A, 2011, EUR J MED CHEM, V46, P4661, DOI 10.1016/j.ejmech.2011.05.026
   LaBute MX, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106298
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lehner R, 1997, BIOCHEMISTRY-US, V36, P1861, DOI 10.1021/bi962186d
   Liang L, 2008, BIOMACROMOLECULES, V9, P50, DOI 10.1021/bm700728k
   Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Perryman AL, 2014, J COMPUT AID MOL DES, V28, P429, DOI 10.1007/s10822-014-9709-3
   Sakulnarmrat K, 2012, FOOD CHEM, V134, P1011, DOI 10.1016/j.foodchem.2012.02.217
   Sengupta B, 2012, INT J BIOL MACROMOL, V51, P250, DOI 10.1016/j.ijbiomac.2012.05.013
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   Singh H, 2009, PROG LIPID RES, V48, P92, DOI 10.1016/j.plipres.2008.12.001
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529
   Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x
   Wilde PJ, 2011, ADV COLLOID INTERFAC, V165, P14, DOI 10.1016/j.cis.2011.02.004
   Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z
   Xiang L, 2015, J MOL STRUCT, V1086, P207, DOI 10.1016/j.molstruc.2015.01.021
   Xiao JB, 2012, CRIT REV FOOD SCI, V52, P85, DOI 10.1080/10408398.2010.499017
   You Q, 2012, LWT-FOOD SCI TECHNOL, V46, P164, DOI 10.1016/j.lwt.2011.10.011
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
NR 46
TC 57
Z9 60
U1 8
U2 75
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP 15
PY 2015
VL 80
IS 
BP 529
EP 535
DI 10.1016/j.ijbiomac.2015.07.031
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR3RO
UT WOS:000361251000063
PM 26193679
DA 2025-04-28
ER

PT J
AU Grosso, G
   Stepaniak, U
   Micek, A
   Topor-Madry, R
   Pikhart, H
   Szafraniec, K
   Pajak, A
AF Grosso, Giuseppe
   Stepaniak, Urszula
   Micek, Agnieszka
   Topor-Madry, Roman
   Pikhart, Hynek
   Szafraniec, Krystyna
   Pajak, Andrzej
TI Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; Tea; Metabolic syndrome; Blood pressure; Waist circumference; Dyslipidemia; Hyperglycemia
ID cardiovascular risk-factors; type-2 diabetes-mellitus; endothelial function; mediterranean diet; amsterdam growth; habitual coffee; blood-pressure; health; prevalence; caffeine
AB The aim of this study was to evaluate whether daily consumption of coffee and tea was associated with components and prevalence of metabolic syndrome (MetS) in the Polish arm of the Health, Alcohol and Psychosocial factors In Eastern Europe cohort study. A cross-sectional population-based survey including 8,821 adults (51.4 % female) was conducted in Krakow, Poland. Coffee and tea consumption was evaluated using food frequency questionnaires. MetS was defined according to the International Diabetes Federation definition. Linear and logistic regression models were performed to estimate odds ratios and confidence intervals. Among high coffee and tea consumers (3 or more cups/day), high prevalence of female gender, young age, medium-high educational and occupational level, high total energy intake, and smoking habit were found. High coffee drinkers had lower BMI, waist circumference, systolic and diastolic blood pressure, triglycerides, and higher HDL cholesterol than those drinking less than 1 cup/day. In contrast, high tea consumers had lower BMI, waist circumference, but not diastolic blood pressure, which was higher than low drinkers. After adjusting for potential confounding factors, both higher coffee and tea consumption were negatively associated with MetS (OR 0.75, 95 % CI 0.66, 0.86 and OR 0.79, 95 % CI 0.67, 0.92, respectively). Among specific components of MetS, high coffee consumption was negatively associated with waist circumference, hypertension, and triglycerides, whereas tea consumption with central obesity and fasting plasma glucose in women, but not in men. Coffee and tea consumption was negatively associated with MetS and some of its components.
C1 [Grosso, Giuseppe] Univ Catania, Dept Clin & Mol Biomed, Sect Pharmacol & Biochem, I-95125 Catania, Italy.
   [Grosso, Giuseppe; Stepaniak, Urszula; Micek, Agnieszka; Topor-Madry, Roman; Szafraniec, Krystyna; Pajak, Andrzej] Jagiellonian Univ, Coll Med, Dept Epidemiol & Populat Studies, Krakow, Poland.
   [Pikhart, Hynek] UCL, Dept Epidemiol & Publ Hlth, London, England.
C3 University of Catania; Jagiellonian University; Collegium Medicum Jagiellonian University; University of London; University College London
RP Grosso, G (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Sect Pharmacol & Biochem, Vle A Doria 6, I-95125 Catania, Italy.
EM giuseppe.grosso@studium.unict.it
FU Wellcome Trust [064947/Z/01/Z, 081081/Z/06/Z]; US National Institute on Ageing [1R01 AG23522-01]; MacArthur Foundation Initiative on Social Upheaval and Health [71208]; International Ph.D. Program in Neuropharmacology, University Medical School of Catania, Catania, Italy
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Barnes S, 2011, FOOD FUNCT, V2, P235, DOI 10.1039/c1fo10025d
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Brunner E, 2001, BRIT J NUTR, V86, P405, DOI 10.1079/BJN2001414
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P1242, DOI 10.1038/ejcn.2010.137
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9
   Buscemi S, 2009, EUR J CLIN NUTR, V63, P1200, DOI 10.1038/ejcn.2009.51
   Buscemi S, 2014, EAT WEIGHT DISORD-ST, V19, P225, DOI 10.1007/s40519-014-0117-4
   Chang CS, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038874
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2014, NUTR METAB CARDIOVAS, V24, P370, DOI 10.1016/j.numecd.2013.09.020
   Grosso G, 2014, NUTRITION, V30, P1398, DOI 10.1016/j.nut.2014.04.012
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Grosso G, 2014, CRIT REV FOOD SCI, V54, P593, DOI 10.1080/10408398.2011.596955
   Grosso G, 2013, FRONT BIOSCI-LANDMRK, V18, P1017, DOI 10.2741/4160
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hashizume C, 2012, J NUTR SCI VITAMINOL, V58, P423, DOI 10.3177/jnsv.58.423
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P635, DOI 10.1139/H10-059
   Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066
   Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5
   Islam Mohammed A, 2012, RECENT PAT CARDIOVASC DRUG DISCOV, V7, P88
   Janszky I, 2011, ANN AGR ENV MED, V18, P270
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Panagiotakos DB, 2009, YONSEI MED J, V50, P31, DOI 10.3349/ymj.2009.50.1.31
   Peasey A, 2006, BMC PUBLIC HEALTH, V6, P0, DOI 10.1186/1471-2458-6-255
   Polychronopoulos E, 2008, EUR J NUTR, V47, P10, DOI 10.1007/s00394-007-0690-7
   Psaltopoulou Theodora, 2010, REV DIABET STUD, V7, P26, DOI 10.1900/RDS.2010.7.26
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Steffen M, 2012, J HYPERTENS, V30, P2245, DOI 10.1097/HJH.0b013e3283588d73
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Szurkowska Magdalena, 2006, PRZEGL LEK, V63, P733
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x
   Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008
NR 52
TC 101
Z9 103
U1 1
U2 61
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT 15
PY 2015
VL 54
IS 7
BP 1129
EP 1137
DI 10.1007/s00394-014-0789-6
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CR8WK
UT WOS:000361634700009
PM 25367317
DA 2025-04-28
ER

PT J
AU Brown, L
   Poudyal, H
   Panchal, SK
AF Brown, L.
   Poudyal, H.
   Panchal, S. K.
TI Functional foods as potential therapeutic options for metabolic syndrome
SO OBESITY REVIEWS
LA English
DT Review
DE Flavonoids; functional food; obesity; prebiotics
ID high-fat-diet; conjugated linoleic-acid; brown adipose-tissue; hepatic lipid-accumulation; medium-chain triglyceride; purified eicosapentaenoic acid; cardiovascular risk-factors; induced insulin-resistance; activated protein-kinase; reduces adipocyte size
AB Obesity as part of metabolic syndrome is a major lifestyle disorder throughout the world. Current drug treatments for obesity produce small and usually unsustainable decreases in body weight with the risk of major adverse effects. Surgery has been the only treatment producing successful long-term weight loss. As a different but complementary approach, lifestyle modification including the use of functional foods could produce a reliable decrease in obesity with decreased comorbidities. Functional foods may include fruits such as berries, vegetables, fibre-enriched grains and beverages such as tea and coffee. Although health improvements continue to be reported for these functional foods in rodent studies, further evidence showing the translation of these results into humans is required. Thus, the concept that these fruits and vegetables will act as functional foods in humans to reduce obesity and thereby improve health remains intuitive and possible rather than proven.
C1 [Brown, L.; Panchal, S. K.] Univ So Queensland, Inst Agr & Environm, Toowoomba, Qld 4350, Australia.
   [Brown, L.] Univ So Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia.
   [Poudyal, H.] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Hakubi Ctr Adv Res, Kyoto, Japan.
C3 University of Southern Queensland; University of Southern Queensland; Kyoto University
RP Panchal, SK (corresponding author), Univ So Queensland, Inst Agr & Environm, Toowoomba, Qld 4350, Australia.
EM Sunil.Panchal@usq.edu.au
CR Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362
   Abenavoli L, 2014, REV RECENT CLIN TRIA, V9, P134, DOI 10.2174/1574887109666141216102458
   Adan RAH, 2008, TRENDS PHARMACOL SCI, V29, P208, DOI 10.1016/j.tips.2008.01.008
   Adiels M, 2008, CURR DIABETES REP, V8, P60, DOI 10.1007/s11892-008-0011-4
   Agatston AS, 2005, CLEV CLIN J MED, V72, P946, DOI 10.3949/ccjm.72.10.946
   Aguilar F, 2013, EFSA J, V11, P0, DOI 10.2903/j.efsa.2013.3145
   Aguirre L, 2014, MOLECULES, V19, P18632, DOI 10.3390/molecules191118632
   Al-Sheraji SH, 2013, J FUNCT FOODS, V5, P1542, DOI 10.1016/j.jff.2013.08.009
   Alberdi G, 2013, FOOD CHEM, V141, P1530, DOI 10.1016/j.foodchem.2013.03.085
   Alissa EM, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/569486
   Alligier M, 2014, OBESITY, V22, P1653, DOI 10.1002/oby.20733
   An HM, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-116
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Arai T, 2009, J ATHEROSCLER THROMB, V16, P283, DOI 10.5551/jat.E463
   Arias N, 2014, GENES NUTR, V9, P0, DOI 10.1007/s12263-013-0361-7
   Arnaud Maurice J, 2011, HANDB EXP PHARMACOL, V0, PP33, DOI 10.1007/978-3-642-13443-2_3
   Ascacio-Valdés JA, 2011, J MED PLANTS RES, V5, P4696
   Assunçao ML, 2009, LIPIDS, V44, P593, DOI 10.1007/s11745-009-3306-6
   Astell KJ, 2013, COMPLEMENT THER MED, V21, P180, DOI 10.1016/j.ctim.2013.01.004
   Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006
   Azizi-Soleiman F, 2013, INT J PREVENTIVE MED, V4, P922
   Bachmann K, 1996, ENVIRON HEALTH PERSP, V104, P400, DOI 10.2307/3432684
   Baek SH, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03879
   Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003
   Baranowski M, 2012, CYTOKINE, V59, P382, DOI 10.1016/j.cyto.2012.04.004
   Barnes AS, 2012, TEX HEART I J, V39, P224
   Barre Douglas Edward, 2007, J OLEO SCI, V56, P319
   Bellesia A, 2015, INT J FOOD SCI NUTR, V66, P85, DOI 10.3109/09637486.2014.953455
   Ben Amara N, 2014, GENES NUTR, V9, P0, DOI 10.1007/s12263-014-0410-x
   Bender N, 2014, OBES REV, V15, P657, DOI 10.1111/obr.12189
   Bes-Rastrollo M, 2010, OLIVES AND OLIVE OIL IN HEALTH AND DISEASE PREVENTION, V0, PP895, DOI 10.1016/B978-0-12-374420-3.00096-6
   Beserra BTS, 2015, CLIN NUTR, V34, P845, DOI 10.1016/j.clnu.2014.10.004
   Binnendijk KH, 2013, BENEF MICROBES, V4, P223, DOI 10.3920/BM2013.0019
   Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Borrelli RC, 2005, MOL NUTR FOOD RES, V49, P673, DOI 10.1002/mnfr.200500011
   Bray GA, 2002, J NUTR, V132, P2488, DOI 10.1093/jn/132.9.2488
   Bray GA, 2014, BEST PRACT RES CL GA, V28, P665, DOI 10.1016/j.bpg.2014.07.015
   Broeders E, 2015, ANN MED, V47, P123, DOI 10.3109/07853890.2013.874663
   Brunerova L, 2007, DIABETIC MED, V24, P533, DOI 10.1111/j.1464-5491.2007.02104.x
   Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cao K, 2014, FREE RADICAL BIO MED, V67, P396, DOI 10.1016/j.freeradbiomed.2013.11.029
   Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001
   CARLOTTI M, 1993, ANN NY ACAD SCI, V683, P349
   Chachay VS, 2014, CLIN GASTROENTEROL H, V12, P2092, DOI 10.1016/j.cgh.2014.02.024
   Chajès V, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0118206
   Chan EW, 2013, OBES REV, V14, P383, DOI 10.1111/obr.12015
   Chandler PD, 2015, NUTR DIABETES, V5, P0, DOI 10.1038/nutd.2014.44
   Chechi K, 2010, BRIT J NUTR, V104, P1313, DOI 10.1017/S0007114510002187
   Chen JJ, 2011, EXP BIOL MED, V236, P823, DOI 10.1258/ebm.2011.010399
   Chen JJ, 2012, BRIT J NUTR, V107, P1429, DOI 10.1017/S0007114511004491
   Chen ZY, 2014, CAN J PHYSIOL PHARM, V92, P797, DOI 10.1139/cjpp-2014-0169
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746
   Coelho MS, 2010, REGUL PEPTIDES, V162, P61, DOI 10.1016/j.regpep.2010.03.008
   Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341
   Covas MI, 2006, NUTR REV, V64, PS20, DOI 10.1111/j.1753-4887.2006.tb00260.x
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766
   Crescenzo R, 2014, EXP PHYSIOL, V99, P1203, DOI 10.1113/expphysiol.2014.079632
   da Costa CAS, 2013, HORM METAB RES, V45, P652, DOI 10.1055/s-0033-1345150
   da Silva ST, 2013, NUTR HOSP, V28, P1039, DOI 10.3305/nh.2013.28.4.6525
   Daniel D, 2015, J COMMUNITY HOSP INT, V5, P0, DOI 10.3402/jchimp.v5.26069
   Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856
   de Ligt M, 2015, BBA-MOL BASIS DIS, V1852, P1137, DOI 10.1016/j.bbadis.2014.11.012
   de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028
   de Roos B, 1999, CURR OPIN LIPIDOL, V10, P41, DOI 10.1097/00041433-199902000-00008
   de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, PG589, DOI 10.1152/ajpgi.00488.2011
   Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126
   desLuis DA, 2011, NUTR HOSP, V26, P827
   DeWeerdt S, 2014, NATURE, V508, PS61, DOI 10.1038/508S61a
   Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304
   Diaz MB, 2014, METABOLISM, V63, P1238, DOI 10.1016/j.metabol.2014.07.002
   DiBaise JK, 2012, AM J GASTROENTEROL, V1, P22, DOI 10.1038/AJGSUP.2012.5
   Dilzer A, 2012, CRIT REV FOOD SCI, V52, P488, DOI 10.1080/10408398.2010.501409
   Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067
   Dombrowski S U, 2014, BMJ, V348, Pg2646, DOI 10.1136/bmj.g2646
   DOUGLAS JG, 1982, PHARMACOL THERAPEUT, V18, P351, DOI 10.1016/0163-7258(82)90037-7
   Dulloo AG, 1996, EUR J CLIN NUTR, V50, P152
   Ebaid GMX, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-46
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Faintuch J, 2007, OBES SURG, V17, P341, DOI 10.1007/s11695-007-9062-x
   Feitoza AB, 2009, NUTR HOSP, V24, P422
   Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132
   Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266
   Fleming JW, 2013, ANN PHARMACOTHER, V47, P1007, DOI 10.1345/aph.1R779
   Franco JG, 2015, EUR J NUTR, V0, P0, DOI DOI 10.1007/s00394-015-0880-7
   Franco JG, 2013, J NUTR BIOCHEM, V24, P960, DOI 10.1016/j.jnutbio.2012.06.019
   Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1
   Gebauer SK, 2011, ADV NUTR, V2, P332, DOI 10.3945/an.111.000521
   Genta S, 2009, CLIN NUTR, V28, P182, DOI 10.1016/j.clnu.2009.01.013
   Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Glanville J, 2015, NUTR J, V14, P0, DOI 10.1186/s12937-015-0004-5
   Gómez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753
   Gómez-Zorita S, 2014, J AGR FOOD CHEM, V62, P8371, DOI 10.1021/jf501318b
   Gómez-Zorita S, 2013, NUTRITION, V29, P1374, DOI 10.1016/j.nut.2013.04.014
   Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Grimsgaard S, 1997, AM J CLIN NUTR, V66, P649, DOI 10.1093/ajcn/66.3.649
   Gulvady AA, 2013, J NUTR BIOCHEM, V24, P1625, DOI 10.1016/j.jnutbio.2013.02.003
   Guo HH, 2015, REV ENDOCR METAB DIS, V16, P1, DOI 10.1007/s11154-014-9302-z
   Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013
   Halford JCG, 2006, APPETITE, V46, P6, DOI 10.1016/j.appet.2005.07.010
   Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005
   Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103
   Hartmann-Boyce J, 2014, OBES REV, V15, P920, DOI 10.1111/obr.12220
   Hartmann-Boyce J, 2014, OBES REV, V15, P598, DOI 10.1111/obr.12165
   Hassanali Z, 2010, DIABETES OBES METAB, V12, P139, DOI 10.1111/j.1463-1326.2009.01130.x
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Hellmann J, 2013, J IMMUNOL, V191, P1383, DOI 10.4049/jimmunol.1203369
   Henagan TM, 2015, GENES NUTR, V10, P0, DOI 10.1007/s12263-014-0451-1
   Fernandes AAH, 2010, BIOMED PHARMACOTHER, V64, P214, DOI 10.1016/j.biopha.2009.08.007
   HORROBIN DF, 1992, PROG LIPID RES, V31, P163, DOI 10.1016/0163-7827(92)90008-7
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200
   Ibrügger S, 2012, APPETITE, V58, P490, DOI 10.1016/j.appet.2011.12.024
   Iepsen EW, 2014, EXPERT OPIN PHARMACO, V15, P2487, DOI 10.1517/14656566.2014.965678
   Ilich JZ, 2014, ARH HIG RADA TOKSIKO, V65, P139, DOI 10.2478/10004-1254-65-2014-2541
   Ivanova Z, 2014, EUR J NUTR, V0, P0, DOI DOI 10.1007/s00394-00014-00782-00390
   Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179
   Jacome-Sosa MM, 2014, J NUTR BIOCHEM, V25, P692, DOI 10.1016/j.jnutbio.2014.02.011
   Jakobsen MU, 2013, BRIT J NUTR, V109, P353, DOI 10.1017/S0007114512001079
   Jensen MG, 2013, OBES REV, V14, P129, DOI 10.1111/j.1467-789X.2012.01056.x
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7
   Jia HJ, 2014, GENES NUTR, V9, P0, DOI 10.1007/s12263-014-0389-3
   Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004
   Jourdes M, 2011, ANAL BIOANAL CHEM, V401, P1531, DOI 10.1007/s00216-011-4949-8
   Jurgonski A, 2015, EUR J NUTR, V54, P991, DOI 10.1007/s00394-014-0775-z
   Juzwiak S, 2005, PHARMACOL REP, V57, P604
   Kam PCA, 2002, ANAESTHESIA, V57, P1083, DOI 10.1046/j.1365-2044.2002.02823.x
   Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8
   Karlsen A, 2007, J NUTR, V137, P1951
   Katan MB, 2012, BENEF MICROBES, V3, P85, DOI 10.3920/BM2012.0008
   Kaume L, 2012, J FUNCT FOODS, V4, P480, DOI 10.1016/j.jff.2012.02.008
   Kechagia Maria, 2013, ISRN NUTR, V2013, P481651, DOI 10.5402/2013/481651
   Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003
   Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim KA, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0047713
   Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012
   Konings E, 2014, INT J OBESITY, V38, P470, DOI 10.1038/ijo.2013.155
   Krishna KM, 2005, CAN J PHYSIOL PHARM, V83, P343, DOI 10.1139/y05-009
   Kunesová M, 2012, PHYSIOL RES, V61, P597, DOI 10.33549/physiolres.932414
   Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721
   Lacroix É, 2012, AM J CLIN NUTR, V95, P318, DOI 10.3945/ajcn.111.023408
   Lai M, 2014, NUTR DIABETES, V4, P0, DOI 10.1038/nutd.2014.30
   Lai YHL, 2013, CLIN NUTR, V32, P966, DOI 10.1016/j.clnu.2013.05.002
   Larsen TM, 2003, J LIPID RES, V44, P2234, DOI 10.1194/jlr.R300011-JLR200
   Le NH, 2014, MEDIAT INFLAMM, V2014, P0, DOI 10.1155/2014/834294
   Lee JH, 2009, NAT REV CARDIOL, V6, P753, DOI 10.1038/nrcardio.2009.188
   Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x
   Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470
   Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82
   Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513
   Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502
   Li SY, 2008, OBESITY, V16, P811, DOI 10.1038/oby.2007.116
   Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012
   Liberato MV, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0036297
   Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702
   Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582
   Lin PH, 2012, OBESITY, V20, P571, DOI 10.1038/oby.2011.17
   Liu CY, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0091163
   Liu YX, 2009, INDIAN J MED RES, V129, P150
   López-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007
   Lorente-Cebrián S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4
   Lou-Bonafonte JM, 2012, CURR VASC PHARMACOL, V10, P392
   Luo J, 2000, J NUTR, V130, P1572, DOI 10.1093/jn/130.6.1572
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mahmoud AAA, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106993
   Makino-Wakagi Y, 2012, BIOCHEM BIOPH RES CO, V417, P880, DOI 10.1016/j.bbrc.2011.12.067
   Malaguarnera M, 2012, DIGEST DIS SCI, V57, P545, DOI 10.1007/s10620-011-1887-4
   Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085
   Mamikutty N, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/263897
   Maric G, 2014, ACTA PHYSIOL HUNG, V101, P395, DOI 10.1556/APhysiol.101.2014.4.1
   Marineli RD, 2015, NUTRITION, V31, P740, DOI 10.1016/j.nut.2014.11.009
   Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378
   Martin CK, 2015, OBESITY, V23, P935, DOI 10.1002/oby.21063
   Martínez-Victoria E, 2012, BRIT J NUTR, V107, PS107, DOI 10.1017/S000711451200150X
   Mason C, 2014, AM J CLIN NUTR, V99, P1015, DOI 10.3945/ajcn.113.073734
   Masquio DCL, 2015, BRIT J NUTR, V113, P1920, DOI 10.1017/S0007114515001129
   McCrorie TA, 2011, NUTR RES REV, V24, P206, DOI 10.1017/S0954422411000114
   McGill AT, 2014, ARCH PUBLIC HEALTH, V72, P0, DOI 10.1186/2049-3258-72-30
   Medjakovic S, 2013, FOOD FUNCT, V4, P19, DOI 10.1039/c2fo30034f
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007
   Mohankumar SK, 2013, BRIT J NUTR, V109, P1628, DOI 10.1017/S000711451200339X
   Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006
   Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Moreno MF, 2014, DIABETOL METAB SYNDR, V6, P0, DOI 10.1186/1758-5996-6-84
   Moreno-Luna R, 2012, AM J HYPERTENS, V25, P1299, DOI 10.1038/ajh.2012.128
   Mori Y, 1999, METABOLISM, V48, P1089, DOI 10.1016/S0026-0495(99)90120-8
   Moroti C, 2012, LIPIDS HEALTH DIS, V11, P0, DOI 10.1186/1476-511X-11-29
   Morrison Shaun F, 2012, FRONT ENDOCRINOL (LAUSANNE), V3, P0
   Motard-Bélanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593
   Moussavi N, 2008, OBESITY, V16, P7, DOI 10.1038/oby.2007.14
   Moy GA, 2013, PHYSIOL BEHAV, V109, P69, DOI 10.1016/j.physbeh.2012.11.008
   Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035
   Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Münzberg H, 2015, OBES REV, V16, P77, DOI 10.1111/obr.12258
   Mumme K, 2015, J ACAD NUTR DIET, V115, P249, DOI 10.1016/j.jand.2014.10.022
   Murkovic M, 2004, J BIOCHEM BIOPH METH, V61, P155, DOI 10.1016/j.jbbm.2004.04.002
   Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505
   Mykkänen OT, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114790
   Nagao K, 2013, LIPIDS HEALTH DIS, V12, P0, DOI 10.1186/1476-511X-12-8
   Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007
   Nakamura K, 2011, J PHYSIOL-LONDON, V589, P3641, DOI 10.1113/jphysiol.2011.210047
   Nakamura YK, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-60
   Nedergaard J, 2010, ANN NY ACAD SCI, V1212, PE20, DOI 10.1111/j.1749-6632.2010.05905.x
   Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI 10.1586/erc.12.74
   Nimptsch K, 2010, PUBLIC HEALTH NUTR, V13, P1636, DOI 10.1017/S1368980009993041
   Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371
   Núñez IN, 2014, NUTRITION, V30, P1423, DOI 10.1016/j.nut.2014.03.025
   ONeill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   OReilly GA, 2014, OBES REV, V15, P453, DOI 10.1111/obr.12156
   Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747
   Oleszczuk J, 2012, POL J VET SCI, V15, P403, DOI 10.2478/v10181-012-0063-x
   Oliva ME, 2013, PROSTAG LEUKOTR ESS, V89, P279, DOI 10.1016/j.plefa.2013.09.010
   Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ozen AE, 2012, NUTR REV, V70, P472, DOI 10.1111/j.1753-4887.2012.00492.x
   Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413
   Päivärinta E, 2006, NUTR CANCER, V54, P79, DOI 10.1207/s15327914nc5401_9
   Pala L, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/253428
   Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI 10.1097/FJC.0b013e3181feb90a
   Panchal SK, 2011, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2011/351982
   Pandey MM, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/376327
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Parker-Barnes JM, 2000, P NATL ACAD SCI USA, V97, P8284, DOI 10.1073/pnas.97.15.8284
   Parkinson L, 2014, INT J MOL SCI, V15, P12323, DOI 10.3390/ijms150712323
   Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163
   Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465
   Passariello A, 2014, CURR MED RES OPIN, V30, P1055, DOI 10.1185/03007995.2014.898138
   Patel J, 2009, INDIAN J BIOCHEM BIO, V46, P66
   Patel S, 2012, 3 BIOTECH, V2, P115, DOI 10.1007/s13205-012-0044-x
   Peirson Leslea, 2014, CMAJ OPEN, V2, PE268, DOI 10.9778/cmajo.20140019
   Pena F, 2014, J FOOD NUTR RES, V2, P491, DOI 10.12691/JFNR
   Pérez-Jiménez F, 2007, MOL NUTR FOOD RES, V51, P1199, DOI 10.1002/mnfr.200600273
   Pérez-Matute P, 2007, BRIT J NUTR, V97, P389, DOI 10.1017/S0007114507207627
   Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8
   Pieterse Z, 2005, NUTRITION, V21, P67, DOI 10.1016/j.nut.2004.09.010
   PINDER RM, 1975, DRUGS, V10, P241, DOI 10.2165/00003495-197510040-00001
   Pojer E, 2013, COMPR REV FOOD SCI F, V12, P483, DOI 10.1111/1541-4337.12024
   Poudyal H, 2013, J NUTR BIOCHEM, V24, P1381, DOI 10.1016/j.jnutbio.2012.11.006
   Poudyal H, 2013, J NUTR BIOCHEM, V24, P1041, DOI 10.1016/j.jnutbio.2012.07.014
   Poudyal H, 2013, ENDOCR METAB IMMUNE, V13, P105, DOI 10.2174/1871530311313010013
   Poudyal H, 2012, AM J PHYSIOL-ENDOC M, V302, PE1472, DOI 10.1152/ajpendo.00102.2012
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003
   Poudyal H, 2010, BRIT J NUTR, V104, P1322, DOI 10.1017/S0007114510002308
   Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   Preuss HG, 2004, DIABETES OBES METAB, V6, P171, DOI 10.1111/j.1462-8902.2004.00328.x
   Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d
   Qiao Y, 2014, FOOD FUNCT, V5, P1241, DOI 10.1039/c3fo60630a
   Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rhee EJ, 2011, AM J MED, V124, P69, DOI 10.1016/j.amjmed.2010.08.012
   Rivière C, 2012, NAT PROD REP, V29, P1317, DOI 10.1039/c2np20049j
   Roberfroid M, 2010, BRIT J NUTR, V104, PS1, DOI 10.1017/S0007114510003363
   Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621
   Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1
   Rusconi RE, 2015, INT J FOOD SCI NUTR, V66, P132, DOI 10.3109/09637486.2014.959902
   Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020
   Sae-tan S, 2014, MOL NUTR FOOD RES, V58, P1156, DOI 10.1002/mnfr.201300621
   Salazar N, 2015, CLIN NUTR, V34, P501, DOI 10.1016/j.clnu.2014.06.001
   Salehpour A, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-78
   Samane S, 2009, METABOLISM, V58, P909, DOI 10.1016/j.metabol.2009.02.013
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Santos S, 2013, NUTR RES, V33, P687, DOI 10.1016/j.nutres.2013.07.002
   Santuré M, 2002, BRIT J PHARMACOL, V137, P185, DOI 10.1038/sj.bjp.0704864
   Scalbert A, 2000, J NUTR, V130, P2073S, DOI 10.1093/jn/130.8.2073S
   Schwingshackl L, 2011, ANN NUTR METAB, V59, P176, DOI 10.1159/000334071
   Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003
   Seeley RJ, 2015, CELL METAB, V21, P369, DOI 10.1016/j.cmet.2015.01.001
   Segula D, 2014, MALAWI MED J, V26, P20
   Sharma N, 2008, J HYPERTENS, V26, P1402, DOI 10.1097/HJH.0b013e3283007dda
   Shen Y, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/971890
   Silveira MB, 2007, PUBLIC HEALTH NUTR, V10, P1181, DOI 10.1017/S1368980007000687
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Sioen I, 2009, LIPIDS, V44, P603, DOI 10.1007/s11745-009-3307-5
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   Speakman J, 2008, LAB ANIM-UK, V42, P413, DOI 10.1258/la.2007.006067
   St-Onge MP, 2008, J AM COLL NUTR, V27, P547, DOI 10.1080/07315724.2008.10719737
   St-Onge MP, 2008, AM J CLIN NUTR, V87, P621, DOI 10.1093/ajcn/87.3.621
   St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467
   St-Onge MP, 2003, INT J OBESITY, V27, P95, DOI 10.1038/sj.ijo.0802169
   Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tan HW, 2008, ACTA PHARMACOL SIN, V29, P1051, DOI 10.1111/j.1745-7254.2008.00843.x
   Thavanesan N, 2011, BRIT J NUTR, V106, P1297, DOI 10.1017/S0007114511003849
   Thirunavukkarasu V, 2004, NUTR METAB CARDIOVAS, V14, P351, DOI 10.1016/S0939-4753(04)80025-5
   Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002
   Tong XL, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-98
   Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853
   Uchiyama-Tanaka Y, 2014, J ALTERN COMPLEM MED, V20, P800, DOI 10.1089/acm.2013.0245
   Valenti L, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/145421
   van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993
   Vandenplas Y, 2015, J PEDIAT-BRAZIL, V91, P6, DOI 10.1016/j.jped.2014.08.005
   Vijay-Kumar M, 2011, J INFLAMM-LOND, V8, P0, DOI 10.1186/1476-9255-8-2
   Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885
   Voigt JP, 2015, BEHAV BRAIN RES, V277, P14, DOI 10.1016/j.bbr.2014.08.065
   Vyas U, 2012, GASTROENT RES PRACT, V2012, P0, DOI 10.1155/2012/872716
   Wach A, 2007, FOOD CHEM, V100, P699, DOI 10.1016/j.foodchem.2005.10.028
   Wadikar DD, 2012, CRIT REV FOOD SCI, V52, P949, DOI 10.1080/10408398.2010.514757
   Wang B, 2014, FOOD FUNCT, V5, P1452, DOI 10.1039/c3fo60714c
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23
   Wang X, 2014, J HUM NUTR DIET, V27, P501, DOI 10.1111/jhn.12181
   Wein S, 2009, DIABETES-METAB RES, V25, P185, DOI 10.1002/dmrr.925
   WEINTRAUB M, 1991, CLIN PHARMACOL THER, V50, P330, DOI 10.1038/clpt.1991.144
   Wendland E, 2006, HEART, V92, P166, DOI 10.1136/hrt.2004.053538
   Whigham LD, 2007, AM J CLIN NUTR, V85, P1203
   Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953
   Williams LM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106159
   Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007
   Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690
   Wright ORL, 2013, CAN J PHYSIOL PHARM, V91, P480, DOI 10.1139/cjpp-2012-0349
   Wu J, 2015, TRENDS GENET, V31, P232, DOI 10.1016/j.tig.2015.03.003
   Wu T, 2013, FOOD FUNCT, V4, P1654, DOI 10.1039/c3fo60251f
   Wu T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077585
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Xue C, 2009, EUR J CLIN NUTR, V63, P879, DOI 10.1038/ejcn.2008.76
   Xue CY, 2009, BIOSCI BIOTECH BIOCH, V73, P1711, DOI 10.1271/bbb.80827
   Yamamoto Y, 2006, BIOSCI BIOTECH BIOCH, V70, P933, DOI 10.1271/bbb.70.933
   Yang ZH, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-120
   Yin YN, 2010, WORLD J GASTROENTERO, V16, P3394, DOI 10.3748/wjg.v16.i27.3394
   Yoshimura Y, 2013, BIOCHEM BIOPH RES CO, V434, P486, DOI 10.1016/j.bbrc.2013.03.100
   Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431
   Yuliana ND, 2014, CRIT REV FOOD SCI, V54, P373, DOI 10.1080/10408398.2011.586739
   Zarfeshany Aida, 2014, ADV BIOMED RES, V3, P100, DOI 10.4103/2277-9175.129371
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zhang YH, 2010, LIPIDS, V45, P501, DOI 10.1007/s11745-010-3418-z
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zhu Y, 2013, NUTR METAB CARDIOVAS, V23, P843, DOI 10.1016/j.numecd.2012.06.005
   Zhu YN, 2014, J CLIN ENDOCR METAB, V99, P561, DOI 10.1210/jc.2013-2845
   Zhu YN, 2011, CLIN CHEM, V57, P1524, DOI 10.1373/clinchem.2011.167361
   Ziaee A, 2009, BASIC CLIN PHARMACOL, V104, P253, DOI 10.1111/j.1742-7843.2008.00368.x
NR 361
TC 127
Z9 129
U1 0
U2 103
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7881
EI 1467-789X
J9 OBES REV
JI Obes. Rev.
PD NOV 15
PY 2015
VL 16
IS 11
BP 914
EP 941
DI 10.1111/obr.12313
PG 28
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CU3KQ
UT WOS:000363424300002
PM 26345360
DA 2025-04-28
ER

PT J
AU Liu, SL
   Peng, BJ
   Zhong, YL
   Liu, YL
   Song, Z
   Wang, Z
AF Liu, Si-Le
   Peng, Bing-Jie
   Zhong, Ying-Li
   Liu, Yun-Long
   Song, Zhuo
   Wang, Zheng
TI Effect of 5-caffeoylquinic acid on the NF-κB signaling pathway, peroxisome proliferator-activated receptor gamma 2, and macrophage infiltration in high-fat diet-fed Sprague-Dawley rat adipose tissue
SO FOOD & FUNCTION
LA English
DT Article
ID chlorogenic acid; insulin-resistance; ppar-gamma; chronic inflammation; metabolic disease; obesity; cells; mice; transcription; accumulation
AB Obesity, considered as a consequence of overnutrition, sustains a low-degree inflammatory state and results in insulin-resistance and type 2 diabetes. Here, we investigated the anti-inflammatory effects of 5-caffeoylquinic acid (5-CQA) in high-fat diet-induced obese rats. Serum interleukin (IL)-6, monocyte chemotactic protein 1 (MCP-1), tumor necrosis factor-alpha (TNF-alpha), total cholesterol (TC), triglyceride (TG), and free fatty acid (FFA) levels were determined. Expression of genes related to TG metabolism, macrophage biomarkers, and inflammation was assessed by real-time PCR. Protein expression of NF-kappa B, PPAR gamma 2, and phosphorylated I kappa B alpha was evaluated by western blotting, and the histology of adipose tissue was examined. Supplementation of the rat diet with 5-CQA reduced obesity development, macrophage infiltration, and steatosis. Additionally, 5-CQA decreased the expression of NF-kappa B and downstream inflammatory cytokines, but increased the expression of PPAR gamma 2, in a dose-dependent manner. Thus, 5-CQA improved obesity and obesity-related metabolic disturbances via PPAR gamma 2 and the NF-kappa B signaling pathway.
C1 [Liu, Si-Le; Peng, Bing-Jie; Zhong, Ying-Li; Liu, Yun-Long; Song, Zhuo; Wang, Zheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
C3 Hunan Agricultural University
RP Liu, SL (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
EM wz8918@163.com
FU National Natural Science Foundation of China [31071531]; Scientific Research Fund of the Hunan Provincial Education Department [14A071]
CR Bahalim AN, 2011, LANCET, V377, P557
   Bajaj M, 2007, DIABETOLOGIA, V50, P1723, DOI 10.1007/s00125-007-0698-9
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z
   Davis MJ, 2013, MBIO, V4, P0, DOI 10.1128/mBio.00264-13
   Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042
   Feng B, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0024358
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Francisco V, 2013, J ETHNOPHARMACOL, V148, P126, DOI 10.1016/j.jep.2013.03.077
   Fujioka K, 2008, FOOD CHEM, V106, P217, DOI 10.1016/j.foodchem.2007.05.091
   Gordon-Larsen P, 2014, OBES REV, V15, P37, DOI 10.1111/obr.12121
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hebeda CB, 2011, J ETHNOPHARMACOL, V135, P261, DOI 10.1016/j.jep.2011.02.033
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Huang JH, 2004, CHIN. J. CLIN. PHARMACOL. THER, V9, P1069
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jernås M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje
   Kastorini CM, 2011, AM HEART J, V162, P717, DOI 10.1016/j.ahj.2011.07.012
   Kim JC, 2012, ARCH ORAL BIOL, V57, P392, DOI 10.1016/j.archoralbio.2011.09.009
   Lakhdari O, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013092
   Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026
   Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011
   Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003
   Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Stienstra R, 2007, PPAR RES, V2007, P0, DOI 10.1155/2007/95974
   Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767
   Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623
   Tsai YT, 2014, APPL MICROBIOL BIOT, V98, P1, DOI 10.1007/s00253-013-5346-3
   Wang Zheng, 2008, YAOXUE XUEBAO, V43, P185
   Wang Z, 2008, FOOD CHEM, V108, P369, DOI 10.1016/j.foodchem.2007.10.083
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, PE1118, DOI 10.1152/ajpendo.00435.2007
   Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004
NR 49
TC 23
Z9 25
U1 0
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUN 15
PY 2015
VL 6
IS 8
BP 2779
EP 2786
DI 10.1039/c5fo00626k
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA CO4KD
UT WOS:000359128700037
PM 26158223
DA 2025-04-28
ER

PT J
AU Takahashi, A
   Shimizu, H
   Okazaki, Y
   Sakaguchi, H
   Taira, T
   Suzuki, T
   Chiji, H
AF Takahashi, Azusa
   Shimizu, Hisae
   Okazaki, Yukako
   Sakaguchi, Hirohide
   Taira, Toshio
   Suzuki, Takashi
   Chiji, Hideyuki
TI Anthocyanin-rich Phytochemicals from Aronia Fruits Inhibit Visceral Fat Accumulation and Hyperglycemia in High-fat Diet-induced Dietary Obese Rats
SO JOURNAL OF OLEO SCIENCE
LA English
DT Article
DE Aronia; phytochemicals; anthocyanin; visceral fat accumulation; postprandial hyperlipidemia
ID ameliorates hyperglycemia; alpha-glucosidase; chlorogenic acid; adipose-tissue; melanocarpa; extract; insulin; supplementation; metabolism; activation
AB Aronia fruits (chokeberry: Aronia melanocarpa E.) containing phenolic phytochemicals, such as cyanidin 3-glycosides and chlorogenic acid, have attracted considerable attention because of their potential human health benefits in humans including antioxidant activities and ability to improved vision. In the present study, the effects of anthocyanin-rich phytochemicals from aronia fruits (aronia phytochemicals) on visceral fat accumulation and fasting hyperglycemia were examined in rats fed a high-fat diet (Experiment 1). Total visceral fat mass was significantly lower in rats fed aronia phytochemicals than that in both the control group and bilberry phytochemicals-supplemented rats (p < 0.05). Moreover, perirenal and epididymal adipose tissue mass in rats fed aronia phytochemicals was significantly lower than that in both the control and bilberry phytochemicals group. Additionally, the mesenteric adipose tissue mass in aronia phytochemicals-fed rats was significantly low (p < 0.05). Furthermore, the fasting blood glucose levels significantly decreased in rats fed aronia phytochemicals for 4 weeks compared to that in the control rats (p <0.05). Therefore, we investigated the effects of phytochemicals on postprandial hyperlipidemia after corn oil loading in rats, pancreatic lipase activity in vitro, and the plasma glycemic response after sucrose loading in order to elucidate the preventive factor of aronia phytochemical on visceral fat accumulation. In the oral corn oil tolerance tests (Experiment 2), aronia phytochemicals significantly inhibited the increases in plasma triglyceride levels, with a half-maximal inhibitory concentration (IC50) of 1.50 mg/mL. However, the inhibitory activity was similar to that of bilberry and tea catechins. In the sucrose tolerance tests (Experiment 3), aronia phytochemicals also significantly inhibited the increases in blood glucose levels that were observed in the control animals (p < 0.05). These results suggest that anthocyanin-rich phytochemicals in aronia fruits suppress visceral fat accumulation and hyperglycemia by inhibiting pancreatic lipase activity and/or intestinal lipid absorption.
C1 [Takahashi, Azusa; Suzuki, Takashi] Hokkaido Univ, Grad Sch Agr, Div Agrobiol, Kita Ku, Sapporo, Hokkaido 0608589, Japan.
   [Shimizu, Hisae; Chiji, Hideyuki] Fuji Womens Univ, Fac Human Life Sci, Dept Food Sci & Human Nutr, Ishikari, Hokkaido 0613204, Japan.
   [Okazaki, Yukako] Fuji Womens Univ, Fac Human Life Sci, Deprtment Human Life Sci, Ishikari, Hokkaido 0613204, Japan.
   [Sakaguchi, Hirohide] Nihonshinyaku Co Ltd, Minami Ku, Kyoto, Kyoto 6018550, Japan.
   [Taira, Toshio] COSMO BIO Co Ltd, Nishi Ku, Sapporo, Hokkaido 0630061, Japan.
C3 Hokkaido University
RP Chiji, H (corresponding author), Fuji Womens Univ, Fac Human Life Sci, Dept Food Sci & Human Nutr, 4-5-7 Hanakawa Minami, Ishikari, Hokkaido 0613204, Japan.
EM hchiji@fujijoshi.ac.jp
FU [25292017]
CR Ardévol A, 2013, FOOD CHEM, V141, P160, DOI 10.1016/j.foodchem.2013.02.104
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Chandra A, 2001, J AGR FOOD CHEM, V49, P3515, DOI 10.1021/jf010389p
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Han LK, 2005, YAKUGAKU ZASSHI, V125, P213, DOI 10.1248/yakushi.125.213
   Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Kawasaki K, 2009, J JPN SOC FOOD SCI, V56, P545, DOI 10.3136/nskkk.56.545
   Krajka-Kuzniak V, 2009, J AGR FOOD CHEM, V57, P5071, DOI 10.1021/jf803973y
   Kristy LW, 2003, J NUTR, V133, P2268
   Matsiu T, 2002, J AGR FOOD CHEM, V50, P7244, DOI 10.1021/jf025913m
   Matsumoto M, 2004, J AGR FOOD CHEM, V52, P2226, DOI 10.1021/jf034818q
   McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926
   McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093
   Noguchi A, 2011, NIPPON EIYO SHOKURYO, V64, P27
   Ohta Y, 2007, J JPN SOC FOOD SCI, V54, P287, DOI 10.3136/nskkk.54.287
   Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008
   Seeram NP, 2006, J AGR FOOD CHEM, V54, P9329, DOI 10.1021/jf061750g
   Taira T, 2015, J CLIN BIOCHEM NUTR, V57, P1
   Takahashi A, 2015, J JPN SOC FOOD SCI, V62, P235, DOI 10.3136/nskkk.62.235
   Takahashi A, 2014, J OLEO SCI, V63, P201, DOI 10.5650/jos.ess13196
   Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216
   Tamura A, 2004, J NUTR SCI VITAMINOL, V50, P13, DOI 10.3177/jnsv.50.13
   Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125
   Valcheva-Kuzmanova S, 2004, EXP TOXICOL PATHOL, V56, P195, DOI 10.1016/j.etp.2004.04.012
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Wang Y, 2012, J NUTR, V142, P1033, DOI 10.3945/jn.112.157701
   Xia XD, 2006, J NUTR, V136, P2220, DOI 10.1093/jn/136.8.2220
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
NR 34
TC 39
Z9 43
U1 3
U2 47
PU JAPAN OIL CHEMISTS SOC
PI TOKYO
PA YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN
SN 1345-8957
EI 1347-3352
J9 J OLEO SCI
JI J. Oleo Sci.
PD DEC 15
PY 2015
VL 64
IS 12
BP 1243
EP 1250
DI 10.5650/jos.ess15181
PG 8
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA CY2LQ
UT WOS:000366240600001
PM 26582155
DA 2025-04-28
ER

PT J
AU Souza, RAG
   Yokoo, EM
   Sichieri, R
   Pereira, RA
AF Souza, Rita A. G.
   Yokoo, Edna M.
   Sichieri, Rosely
   Pereira, Rosangela A.
TI Energy and macronutrient intakes in Brazil: results of the first nationwide individual dietary survey
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Food consumption; Dietary survey; Food records; Energy intake
ID fatty-acids; meat consumption; nutrition; food; cholesterol; adults; lipids
AB Objective: To characterize energy and macronutrient intakes in Brazil and to describe the top food items contributing to energy and macronutrient intakes. Design: Two non-consecutive 24 h dietary records were collected and energy and macronutrient data were adjusted for usual intake distribution. Descriptive statistics and ANOVA with the Bonferroni post hoc test were analysed using SAS version 9.1. Means and standard deviations were estimated for sex, age and income strata. Setting: Nationwide cross-sectional survey, 2008-2009. Subjects: Nationally representative sample of individuals 10 years old (n32 749), excluding pregnant and lactating women (n 1254). Results: The average energy intake was 7958 kJ/d (1902 kcal/d) and mean energy density was 6.82 kJ/g (1.63 kcal/g). Added sugar represented 13 % of total energy intake and animal protein represented 10 %. The mean contribution of total fat to energy intake was 27 %, while the mean saturated fat contribution was 9 %. Compared with the lowest quartile of income, individuals in the highest income quartile had greater mean intakes of energy, added sugar, alcohol, animal protein, total fat, saturated fat, monounsaturated fat and trans fat. Rice, beans, beef, bread and coffee were among the top five foods contributing most to the intakes of energy, carbohydrates, protein, fat and fibre. Conclusions: In general, Brazilians' dietary intake is compatible with a high risk of obesity and non-communicable chronic diseases, being characterized by high intakes of added sugar and saturated fat. Income may be a major determinant of diet nutritional characteristics.
C1 [Souza, Rita A. G.] Univ Fed Mato Grosso, Inst Community Hlth, Cuiaba, MT, Brazil.
   [Yokoo, Edna M.] Univ Fed Fluminense, Dept Epidemiol & Biostat, Niteroi, RJ, Brazil.
   [Sichieri, Rosely] Univ Estado Rio De Janeiro, Dept Epidemiol, Rio De Janeiro, Brazil.
   [Pereira, Rosangela A.] Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, BR-21941902 Rio De Janeiro, RJ, Brazil.
C3 Universidade Federal de Mato Grosso; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro
RP Pereira, RA (corresponding author), Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, Ave Carlos Chagas Filho 373,CCS Bloco J-2 Andar, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM roapereira@gmail.com
FU Brazilian Federal Agency for the Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES) [23038.008544/2010-78]; Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq)
CR Unknown -, 2004, PESQ ORC FAM 2002 20, V0, P0
   Unknown -, 2011, TAB BRAS COMP AL TAC, V0, P0
   Unknown -, 2012, VIG BRAS 2011 VIG FA, V0, P0
   Azevedo MR, 2007, REV SAUDE PUBL, V41, P69, DOI 10.1590/S0034-89102007000100010
   BrasilInstituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQUISA DE ORGAMENTOS FAMILIARES 2008-2009: ANDLISE DO CONSUMO ALIMENTAR PESSOAL NO BRASIL, V0, P0
   Drewnowski A, 2003, LIPIDS, V38, P109, DOI 10.1007/s11745-003-1039-3
   Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625
   Elmadfa I, 2009, FORUM NUTR, V62, P1, DOI 10.1159/000244607
   Gharib N, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-62
   Gupta N, 2010, J AM COLL NUTR, V29, P81, DOI 10.1080/07315724.2010.10719820
   Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394
   Instituto Brasileiro de Geografia e Estatistica Diretoria de Pesquisas Coordenacao de Trabalho e Re, 2010, PESQ ORC FAM 2008 20, V0, P0
   Jebb SA, 2005, P NUTR SOC, V64, P217, DOI 10.1079/PNS2005429
   Kumar V, 2012, CRIT REV FOOD SCI, V52, P899, DOI 10.1080/10408398.2010.512671
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Martin Clayton Antunes, 2006, REV. NUTR., V19, P761, DOI 10.1590/S1415-52732006000600011
   MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703
   Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146
   Montonen J, 2013, EUR J NUTR, V52, P337, DOI 10.1007/s00394-012-0340-6
   Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P920, DOI 10.1017/S1368980010001102
   Pot GK, 2012, BRIT J NUTR, V107, P405, DOI 10.1017/S0007114511002911
   Salter AM, 2013, ANIMAL, V7, P163, DOI 10.1017/S1751731111002023
   Santos RD, 2013, ARQ BRAS CARDIOL, V100, P0
   Sarkadi Nagy Eszter, 2012, ORVOSI HETILAP, V153, P1057, DOI 10.1556/OH.2012.29376
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Temme E, 2010, BRIT J NUTR, V103, P1823, DOI 10.1017/S0007114510000085
   Tessier S, 2005, PUBLIC HEALTH NUTR, V8, P1286, DOI 10.1079/PHN2005747
   Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923
   World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P, V0, P0
   World Health Organization, 2007, PREV CARD DIS POCK G, V0, P0
NR 35
TC 29
Z9 30
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD DEC 15
PY 2015
VL 18
IS 17
BP 3086
EP 3095
DI 10.1017/S1368980015000750
PG 10
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA CW5IS
UT WOS:000365029500004
PM 25905449
DA 2025-04-28
ER

PT J
AU Huang, K
   Liang, XC
   Zhong, YL
   He, WY
   Wang, Z
AF Huang, Kang
   Liang, Xiu-ci
   Zhong, Ying-li
   He, Wan-yan
   Wang, Zheng
TI 5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPAR and LXR transcription
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE CGA; 5-CQA; PPAR; LXR; obesity; lipid metabolism
ID activated receptor-alpha; liver-x-receptor; high-fat diet; chlorogenic acid; oxysterol receptors; metabolic syndrome; hdl-cholesterol; binding protein; mice lacking; in-vitro
AB BackgroundChlorogenic acids (CGAs) are widely distributed in plant material, including foods and beverages. 5-Caffeoylquinic acid (5-CQA) is the most studied CGA, but the mechanism of its hypolipidaemic effect remains unclear. This study aimed to determine the effect of 5-CQA on lipid metabolism in the liver of Sprague-Dawley rats fed a high-fat diet (HFD). Results5-CQA suppressed HFD-induced increases in body weight and visceral fat-pad weight, serum lipid levels, and serum and hepatic free fatty acids in a dose-dependent manner. Real-time polymerase chain reaction revealed that 5-CQA altered the mRNA expression of the transcription factors peroxisome proliferator-activated receptor (PPAR) and liver X receptor (LXR) and target genes involved in hepatic fatty acid uptake, -oxidation, fatty acid synthesis, and cholesterol synthesis. Moreover, hepatic tissue sections from HFD-fed rats showed many empty vacuoles, suggesting that liver cells were filled with more fat droplets. However, 5-CQA significantly ameliorated this effect. Conclusion5-CQA may improve lipid metabolism disorders by altering the expression of PPAR and LXR, which are involved in multiple intracellular signalling pathways. (c) 2014 Society of Chemical Industry
C1 [Huang, Kang; Liang, Xiu-ci; Zhong, Ying-li; He, Wan-yan; Wang, Zheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
C3 Hunan Agricultural University
RP Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
EM wz8918@163.com
FU National Natural Science Foundation of China [31071531]; Scientific Research Fund of Hunan Provincial Education Department [14A071]
CR Unknown -, 1900, DOI 10.1111/J.1432-1033.1968.TB00328.X, V0, P0
   Unknown -, 1900, DOI 10.1155/2013/269038, V0, P0
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Berge RK, 2005, BIOCHIMIE, V87, P15, DOI 10.1016/j.biochi.2004.11.011
   Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11
   Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho KW, 2011, EUR J NUTR, V50, P81, DOI 10.1007/s00394-010-0117-8
   Crook MA, 2000, J CLIN PATHOL, V53, P796, DOI 10.1136/jcp.53.10.796
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042
   Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498
   Gong LX, 2014, NUTRIENTS, V6, P1635, DOI 10.3390/nu6041635
   Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638
   Gutschi LM, 2006, ANN PHARMACOTHER, V40, P1672, DOI 10.1345/aph.1H020
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Huang JH, 2004, CHIN. J. CLIN. PHARMACOL. THER, V9, P1069
   Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200
   Kampe K, 2014, AM J PHYSIOL-RENAL, V306, PF401, DOI 10.1152/ajprenal.00454.2013
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Kasai H, 2000, FOOD CHEM TOXICOL, V38, P467, DOI 10.1016/S0278-6915(00)00014-4
   Kastorini CM, 2011, AM HEART J, V162, P717, DOI 10.1016/j.ahj.2011.07.012
   Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013
   Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076
   Marques V, 2009, FOOD CHEM, V113, P1370, DOI 10.1016/j.foodchem.2008.08.086
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Nicholls SJ, 2012, DIABETES VASC DIS RE, V9, P89, DOI 10.1177/1479164112441477
   Ohnaka K, 2012, J NUTR METAB, V2012, P9
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Panchal SK, 2011, J BIOMED BIOTECHNOL, V2011, P14
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Ravikumar B, 2005, AM J PHYSIOL-ENDOC M, V288, PE789, DOI 10.1152/ajpendo.00557.2004
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400
   Shimoda H, 2006, BMC COMPLEM ALTERN M, V0, P0, DOI DOI 10. 1186/472-6882-6-9
   Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200
   Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388
   Wakil SJ, 2009, J LIPID RES, V50, PS138, DOI 10.1194/jlr.R800079-JLR200
   Wang Z, 2008, FOOD CHEM, V108, P369, DOI 10.1016/j.foodchem.2007.10.083
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190
   Yue LD, 2005, PROTEIN SCI, V14, P812, DOI 10.1110/ps.04951405
   Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200
NR 53
TC 102
Z9 109
U1 0
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JUL 15
PY 2015
VL 95
IS 9
BP 1903
EP 1910
DI 10.1002/jsfa.6896
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA CJ6UQ
UT WOS:000355630400017
PM 25186103
DA 2025-04-28
ER

PT J
AU Nordestgaard, AT
   Thomsen, M
   Nordestgaard, BG
AF Nordestgaard, Ask Tybjaerg
   Thomsen, Mette
   Nordestgaard, Borge Gronne
TI Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE Coffee; metabolic syndrome; type 2 diabetes; BMI; blood pressure; plasma cholesterol; plasma glucose
ID decaffeinated coffee; tea consumption; association; metaanalysis; caffeine; genetics; mellitus; heart
AB Background: Coffee is one of the most widely consumed beverages. We tested the hypothesis that genetically high coffee intake is associated with low risk of obesity, metabolic syndrome and type 2 diabetes, and with related components thereof. Methods: We included 93 179 individuals from two large general population cohorts in a Mendelian randomization study. We tested first whether high coffee intake is associated with low risk of obesity, metabolic syndrome and type 2 diabetes, and with related components thereof, in observational analyses; second, whether five genetic variants near the CYP1A1, CYP1A2 and AHR genes are associated with coffee intake; and third, whether the genetic variants are associated with obesity, metabolic syndrome and type 2 diabetes, and with related components thereof. Finally, we tested the genetic association with type 2 diabetes in a meta-analysis including up to 78 021 additional individuals from the DIAGRAM consortium. Results: Observationally, high coffee intake was associated with low risk of obesity, metabolic syndrome and type 2 diabetes. Further, high coffee intake was associated with high body mass index, waist circumference, weight, height, systolic/diastolic blood pressure, triglycerides and total cholesterol and with low high-density lipoprotein cholesterol, but not with glucose levels. In genetic analyses, 9-10 vs 0-3 coffee-intake alleles were associated with 29% higher coffee intake. However, genetically derived high coffee intake was not associated convincingly with obesity, metabolic syndrome, type 2 diabetes, body mass index, waist circumference, weight, height, systolic/diastolic blood pressure, triglycerides, total cholesterol, high-density lipoprotein cholesterol or glucose levels. Perallele meta-analysed odds ratios for type 2 diabetes were 1.01 (0.98-1.04) for AHR rs4410790, 0.98 (0.95-1.01) for AHR rs6968865, 1.01 (0.99-1.03) for CYP1A1/2 rs2470893, 1.01 (0.98-1.03) for CYP1A1/2 rs2472297 and 0.98 (0.95-1.01) for CYP1A1 rs2472299. Conclusions: High coffee intake was associated observationally with low risk of obesity, metabolic syndrome and type 2 diabetes, and was associated observationally with related components thereof, but with no genetic evidence to support corresponding causal relationships.
C1 [Nordestgaard, Ask Tybjaerg; Thomsen, Mette; Nordestgaard, Borge Gronne] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.
   [Nordestgaard, Ask Tybjaerg; Thomsen, Mette; Nordestgaard, Borge Gronne] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark.
   [Nordestgaard, Borge Gronne] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark.
   [Nordestgaard, Ask Tybjaerg; Thomsen, Mette; Nordestgaard, Borge Gronne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.
C3 University of Copenhagen; Herlev & Gentofte Hospital; Copenhagen University Hospital; University of Copenhagen; Copenhagen University Hospital; Herlev & Gentofte Hospital; University of Copenhagen; Copenhagen University Hospital; University of Copenhagen
RP Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
EM Boerge.Nordestgaard@regionh.dk
FU Herlev Hospital, Copenhagen University Hospital
CR Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x
   Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801
   Knowler William C, 2002, N ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   McMahon G, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103448
   Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nordestgaard BG, 2012, PLOS MED, V9, P0, DOI 10.1371/journal.pmed.1001212
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031
   Rebello SA, 2013, CURR CARDIOL REP, V15, P0, DOI 10.1007/s11886-013-0403-1
   Rodenburg EM, 2012, AM J CLIN NUTR, V96, P182, DOI 10.3945/ajcn.111.027102
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Tuomilehto Jaakko, 2001, NEW ENGLAND JOURNAL OF MEDICINE, V344, P1343, DOI 10.1056/NEJM200105033441801
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402
   Zhou SF, 2010, DRUG METAB REV, V42, P268, DOI 10.3109/03602530903286476
NR 36
TC 139
Z9 145
U1 1
U2 70
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD APR 15
PY 2015
VL 44
IS 2
BP 551
EP 565
DI 10.1093/ije/dyv083
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CL6VO
UT WOS:000357106100018
PM 26002927
DA 2025-04-28
ER

PT J
AU Cornelis, MC
   Byrne, EM
   Esko, T
   Nalls, MA
   Ganna, A
   Paynter, N
   Monda, KL
   Amin, N
   Fischer, K
   Renstrom, F
   Ngwa, JS
   Huikari, V
   Cavadino, A
   Nolte, IM
   Teumer, A
   Yu, K
   Marques-Vidal, P
   Rawal, R
   Manichaikul, A
   Wojczynski, MK
   Vink, JM
   Zhao, JH
   Burlutsky, G
   Lahti, J
   Mikkilä, V
   Lemaitre, RN
   Eriksson, J
   Musani, SK
   Tanaka, T
   Geller, F
   Luan, J
   Hui, J
   Mägi, R
   Dimitriou, M
   Garcia, ME
   Ho, WK
   Wright, MJ
   Rose, LM
   Magnusson, PKE
   Pedersen, NL
   Couper, D
   Oostra, BA
   Hofman, A
   Ikram, MA
   Tiemeier, HW
   Uitterlinden, AG
   van Rooij, FJA
   Barroso, I
   Johansson, I
   Xue, L
   Kaakinen, M
   Milani, L
   Power, C
   Snieder, H
   Stolk, RP
   Baumeister, SE
   Biffar, R
   Gu, F
   Bastardot, F
   Kutalik, Z
   Jacobs, DR
   Forouhi, NG
   Mihailov, E
   Lind, L
   Lindgren, C
   Michaëlsson, K
   Morris, A
   Jensen, M
   Khaw, KT
   Luben, RN
   Wang, JJ
   Männistö, S
   Perälä, MM
   Kähönen, M
   Lehtimäki, T
   Viikari, J
   Mozaffarian, D
   Mukamal, K
   Psaty, BM
   Döring, A
   Heath, AC
   Montgomery, GW
   Dahmen, N
   Carithers, T
   Tucker, KL
   Ferrucci, L
   Boyd, HA
   Melbye, M
   Treur, JL
   Mellström, D
   Hottenga, JJ
   Prokopenko, I
   Tönjes, A
   Deloukas, P
   Kanoni, S
   Lorentzon, M
   Houston, DK
   Liu, Y
   Danesh, J
   Rasheed, A
   Mason, MA
   Zonderman, AB
   Franke, L
   Kristal, BS
   Karjalainen, J
   Reed, DR
   Westra, HJ
   Evans, MK
   Saleheen, D
   Harris, TB
   Dedoussis, G
   Curhan, G
   Stumvoll, M
   Beilby, J
   Pasquale, LR
   Feenstra, B
   Bandinelli, S
   Ordovas, JM
   Chan, AT
   Peters, U
   Ohlsson, C
   Gieger, C
   Martin, NG
   Waldenberger, M
   Siscovick, DS
   Raitakari, O
   Eriksson, JG
   Mitchell, P
   Hunter, DJ
   Kraft, P
   Rimm, EB
   Boomsma, DI
   Borecki, IB
   Loos, RJF
   Wareham, NJ
   Vollenweider, P
   Caporaso, N
   Grabe, HJ
   Neuhouser, ML
   Wolffenbuttel, BHR
   Hu, FB
   Hyppönen, E
   Järvelin, MR
   Cupples, LA
   Franks, PW
   Ridker, PM
   van Duijn, CM
   Heiss, G
   Metspalu, A
   North, KE
   Ingelsson, E
   Nettleton, JA
   van Dam, RM
   Chasman, DI
AF Cornelis, M. C.
   Byrne, E. M.
   Esko, T.
   Nalls, M. A.
   Ganna, A.
   Paynter, N.
   Monda, K. L.
   Amin, N.
   Fischer, K.
   Renstrom, F.
   Ngwa, J. S.
   Huikari, V.
   Cavadino, A.
   Nolte, I. M.
   Teumer, A.
   Yu, K.
   Marques-Vidal, P.
   Rawal, R.
   Manichaikul, A.
   Wojczynski, M. K.
   Vink, J. M.
   Zhao, J. H.
   Burlutsky, G.
   Lahti, J.
   Mikkila, V.
   Lemaitre, R. N.
   Eriksson, J.
   Musani, S. K.
   Tanaka, T.
   Geller, F.
   Luan, J.
   Hui, J.
   Maegi, R.
   Dimitriou, M.
   Garcia, M. E.
   Ho, W-K
   Wright, M. J.
   Rose, L. M.
   Magnusson, P. K. E.
   Pedersen, N. L.
   Couper, D.
   Oostra, B. A.
   Hofman, A.
   Ikram, M. A.
   Tiemeier, H. W.
   Uitterlinden, A. G.
   van Rooij, F. J. A.
   Barroso, I.
   Johansson, I.
   Xue, L.
   Kaakinen, M.
   Milani, L.
   Power, C.
   Snieder, H.
   Stolk, R. P.
   Baumeister, S. E.
   Biffar, R.
   Gu, F.
   Bastardot, F.
   Kutalik, Z.
   Jacobs, D. R., Jr.
   Forouhi, N. G.
   Mihailov, E.
   Lind, L.
   Lindgren, C.
   Michaelsson, K.
   Morris, A.
   Jensen, M.
   Khaw, K-T
   Luben, R. N.
   Wang, J. J.
   Mannisto, S.
   Perala, M-M
   Kahonen, M.
   Lehtimaki, T.
   Viikari, J.
   Mozaffarian, D.
   Mukamal, K.
   Psaty, B. M.
   Doering, A.
   Heath, A. C.
   Montgomery, G. W.
   Dahmen, N.
   Carithers, T.
   Tucker, K. L.
   Ferrucci, L.
   Boyd, H. A.
   Melbye, M.
   Treur, J. L.
   Mellstrom, D.
   Hottenga, J. J.
   Prokopenko, I.
   Toenjes, A.
   Deloukas, P.
   Kanoni, S.
   Lorentzon, M.
   Houston, D. K.
   Liu, Y.
   Danesh, J.
   Rasheed, A.
   Mason, M. A.
   Zonderman, A. B.
   Franke, L.
   Kristal, B. S.
   Karjalainen, J.
   Reed, D. R.
   Westra, H-J
   Evans, M. K.
   Saleheen, D.
   Harris, T. B.
   Dedoussis, G.
   Curhan, G.
   Stumvoll, M.
   Beilby, J.
   Pasquale, L. R.
   Feenstra, B.
   Bandinelli, S.
   Ordovas, J. M.
   Chan, A. T.
   Peters, U.
   Ohlsson, C.
   Gieger, C.
   Martin, N. G.
   Waldenberger, M.
   Siscovick, D. S.
   Raitakari, O.
   Eriksson, J. G.
   Mitchell, P.
   Hunter, D. J.
   Kraft, P.
   Rimm, E. B.
   Boomsma, D. I.
   Borecki, I. B.
   Loos, R. J. F.
   Wareham, N. J.
   Vollenweider, P.
   Caporaso, N.
   Grabe, H. J.
   Neuhouser, M. L.
   Wolffenbuttel, B. H. R.
   Hu, F. B.
   Hyppoenen, E.
   Jarvelin, M-R
   Cupples, L. A.
   Franks, P. W.
   Ridker, P. M.
   van Duijn, C. M.
   Heiss, G.
   Metspalu, A.
   North, K. E.
   Ingelsson, E.
   Nettleton, J. A.
   van Dam, R. M.
   Chasman, D. I.
TI Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption
SO MOLECULAR PSYCHIATRY
LA English
DT Article
ID protein; caffeine; glucokinase; involvement; variants; receptor; binding; brain; bdnf
AB Coffee, a major dietary source of caffeine, is among the most widely consumed beverages in the world and has received considerable attention regarding health risks and benefits. We conducted a genome-wide (GW) meta-analysis of predominately regular-type coffee consumption (cups per day) among up to 91 462 coffee consumers of European ancestry with top single-nucleotide polymorphisms (SNPs) followed-up in similar to 30 062 and 7964 coffee consumers of European and African-American ancestry, respectively. Studies from both stages were combined in a trans-ethnic meta-analysis. Confirmed loci were examined for putative functional and biological relevance. Eight loci, including six novel loci, met GW significance (log(10)Bayes factor (BF) > 5.64) with per-allele effect sizes of 0.03-0.14 cups per day. Six are located in or near genes potentially involved in pharmacokinetics (ABCG2, AHR, POR and CYP1A2) and pharmacodynamics (BDNF and SLC6A4) of caffeine. Two map to GCKR and MLXIPL genes related to metabolic traits but lacking known roles in coffee consumption. Enhancer and promoter histone marks populate the regions of many confirmed loci and several potential regulatory SNPs are highly correlated with the lead SNP of each. SNP alleles near GCKR, MLXIPL, BDNF and CYP1A2 that were associated with higher coffee consumption have previously been associated with smoking initiation, higher adiposity and fasting insulin and glucose but lower blood pressure and favorable lipid, inflammatory and liver enzyme profiles (P < 5x10(-8)). Our genetic findings among European and African-American adults reinforce the role of caffeine in mediating habitual coffee consumption and may point to molecular mechanisms underlying inter-individual variability in pharmacological and health effects of coffee.
C1 [Cornelis, M. C.; Mozaffarian, D.; Curhan, G.; Pasquale, L. R.; Chan, A. T.; Hunter, D. J.; Rimm, E. B.; Hu, F. B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02215 USA.
   [Cornelis, M. C.; Jensen, M.; Mozaffarian, D.; Rimm, E. B.; Hu, F. B.; Franks, P. W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA.
   [Byrne, E. M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.
   [Esko, T.; Fischer, K.; Maegi, R.; Milani, L.; Mihailov, E.; Metspalu, A.] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia.
   [Esko, T.] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA.
   [Esko, T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA.
   [Esko, T.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.
   [Nalls, M. A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.
   [Ganna, A.; Magnusson, P. K. E.; Pedersen, N. L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Karolinska, Sweden.
   [Paynter, N.; Rose, L. M.; Ridker, P. M.; Chasman, D. I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA.
   [Monda, K. L.; Heiss, G.; North, K. E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.
   [Amin, N.; Hofman, A.; Ikram, M. A.; Tiemeier, H. W.; Uitterlinden, A. G.; van Rooij, F. J. A.; van Duijn, C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.
   [Renstrom, F.; Franks, P. W.] Lund Univ, Dept Clin Sci, Malmo, Sweden.
   [Ngwa, J. S.; Xue, L.; Cupples, L. A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Huikari, V.; Kaakinen, M.; Jarvelin, M-R] Univ Oulu, Inst Hlth Sci, Oulu, Finland.
   [Cavadino, A.; Power, C.; Hyppoenen, E.] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, Ctr Epidemiol Child Hlth,MRC, London, England.
   [Nolte, I. M.; Snieder, H.; Stolk, R. P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.
   [Teumer, A.] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany.
   [Yu, K.; Gu, F.; Caporaso, N.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.
   [Marques-Vidal, P.] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.
   [Rawal, R.; Gieger, C.] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Munich, Germany.
   [Manichaikul, A.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA.
   [Wojczynski, M. K.; Borecki, I. B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA.
   [Vink, J. M.; Treur, J. L.; Hottenga, J. J.; Boomsma, D. I.] Vrije Univ Amsterdam, Dept Biol Psychol Netherlands Twin Register, Amsterdam, Netherlands.
   [Zhao, J. H.; Luan, J.; Forouhi, N. G.; Loos, R. J. F.; Wareham, N. J.] Univ Cambridge, Epidemiol Unit, MRC, Cambridge, England.
   [Burlutsky, G.; Wang, J. J.; Mitchell, P.] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia.
   [Burlutsky, G.; Wang, J. J.; Mitchell, P.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia.
   [Lahti, J.] Univ Helsinki, Inst Behav Sci, Helsinki, Finland.
   [Lahti, J.; Eriksson, J. G.] Folkhalsan Res Ctr, Helsinki, Finland.
   [Mikkila, V.] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.
   [Mikkila, V.; Raitakari, O.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland.
   [Mikkila, V.; Raitakari, O.] Turku Univ Hosp, FIN-20520 Turku, Finland.
   [Lemaitre, R. N.; Psaty, B. M.; Siscovick, D. S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA.
   [Eriksson, J.; Mellstrom, D.; Lorentzon, M.; Ohlsson, C.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.
   [Musani, S. K.] Univ Mississippi, Med Ctr, Jackson, MI USA.
   [Tanaka, T.; Ferrucci, L.] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Geller, F.; Boyd, H. A.; Melbye, M.; Feenstra, B.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.
   [Hui, J.; Beilby, J.] Busselton Populat Med Res Fdn Inc, Busselton, WA, Australia.
   [Hui, J.; Beilby, J.] PathWest Lab Med, Nedlands, WA, Australia.
   [Hui, J.; Beilby, J.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.
   [Hui, J.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia.
   [Dimitriou, M.; Dedoussis, G.] Harokopio Univ, Athens, Greece.
   [Garcia, M. E.; Harris, T. B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA.
   [Ho, W-K; Khaw, K-T; Luben, R. N.; Danesh, J.; Saleheen, D.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Wright, M. J.; Montgomery, G. W.; Martin, N. G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Couper, D.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA.
   [Oostra, B. A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.
   [Ikram, M. A.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands.
   [Ikram, M. A.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Tiemeier, H. W.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands.
   [Uitterlinden, A. G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.
   [Barroso, I.; Deloukas, P.] Wellcome Trust Sanger Inst, Cambridge, England.
   [Barroso, I.] Univ Cambridge, Metab Res Labs, Cambridge, England.
   [Barroso, I.] NIHR Cambridge Biomed Res Ctr, Cambridge, England.
   [Johansson, I.] Umea Univ, Dept Odontol, Umea, Sweden.
   [Kaakinen, M.; Jarvelin, M-R] Univ Oulu, Bioctr Oulu, Oulu, Finland.
   [Kaakinen, M.; Jarvelin, M-R] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPE, Ctr Environm & Hlth,Sch Publ Hlth, London SW7 2AZ, England.
   [Baumeister, S. E.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany.
   [Biffar, R.] Univ Med Greifswald, Ctr Oral Hlth, Dept Prosthodont Gerodontol & Biomat, Greifswald, Germany.
   [Bastardot, F.; Vollenweider, P.] CHU Vaudois, Dept Internal Med, Lausanne, Switzerland.
   [Bastardot, F.; Stumvoll, M.] Univ Lausanne, Lausanne, Switzerland.
   [Kutalik, Z.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.
   [Kutalik, Z.] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1011 Lausanne, Switzerland.
   [Kutalik, Z.] Swiss Inst Bioinformat, Lausanne, Switzerland.
   [Jacobs, D. R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA.
   [Lind, L.; Ingelsson, E.] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden.
   [Lindgren, C.; Morris, A.; Prokopenko, I.; Ingelsson, E.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Michaelsson, K.] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.
   [Mannisto, S.; Perala, M-M] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.
   [Kahonen, M.] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland.
   [Kahonen, M.; Lehtimaki, T.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.
   [Lehtimaki, T.] Univ Tampere, Fimlab Labs, Dept Clin Chem, FIN-33101 Tampere, Finland.
   [Viikari, J.] Univ Turku, Dept Med, Turku, Finland.
   [Viikari, J.] Turku Univ Hosp, FIN-20520 Turku, Finland.
   [Mozaffarian, D.; Rimm, E. B.; Hu, F. B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Mozaffarian, D.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
   [Mukamal, K.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Psaty, B. M.; Siscovick, D. S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.
   [Psaty, B. M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
   [Psaty, B. M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA.
   [Doering, A.] Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany.
   [Heath, A. C.] Washington Univ, Dept Psychiat, St Louis, MO USA.
   [Dahmen, N.] Johannes Gutenberg Univ Mainz, Dept Psychiat, Mainz, Germany.
   [Carithers, T.] Univ Mississippi, Sch Appl Sci, Oxford, MS USA.
   [Tucker, K. L.] Univ MA Lowell, Clin Lab & Nutr Sci, Lowell, MA USA.
   [Prokopenko, I.] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England.
   [Toenjes, A.; Stumvoll, M.] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany.
   [Toenjes, A.; Stumvoll, M.] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany.
   [Deloukas, P.; Kanoni, S.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.
   [Deloukas, P.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia.
   [Houston, D. K.] Wake Forest Sch Med, Winston Salem, NC USA.
   [Houston, D. K.; Liu, Y.] Wake Forest Univ Hlth Sci, Winston Salem, NC USA.
   [Rasheed, A.; Saleheen, D.] Ctr Noncommunicable Dis, Karachi, Pakistan.
   [Mason, M. A.; Evans, M. K.] NIA, Hlth Dispar Res Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA.
   [Zonderman, A. B.] NIA, Lab Personal & Cognit, NIH, Baltimore, MD 21224 USA.
   [Franke, L.; Karjalainen, J.; Westra, H-J] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.
   [Kristal, B. S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA.
   [Kristal, B. S.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.
   [Reed, D. R.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA.
   [Pasquale, L. R.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.
   [Bandinelli, S.] Azienda Sanitaria Firenze, Geriatr Unit, Florence, Italy.
   [Ordovas, J. M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Chan, A. T.] MA Gen Hosp, Div Gastroenterol, Boston, MA USA.
   [Peters, U.; Neuhouser, M. L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA.
   [Waldenberger, M.] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany.
   [Raitakari, O.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland.
   [Eriksson, J. G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland.
   [Eriksson, J. G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland.
   [Hunter, D. J.; Kraft, P.] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA.
   [Loos, R. J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA.
   [Loos, R. J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA.
   [Grabe, H. J.] Univ Med Greifswald, HELIOS Hosp Stralsund, Dept Psychiat & Psychotherapy, Greifswald, Germany.
   [Wolffenbuttel, B. H. R.] Univ Groningen, Dept Endocrinol, Univ Med Ctr Groningen, Groningen, Netherlands.
   [Hyppoenen, E.] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia.
   [Hyppoenen, E.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
   [Jarvelin, M-R] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland.
   [Jarvelin, M-R] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland.
   [Cupples, L. A.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA.
   [Franks, P. W.] Umea Univ, Med Sect, Dept Publ Hlth & Clin Med, Umea, Sweden.
   [van Duijn, C. M.] Netherlands Consortium Hlth Ageing, Leiden, Netherlands.
   [van Duijn, C. M.] Natl Genom Initiat, Leiden, Netherlands.
   [Nettleton, J. A.] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.
   [van Dam, R. M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.
   [van Dam, R. M.] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore.
   [van Dam, R. M.] Natl Univ Hlth Syst, Singapore, Singapore.
C3 Harvard University; Harvard Medical School; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; University of Tartu; Harvard University; Harvard University Medical Affiliates; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Karolinska Institutet; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Lund University; Boston University; University of Oulu; University of London; University College London; University of Groningen; Universitat Greifswald; Greifswald Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Virginia; Washington University (WUSTL); Vrije Universiteit Amsterdam; University of Cambridge; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Helsinki; Folkhalsan Research Center; University of Helsinki; University of Turku; University of Turku; University of Washington; University of Washington Seattle; University of Gothenburg; University of Mississippi Medical Center; University of Mississippi; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Statens Serum Institut; Pathwest Laboratory Medicine; University of Western Australia; University of Western Australia; University of Western Australia; Harokopio University Athens; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Cambridge; QIMR Berghofer Medical Research Institute; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Umea University; University of Oulu; Imperial College London; Universitat Greifswald; Greifswald Medical School; Universitat Greifswald; Greifswald Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Minnesota System; University of Minnesota Twin Cities; Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; Uppsala University; Finland National Institute for Health & Welfare; Tampere University; Tampere University Hospital; Tampere University; Tampere University; University of Turku; University of Turku; Harvard University; Harvard T.H. Chan School of Public Health; Tufts University; Harvard University; Harvard University Medical Affiliates; Beth Israel Deaconess Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Washington University (WUSTL); Johannes Gutenberg University of Mainz; University of Mississippi; University of Massachusetts System; University of Massachusetts Lowell; Imperial College London; Leipzig University; Leipzig University; University of London; Queen Mary University London; King Abdulaziz University; Wake Forest University; Wake Forest University; Wake Forest University School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Groningen; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Monell Chemical Senses Center; Harvard University; Harvard University Medical Affiliates; Massachusetts Eye & Ear Infirmary; Azienda Sanitaria di Firenze; Tufts University; United States Department of Agriculture (USDA); Fred Hutchinson Cancer Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Turku; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Universitat Greifswald; Greifswald Medical School; University of Groningen; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); Finland National Institute for Health & Welfare; University of Oulu; Framingham Heart Study; Umea University; University of Texas System; University of Texas Health Science Center Houston; National University of Singapore; National University of Singapore; National University of Singapore
RP Cornelis, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 401 Pk Dr, Boston, MA 02215 USA.
EM mcorneli@hsph.harvard.edu; dchasman@research.bwh.harvard.edu
FU MRC [MC_UU_12015/1, MC_UP_A100_1003, MC_UU_12015/5, MR/L003120/1] Funding Source: UKRI
CR Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357
   Byrne EM, 2012, SLEEP, V35, P967, DOI 10.5665/sleep.1962
   Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Cornelis MC, 2014, CURRENT NUTRITION REPORTS, V3, P178
   Cornelis MC, 2012, PROG MOL BIOL TRANSL, V108, P293, DOI 10.1016/B978-0-12-398397-8.00012-5
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571
   Hindorff LA, 2013, A CATALOG OF PUBLISHED GENOME-WIDE ASSOCIATION STUDIES, V0, P0
   Hu L, 2012, PHARMACOGENET GENOM, V22, P812, DOI 10.1097/FPC.0b013e328358d92b
   Jorge-Nebert LF, 2010, HUM MUTAT, V31, P27, DOI 10.1002/humu.21132
   Kot M, 2008, BIOCHEM PHARMACOL, V76, P543, DOI 10.1016/j.bcp.2008.05.025
   Le Vee M, 2010, TOXICOL IN VITRO, V24, P1775, DOI 10.1016/j.tiv.2010.07.001
   Ledda M, 2014, HUM MOL GENET, V23, P259, DOI 10.1093/hmg/ddt404
   Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817
   Mägi R, 2010, BMC BIOINFORMATICS, V11, P0, DOI 10.1186/1471-2105-11-288
   Nosrat IV, 2012, J BIOL CHEM, V287, P16791, DOI 10.1074/jbc.M111.328476
   Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237
   Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010
   Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324
   Rome S, 2009, DIABETOLOGIA, V52, P1899, DOI 10.1007/s00125-009-1442-4
   Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108
   Segrè AV, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001058
   Sellke T, 2001, AM STAT, V55, P62, DOI 10.1198/000313001300339950
   Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982
   Söderberg MM, 2013, PHARMACOGENET GENOM, V23, P279, DOI 10.1097/FPC.0b013e3283602876
   Spiller MA, 1998, CAFFEINE, V0, P97
   Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2
   Vinkhuyzen AAE, 2013, ANNU REV GENET, V47, P75, DOI 10.1146/annurev-genet-111212-133258
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213
   Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011
NR 42
TC 202
Z9 210
U1 0
U2 88
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1359-4184
EI 1476-5578
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD MAY 15
PY 2015
VL 20
IS 5
BP 647
EP 656
DI 10.1038/mp.2014.107
PG 10
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA CH0JS
UT WOS:000353706400016
PM 25288136
DA 2025-04-28
ER

PT J
AU Wu, Y
   Zhang, D
   Jiang, X
   Jiang, W
AF Wu, Y.
   Zhang, D.
   Jiang, X.
   Jiang, W.
TI Fruit and vegetable consumption and risk of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Fruit; Vegetable; Type 2 diabetes mellitus; Prospective cohort studies; Dose-response analysis
ID heart-disease; dietary fiber; obesity; association; prevalence; prevention; validity; coffee; bias; men
AB Background and aims: We conducted a dose-response meta-analysis to summarize the evidence from prospective cohort studies regarding the association of fruit and vegetable consumption with risk of type 2 diabetes mellitus (T2DM). Methods and results: Pertinent studies were identified by searching Embase and PubMed through June 2014. Study-specific results were pooled using a random-effect model. The dose-response relationship was assessed by the restricted cubic spline model and the multivariate randomeffect meta-regression. We standardized all data using a standard portion size of 106 g. The Relative Risk (95% confidence interval) [RR (95% CI)] of T2DM was 0.99 (0.98-1.00) for every 1 serving/day increment in fruit and vegetable (FV) (P = 0.18), 0.98 (0.95-1.01) for vegetable (P = 0.12), and 0.99 (0.97-1.00) for fruit (P = 0.05). The RR (95% CI) of T2DM was 0.99 (0.97-1.01), 0.98 (0.96-1.01), 0.97 (0.93-1.01), 0.96 (0.92-1.01), 0.96 (0.91-1.01) and 0.96 (0.91-1.01) for 1, 2, 3, 4, 5 and 6 servings/day of FV (Pfor non-linearity = 0.44). The T2DM risk was 0.96 (0.95-0.99), 0.94 (0.90-0.98), 0.94 (0.89-0.98), 0.96 (0.91-1.01), 0.98 (0.92-1.05) and 1.00 (0.93-1.08) for 1, 2, 3, 4, 5 and 6 servings/day of vegetable (Pfor non-linearity < 0.01). The T2DM risk was 0.95 (0.93-0.97), 0.91 (0.89-0.94), 0.88 (0.85-0.92), 0.92 (0.88-0.96) and 0.96 (0.92-1.01) for 0.5, 1, 2, 3 and 4 servings/day of fruit (Pfor non-linearity < 0.01). Conclusions: Two-three servings/day of vegetable and 2 servings/day of fruit conferred a lower risk of T2DM than other levels of vegetable and fruit consumption, respectively. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Wu, Y.; Zhang, D.; Jiang, X.; Jiang, W.] Qingdao Univ, Dept Epidemiol & Hlth Stat, Coll Med, Qingdao 266021, Shandong, Peoples R China.
C3 Qingdao University
RP Zhang, D (corresponding author), Qingdao Univ, Dept Epidemiol & Hlth Stat, Dongzhou Rd 38, Qingdao 266021, Shandong, Peoples R China.
EM zhangdf1962@aliyun.com
FU National Natural Science Foundation of China [818302485]
CR Alinia S, 2009, OBES REV, V10, P639, DOI 10.1111/j.1467-789X.2009.00582.x
   Aune D, 2014, NUTR METAB CARDIOVAS, V24, P107, DOI 10.1016/j.numecd.2013.10.028
   Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030
   Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Bountziouka V, 2012, NUTR METAB CARDIOVAS, V22, P659, DOI 10.1016/j.numecd.2010.10.015
   Bruno G, 2012, NUTR METAB CARDIOVAS, V22, P684, DOI 10.1016/j.numecd.2011.04.007
   Capewell S, 2012, NUTR METAB CARDIOVAS, V22, P307, DOI 10.1016/j.numecd.2012.01.005
   Carter P, 2010, BMJ-BRIT MED J, V341, P0, DOI 10.1136/bmj.c4229
   Chatterjee R, 2012, DIABETOLOGIA, V55, P1295, DOI 10.1007/s00125-012-2487-3
   Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85
   Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588
   De Berardis G, 2012, NUTR METAB CARDIOVAS, V22, P605, DOI 10.1016/j.numecd.2010.10.016
   Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elwood P, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0081877
   Esposito K, 2014, ENDOCRINE, V47, P107, DOI 10.1007/s12020-014-0264-4
   Ford ES, 2001, PREV MED, V32, P33, DOI 10.1006/pmed.2000.0772
   Fulton SL, 2011, P NUTR SOC, V70, PE66, DOI 10.1017/S0029665111001066
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Hartling L, 2012, VALIDITY AND INTER-RATER RELIABILITY TESTING OF QUALITY ASSESSMENT INSTRUMENTS, V0, P1
   Higgins J, 2009, COCHRANE HANDBOOK FOR SYSTEMATIC REVIEWS OF INTERVENTIONS, V0, P0
   Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Holt EM, 2009, J AM DIET ASSOC, V109, P414, DOI 10.1016/j.jada.2008.11.036
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172
   Kuroda Kensuke, 2012, BIOINORG CHEM APPL, V2012, P730693, DOI 10.1155/2012/730693
   Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976
   Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993
   Margetts BM, 1997, INT J EPIDEMIOL, V26, PS1, DOI 10.1093/ije/26.suppl_1.S1
   Meyer KA, 2000, AM J CLIN NUTR, V71, P921
   Michels KB, 2005, AM J EPIDEMIOL, V161, P987, DOI 10.1093/aje/kwi115
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Moreno JA, 2013, NUTR METAB CARDIOVAS, V23, P536, DOI 10.1016/j.numecd.2011.10.008
   Muraki I, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5001
   Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.069641
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Orsini N, 2011, STATA J, V11, P1
   Sauvageot N, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-143
   Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738
   Stanhope KL, 2013, CURR OPIN LIPIDOL, V24, P198, DOI 10.1097/MOL.0b013e3283613bca
   Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Uusitupa M, 2011, NUTR METAB CARDIOVAS, V21, P380, DOI 10.1016/j.numecd.2010.12.007
   Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574
   von Ruesten A, 2013, EUR J CLIN NUTR, V67, P412, DOI 10.1038/ejcn.2013.7
   Wang X, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g4490
   Woodside JV, 2013, P NUTR SOC, V72, P236, DOI 10.1017/S0029665112003059
   Xi B, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093471
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Yao BD, 2014, EUR J EPIDEMIOL, V29, P79, DOI 10.1007/s10654-013-9876-x
NR 60
TC 105
Z9 124
U1 0
U2 41
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD FEB 15
PY 2015
VL 25
IS 2
BP 140
EP 147
DI 10.1016/j.numecd.2014.10.004
PG 8
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition & Dietetics
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism; Nutrition & Dietetics
GA CB1QL
UT WOS:000349402700002
PM 25456152
DA 2025-04-28
ER

PT J
AU Bucher, T
   Siegrist, M
AF Bucher, Tamara
   Siegrist, Michael
TI Children's and parents' health perception of different soft drinks
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Beverages; Soft drinks; Children; Health perception; Multidimensional scaling
ID carbonated mineral-water; childhood obesity; energy drinks; food; consumption; adolescents; beverages; prevention
AB Beverages are among the first independent product choices that school-aged children will make and unhealthy choices can be a threat to children's health. The present study investigated which beverage attributes shape adults' and children's health perceptions. For this purpose, 100 children (fifty-two boys; mean age 8.8 (SD 1.1) years) and their parents were invited to independently perform a beverage-sorting task. Participants were asked to place twenty commonly consumed soft drinks in a line ranging from 'unhealthy' to 'healthy'. The sorting data were analysed using multidimensional scaling with property fitting and hierarchical clustering. Sugar content (beta parents = 20.78, beta(children) = 20.68; P<0.001), artificial sweeteners (beta(parents) = 20.68, beta(children) = 20.66; P<0.001), fruit content (beta(parents) = 0.33, beta(children) = 0.36; P<0.05) and caffeine content (beta(parents) = 20.45, beta(children) = 20.46; P<0.01) were found to be the predictors of parents' and children's health perceptions. Parents' and children's estimates were strongly related (r(s) 0.70 (SD 0.15)); both groups classified the beverages into similar clusters. However, compared with their parents, children perceived beverages such as fruit juices and grapefruit soda to be healthier. In conclusion, parents' and children's health perceptions were strongly related based on the same relevant attributes for evaluation. However, fruit content was considered a more important criterion by children, which might lead to differences in the health perception between children and their parents. Low fruit content and the belief of beverages being 'natural' could positively bias perceptions. Therefore, certain soft drinks such as squashes or fruit lemonades are problematic, and the consumer's awareness of their low nutritional quality should be raised.
C1 [Bucher, Tamara; Siegrist, Michael] ETH, Dept Hlth Sci & Technol D HEST, IFNH, CH-8092 Zurich, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich
RP Bucher, T (corresponding author), ETH, Dept Hlth Sci & Technol D HEST, IFNH, CHN J 75-3,Univ Str 16, CH-8092 Zurich, Switzerland.
EM tbucher@ethz.ch
FU Swiss Foundation for Nutrition Research (SFEFS)
CR Academy of Nutrition and Dietetics, 2006, CHILDH OV EV AN PROJ, V0, P0
   Unknown -, 2002, EXPERT CONSULTATION ON DIET, V0, P0
   Unknown -, 2013, OB OV, V0, P0, DOI DOI 10.1017/S1368980023000988
   Atik D, 2013, INT J CONSUM STUD, V37, P59, DOI 10.1111/j.1470-6431.2011.01049.x
   Backhaus K, 2011, FORTGESCHRITTENE MULTIVARATE ANALYSEMETHODEN. EINE ANWENDUNGSORIENTIERTE EINFUHRUNG, V0, P0
   Bere E, 2008, PUBLIC HEALTH NUTR, V11, P49, DOI 10.1017/S1368980007000122
   Bevelander KE, 2013, THESIS AMSTERDAM, V0, P0
   Borg I, 2007, MODERN MULTIDIMENSIONAL SCALING: THEORY AND APPLICATIONS, V0, P0
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Chandon P, 2007, J CONSUM RES, V34, P301, DOI 10.1086/519499
   Cohen Jacob, 1988, STATISTICAL POWER ANALYSIS FOR THE BEHAVIORAL SCIENCES, V0, P0
   Croll JK, 2001, J NUTR EDUC, V33, P193, DOI 10.1016/S1499-4046(06)60031-6
   Cuomo R, 2002, EUR J GASTROEN HEPAT, V14, P991, DOI 10.1097/00042737-200209000-00010
   Currie C, 2012, HEALTH POLICY FOR CHILDREN AND ADOLESCENTS, V6, P0
   Davis MM, 2007, PEDIATRICS, V120, PS229, DOI 10.1542/peds.2007-2329E
   Dohle S, 2014, FOOD QUAL PREFER, V33, P14, DOI 10.1016/j.foodqual.2013.11.001
   Elliott CD, 2009, CAN J COMMUN, V34, P359, DOI 10.22230/cjc.2009v34n3a2220
   Federal Office of Public Health (FOPH), 2013, SWISS NAT DRINK WAT, V0, P0
   Fitzgerald A, 2010, HEALTH PROMOT INT, V25, P289, DOI 10.1093/heapro/daq021
   Golan M, 2004, NUTR REV, V62, P39, DOI 10.1301/nr.2004.jan.39-50
   Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304
   Herzig M, 2012, INT J BEHAV NUTR PHY, V9, P0, DOI 10.1186/1479-5868-9-139
   Kruskal JB, 1986, MULTIDIMENSIONAL SCALING, V0, P0
   Lähteenmäki L, 2013, FOOD QUAL PREFER, V27, P196, DOI 10.1016/j.foodqual.2012.03.006
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, V0, P0
   Nestle M, 2000, PUBLIC HEALTH REP, V115, P308, DOI 10.1093/phr/115.4.308
   Parry J, 2001, J ORAL REHABIL, V28, P766, DOI 10.1046/j.1365-2842.2001.00795.x
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Rivella AG, 2012, RIVELLA KENNZAHLEN 2, V0, P0
   Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009
   Rozin P, 2004, APPETITE, V43, P147, DOI 10.1016/j.appet.2004.03.005
   Schoppen S, 2005, BRIT J NUTR, V93, P339, DOI 10.1079/BJN20041332
   Schoppen S, 2004, J NUTR, V134, P1058, DOI 10.1093/jn/134.5.1058
   Schornoz L, 2006, ALIMENTA ONLINE DUNN, V0, P0
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Siegrist M, 2013, 10 PANGB SENS SCI S, V0, P0
   SSP (Swiss Society of Paediatrics), 2008, PEDIATRICA, V0, P0
   Story Mary, 2004, INT J BEHAV NUTR PHYS ACT, V1, P3, DOI 10.1186/1479-5868-1-3
   Strachan J, 2008, INT J MARKET RES, V50, P13, DOI 10.1177/147078530805000104
   Toumpakari Z, 2013, ISBNPA 2013 ANN M GH, V0, P0
   Troiano RP, 2000, AM J CLIN NUTR, V72, P1343S, DOI 10.1093/ajcn/72.5.1343s
   Tucker KL, 2006, AM J CLIN NUTR, V84, P936, DOI 10.1093/ajcn/84.4.936
   van der Horst K, 2007, HEALTH EDUC RES, V22, P295, DOI 10.1093/her/cyl080
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   von Normann K, 2009, INT J CONSUM STUD, V33, P382, DOI 10.1111/j.1470-6431.2009.00786.x
NR 46
TC 42
Z9 46
U1 1
U2 51
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD FEB 14
PY 2015
VL 113
IS 3
BP 526
EP 535
DI 10.1017/S0007114514004073
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CC3FB
UT WOS:000350230300015
PM 25612601
DA 2025-04-28
ER

PT J
AU Liu, AG
   Arceneaux, KP
   Chu, JT
   Jacob, G
   Schreiber, AL
   Tipton, RC
   Yu, Y
   Johnson, WD
   Greenway, FL
   Primeaux, SD
AF Liu, Ann G.
   Arceneaux, Kenneth P., III
   Chu, Jessica T.
   Jacob, Gregory, Jr.
   Schreiber, Allyson L.
   Tipton, Russell C.
   Yu, Ying
   Johnson, William D.
   Greenway, Frank L.
   Primeaux, Stefany D.
TI The effect of caffeine and albuterol on body composition and metabolic rate
SO OBESITY
LA English
DT Article
ID protein-turnover; salbutamol; clenbuterol; ephedrine; skeletal; muscle; mass
AB ObjectiveCaffeine and ephedrine was an effective combination therapy for weight loss until ephedrine was removed from the market due to safety concerns. This study investigated the combination of caffeine and albuterol as a possibly safer alternative to ephedrine. MethodsIn a series of experiments using cultured adipocytes, rat models, and humans, the effects of caffeine and albuterol on lipolysis, metabolic rate, food intake, and body composition were evaluated. ResultsBoth caffeine and albuterol enhanced lipolysis in cultured adipocytes. Acute treatment of humans with caffeine and/or albuterol increased resting metabolic rate. Longer-term studies of rats revealed a trend for increased metabolic rate with albuterol treatment. There was increased lean mass gain concurrent with decreased fat mass gain with caffeine/albuterol treatment that was greater than albuterol treatment alone. ConclusionsIn rats, albuterol with caffeine produced significantly greater increases in lean body mass and reductions in fat mass without changes in food intake after 4-8 weeks of treatment. Since caffeine and albuterol are approved for the treatment of asthma in children and adolescents at the doses tested and change body composition without changing food intake, this combination may deserve further exploration for use in treating pediatric obesity.
C1 [Liu, Ann G.; Arceneaux, Kenneth P., III; Schreiber, Allyson L.; Yu, Ying; Johnson, William D.; Greenway, Frank L.; Primeaux, Stefany D.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
   [Chu, Jessica T.; Jacob, Gregory, Jr.; Tipton, Russell C.; Primeaux, Stefany D.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, New Orleans, LA USA.
C3 Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans
RP Greenway, FL (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM frank.greenway@pbrc.edu
FU Pennington Biomedical Research Center of the Louisiana State University; Nutrition Obesity Research Center from NIDDK [NIH 2P30DK072476]; Botanical Research Center from NCCAM [P50AT002776]; Botanical Research Center from ODS; NIGMS [1 U54 GM104940]
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   AMOROSO P, 1993, THORAX, V48, P882, DOI 10.1136/thx.48.9.882
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   BATES PC, 1991, BRIT J NUTR, V65, P115, DOI 10.1079/BJN19910074
   Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2
   BUTCHER RW, 1968, J BIOL CHEM, V243, P1705
   CARTER WJ, 1994, METABOLISM, V43, P1119, DOI 10.1016/0026-0495(94)90054-X
   COLLIER JG, 1980, BRIT J CLIN PHARMACO, V9, P273, DOI 10.1111/j.1365-2125.1980.tb04837.x
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   GOLDBERG R, 1975, POSTGRAD MED J, V51, P53, DOI 10.1136/pgmj.51.592.53
   Greenway F L, 2001, OBES REV, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   ROGERS KL, 1991, P SOC EXP BIOL MED, V197, P482
   Skura CL, 2008, NEUROLOGY, V70, P137, DOI 10.1212/01.WNL.0000287070.00149.a9
   WENKEOVA J, 1975, EUR J PHARMACOL, V30, P49, DOI 10.1016/0014-2999(75)90201-0
NR 15
TC 15
Z9 19
U1 3
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD SEP 15
PY 2015
VL 23
IS 9
BP 1830
EP 1835
DI 10.1002/oby.21163
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA CQ1VK
UT WOS:000360388100016
PM 26239482
DA 2025-04-28
ER

PT J
AU Nowotny, B
   Zahiragic, L
   Bierwagen, A
   Kabisch, S
   Groener, JB
   Nowotny, PJ
   Fleitmann, AK
   Herder, C
   Pacini, G
   Erlund, I
   Landberg, R
   Haering, HU
   Pfeiffer, AFH
   Nawroth, PP
   Roden, M
AF Nowotny, Bettina
   Zahiragic, Lejla
   Bierwagen, Alessandra
   Kabisch, Stefan
   Groener, Jan B.
   Nowotny, Peter J.
   Fleitmann, Ann Kristin
   Herder, Christian
   Pacini, Giovanni
   Erlund, Iris
   Landberg, Rikard
   Haering, Hans-Ulrich
   Pfeiffer, Andreas F. H.
   Nawroth, Peter P.
   Roden, Michael
TI Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial
SO DIABETOLOGIA
LA English
DT Article
DE Diet; Inflammation; Insulin sensitivity; Type 2 diabetes; Weight loss
ID life-style intervention; beta-cell function; postmenopausal women; skeletal-muscle; cereal fiber; amino-acids; risk; resistance; humans; consumption
AB Epidemiological studies have found that a diet high in fibre and coffee, but low in red meat, reduces the risk for type 2 diabetes. We tested the hypothesis that these nutritional modifications differentially improve whole-body insulin sensitivity (primary outcome) and secretion. Inclusion criteria were: age 18-69 years, BMI a parts per thousand yen30 kg/m(2), type 2 diabetes treated with diet, metformin or acarbose and known disease duration of a parts per thousand currency sign5 years. Exclusion criteria were: HbA(1c) > 75 mmol/mol (9.0%), type 1 or secondary diabetes types and acute or chronic diseases including cancer. Patients taking any medication affecting the immune system or insulin sensitivity, other than metformin, were also excluded. Of 59 patients (randomised using randomisation blocks [four or six patients] with consecutive numbers), 37 (54% female) obese type 2 diabetic patients completed this controlled parallel-group 8-week low-energy dietary intervention. The participants consumed either a diet high in cereal fibre (whole grain wheat/rye: 30-50 g/day) and coffee (a parts per thousand yen5 cups/day), and free of red meat (L-RISK, n = 17) or a diet low in fibre (a parts per thousand currency sign10 g/day), coffee-free and high in red meat (a parts per thousand yen150 g/day) diet (H-RISK, n = 20). Insulin sensitivity and secretion were assessed by hyperinsulinaemic-euglycaemic clamp and intravenous glucose tolerance tests with isotope dilution. Whole-body and organ fat contents were measured by magnetic resonance imaging and spectroscopy. Whole-body insulin sensitivity increased in both groups (mean [95% CI]) (H-RISK vs L-RISK: 0.8 [0.2, 1.4] vs 1.0 [0.4, 1.7] mg kg(-1) min(-1), p = 0.59), while body weight decreased (-4.8% [-6.1%, -3.5%] vs -4.6% [-6.0%, -3.3%], respectively). Hepatic insulin sensitivity remained unchanged, whereas hepatocellular lipid content fell in both groups (-7.0% [-9.6%, -4.5%] vs -6.7% [-9.5%, -3.9%]). Subcutaneous fat mass (-1,553 [-2,767, -340] cm(3) vs -751 [-2,047; 546] cm(3), respectively) visceral fat mass (-206 [-783, 371] cm(3) vs -241 [-856, 373] cm(3), respectively) and muscle fat content (-0.09% [-0.16%, -0.02%] vs -0.02% [-0.10%, 0.05%], respectively) decreased similarly. Insulin secretion remained unchanged, while the proinflammatory marker IL-18 decreased only after the L-RISK diet. No evidence of a difference between both low-energy diets was identified. Thus, energy restriction per se seems to be key for improving insulin action in phases of active weight loss in obese type 2 diabetic patients, with a potential improvement of subclinical inflammation with the L-RISK diet. Trial Registration: Clinicaltrials.gov NCT01409330 Funding: This study was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW), the German Federal Ministry of Health (BMG), the Federal Ministry for Research (BMBF) to the Center for Diabetes Research (DZD e.V.) and the Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED).
C1 [Nowotny, Bettina; Zahiragic, Lejla; Bierwagen, Alessandra; Nowotny, Peter J.; Fleitmann, Ann Kristin; Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany.
   [Nowotny, Bettina; Zahiragic, Lejla; Bierwagen, Alessandra; Nowotny, Peter J.; Fleitmann, Ann Kristin; Herder, Christian; Roden, Michael] Partner Dusseldorf, German Ctr Diabet Res, Dusseldorf, Germany.
   [Nowotny, Bettina; Zahiragic, Lejla; Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, D-40225 Dusseldorf, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] German Inst Nutr Res DIfE Potsdam, Dept Clin Nutr, Bergholz Rehbrucke, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] Partner Berlin, German Ctr Diabet Res, Berlin, Germany.
   [Groener, Jan B.; Nawroth, Peter P.] Univ Clin Heidelberg, Dept Internal Med 1, Heidelberg, Germany.
   [Pacini, Giovanni] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy.
   [Erlund, Iris] Natl Publ Hlth Inst, Dept Hlth & Funct Capac, Helsinki, Finland.
   [Landberg, Rikard] Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden.
   [Landberg, Rikard] Karolinska Inst, Inst Environm Med, Nutr Epidemiol Unit, S-10401 Stockholm, Sweden.
   [Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Tubingen, Germany.
   [Haering, Hans-Ulrich] Univ Tubingen Hosp, Inst Diabet Res & Metab Dis, Tubingen, Germany.
   [Haering, Hans-Ulrich] Partner Tubingen Neuherberg, German Ctr Diabet Res, Tubingen, Germany.
C3 Leibniz Association; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Association; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle Ricerche (CNR); Finland National Institute for Health & Welfare; Swedish University of Agricultural Sciences; Karolinska Institutet; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital
RP Roden, M (corresponding author), Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
EM michael.roden@ddz.uni-duesseldorf.de
CR Andersson A, 2007, J NUTR, V137, P1401, DOI 10.1093/jn/137.6.1401
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Cho SS, 2013, AM J CLIN NUTR, V98, P594, DOI 10.3945/ajcn.113.067629
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Giacco R, 2013, CLIN NUTR, V32, P941, DOI 10.1016/j.clnu.2013.01.016
   Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Juntunen KS, 2003, AM J CLIN NUTR, V77, P385
   Kahl S, 2014, DIABETOLOGIA, V57, P2094, DOI 10.1007/s00125-014-3328-3
   Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Krebs M, 2003, DIABETOLOGIA, V46, P917, DOI 10.1007/s00125-003-1129-1
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Laufs A, 2014, MAGN RESON MED, V71, P1670, DOI 10.1002/mrm.24835
   Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7
   Lindström J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162
   Machann J, 2010, RADIOLOGY, V257, P353, DOI 10.1148/radiol.10092284
   Marklund M, 2010, J CHROMATOGR B, V878, P888, DOI 10.1016/j.jchromb.2010.02.007
   Martínez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104
   Moazzami AA, 2014, J NUTR, V144, P807, DOI 10.3945/jn.113.188912
   Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024
   Noble D, 2011, BMJ-BRIT MED J, V343, P0, DOI 10.1136/bmj.d7163
   Nowotny B, 2012, DIABETIC MED, V29, P260, DOI 10.1111/j.1464-5491.2011.03406.x
   Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179
   Pacini G, 2003, BEST PRACT RES CL EN, V17, P305, DOI 10.1016/S1521-690X(03)00042-3
   Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633
   Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Schadewaldt P, 2013, AM J CLIN NUTR, V97, P763, DOI 10.3945/ajcn.112.035014
   Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089
   Sharma N, 2012, BBA-MOL BASIS DIS, V1822, P1735, DOI 10.1016/j.bbadis.2012.07.012
   Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007
   Stefan N, 2014, LANCET DIABETES ENDO, V2, P406, DOI 10.1016/S2213-8587(13)70170-0
   Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674
   Weickert MO, 2011, AM J CLIN NUTR, V94, P459, DOI 10.3945/ajcn.110.004374
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
NR 37
TC 35
Z9 37
U1 0
U2 57
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD FEB 15
PY 2015
VL 58
IS 2
BP 255
EP 264
DI 10.1007/s00125-014-3457-8
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AY6SY
UT WOS:000347697000006
PM 25425219
DA 2025-04-28
ER

PT J
AU He, YF
   Liu, FY
   Zhang, WX
AF He, Y. F.
   Liu, F. Y.
   Zhang, W. X.
TI Tangeritin inhibits adipogenesis by down-regulating C/EBPα, C/EBPβ, and PPARγ expression in 3T3-L1 fat cells
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Tangeritin; 3T3-L1; C/EBP alpha; C/EBP beta; PPAR gamma; Adipogenesis
ID nf-kappa-b; induced inflammation; differentiation; phosphorylation; adipocytes; activation; promoter; coffee; nrf2; mice
AB The treatment of obese patients is a topic investigated by an increasing number of researchers. This study aimed to elucidate the possible inhibitory effect of tangeritin on the development and function of fat cells. 3T3-L1 fat cells were grown to confluence and subjected to different concentrations of tangeritin. The most effective tangeritin inhibition concentration was determined by the MTT assay. The treated cells were subjected to real-time reverse transcriptase FOR and western blot analysis, to detect changes in the CCAAT/enhancer binding protein (C/EBP)a, C/EBPI3, and peroxisome proliferator activated receptor (PPAR) y expression levels. The MTT assay revealed that the fat cell growth was inhibited at a 20 ng/mL concentration of tangeritin. The results of realtime FOR revealed a significant decrease in the expression of C/EBP alpha, C/ EBP beta, and PPAR gamma mRNA, following the treatment with tangeritin. Western blot analysis also presented similar results at a protein level. Therefore, we concluded that tangeritin inhibits adipogenesis via the down-regulation of C/EBP alpha, C/EBP beta, and PPAR gamma mRNA and protein expression in 3T3-L1 cells.
C1 [He, Y. F.; Liu, F. Y.; Zhang, W. X.] Cent Hosp Xinxiang City, Dept Pediat 1, Xinxiang, Henan, Peoples R China.
RP Zhang, WX (corresponding author), Cent Hosp Xinxiang City, Dept Pediat 1, Xinxiang, Henan, Peoples R China.
EM weixingty@126.com
CR Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3
   Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   Esteves CL, 2014, J CLIN ENDOCR METAB, V99, PE160, DOI 10.1210/jc.2013-1708
   Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014
   Harmon AW, 2002, BIOCHEM J, V367, P203, DOI 10.1042/BJ20020300
   Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, PG1211, DOI 10.1152/ajpgi.00322.2010
   Huang JQ, 2012, J PHARM PHARMACOL, V64, P1119, DOI 10.1111/j.2042-7158.2012.01504.x
   Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892
   Maier PJ, 2014, J BIOL CHEM, V289, P12896, DOI 10.1074/jbc.M114.550517
   Paur I, 2010, CANCER PREV RES, V3, P653, DOI 10.1158/1940-6207.CAPR-09-0089
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613
   Rosati M, 2001, J IMMUNOL, V167, P1654, DOI 10.4049/jimmunol.167.3.1654
   Staikos C, 2013, RHEUMATOLOGY, V52, P1077, DOI 10.1093/rheumatology/kes422
   WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370
   White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023
   Yang MH, 2014, J ENZYM INHIB MED CH, V29, P1, DOI 10.3109/14756366.2012.742517
   Yasmeen R, 2012, BBA-MOL CELL BIOL L, V1821, P190, DOI 10.1016/j.bbalip.2011.06.004
   Zhan LJ, 2012, FREE RADICAL BIO MED, V53, P758, DOI 10.1016/j.freeradbiomed.2012.05.041
   Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200
NR 21
TC 14
Z9 22
U1 0
U2 15
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL
SN 1676-5680
EI 
J9 GENET MOL RES
JI Genet. Mol. Res.
PD JUN 15
PY 2015
VL 14
IS 4
BP 13642
EP 13648
DI 10.4238/2015.October.28.26
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CV9BJ
UT WOS:000364582000062
PM 26535679
DA 2025-04-28
ER

PT J
AU Jang, YJ
   Koo, HJ
   Sohn, EH
   Kang, SC
   Rhee, DK
   Pyo, S
AF Jang, Yeon Jeong
   Koo, Hyun Jung
   Sohn, Eun-Hwa
   Kang, Se Chan
   Rhee, Dong-Kwon
   Pyo, Suhkneung
TI Theobromine inhibits differentiation of 3T3-L1 cells during the early stage of adipogenesis via AMPK and MAPK signaling pathways
SO FOOD & FUNCTION
LA English
DT Article
ID mitotic clonal expansion; activated protein-kinase; adipocyte differentiation; receptor-gamma; insulin-resistance; cycle arrest; ppar-gamma; expression; caffeine; obesity
AB Obesity is characterized by hypertrophy and/or by the differentiation or adipogenesis of pre-existing adipocytes. In this study, we investigated the inhibitory effects of theobromine, a type of alkaloid in cocoa, on adipocyte differentiation of 3T3-L1 preadipocytes and its mechanisms of action. Theobromine inhibited the accumulation of lipid droplets, the expression of PPAR gamma and C/EBP alpha, and the mRNA expression of aP2 and leptin. The inhibition of adipogenic differentiation by theobromine occurred primarily in the early stages of differentiation. In addition, theobromine arrested the cell cycle at the G(0)/G(1) phase and regulated the expressions of CDK2, p27, and p21. Theobromine treatment increased AMPK phosphorylation and knockdown of AMPK alpha 1/alpha 2 prevented the ability of theobromine to inhibit PPAR. expression in the differentiating 3T3-L1 cells. Theobromine reduced the phosphorylation of ERK and JNK. Moreover, the secretion and the mRNA level of TNF-alpha and IL-6 were inhibited by theobromine treatment. These data suggest that theobromine inhibits adipocyte differentiation during the early stages of adipogenesis by regulating the expression of PPAR. and C/EBP alpha through the AMPK and ERK/JNK signaling pathways in 3T3-L1 preadipocytes.
C1 [Jang, Yeon Jeong; Rhee, Dong-Kwon; Pyo, Suhkneung] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, Gyeonggi Do, South Korea.
   [Koo, Hyun Jung] Korea Natl Coll Agr & Fisheries, Dept Med & Ind Crops, Jeonju 560500, Jeollabuk Do, South Korea.
   [Sohn, Eun-Hwa] Kangwon Natl Univ, Dept Herbal Med Resources, Samcheok 245710, Gangwon Do, South Korea.
   [Kang, Se Chan] Gachon Univ, Dept Life Sci, Songnam 461701, Gyeonggi Do, South Korea.
C3 Sungkyunkwan University (SKKU); Kangwon National University; Gachon University
RP Jang, YJ (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon 440746, Gyeonggi Do, South Korea.
EM snpyo@skku.edu
CR Akiba T, 2004, BIOCHEM PHARMACOL, V68, P1929, DOI 10.1016/j.bcp.2004.07.036
   Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022
   Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018
   Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI 10.1038/NCHEMBIO.610
   Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388
   Do H, 2013, CELL BIOL TOXICOL, V29, P365, DOI 10.1007/s10565-013-9260-3
   Dorenkott MR, 2014, J AGR FOOD CHEM, V62, P2216, DOI 10.1021/jf500333y
   Fajas L, 1999, MOL CELL BIOL, V19, P5495
   Farmer SR, 2005, INT J OBESITY, V29, PS13, DOI 10.1038/sj.ijo.0802907
   Franco R, 2013, NUTRIENTS, V5, P4159, DOI 10.3390/nu5104159
   Gonzales AM, 2008, NUTR METAB, V5, P0, DOI 10.1186/1743-7075-5-17
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Gwon SY, 2013, BMC COMPLEM ALTERN M, V13, P0, DOI 10.1186/1472-6882-13-207
   Jo J, 2009, PLOS COMPUT BIOL, V5, P0, DOI 10.1371/journal.pcbi.1000324
   Kim SH, 2008, BIOCHEM BIOPH RES CO, V372, P108, DOI 10.1016/j.bbrc.2008.04.188
   LARSSON B, 1984, BMJ-BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401
   Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001
   Madsen MS, 2014, MOL CELL BIOL, V34, P939, DOI 10.1128/MCB.01344-13
   Martin ASG, 2006, AM J CLIN NUTR, V83, P461S, DOI 10.1093/ajcn/83.2.461s
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Nasri H, 2014, INT J PREVENTIVE MED, V5, P1487
   Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749
   Ntambi JM, 2000, J NUTR, V130, P3122S, DOI 10.1093/jn/130.12.3122S
   Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005
   Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   Shimba S, 2001, J CELL SCI, V114, P2809
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   STEINFELDER HJ, 1990, BIOCHEM PHARMACOL, V40, P1154, DOI 10.1016/0006-2952(90)90508-I
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sugimoto N, 2014, NUTR CANCER, V66, P419, DOI 10.1080/01635581.2013.877497
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231
   Tarantino G, 2011, WORLD J GASTROENTERO, V17, P3785, DOI 10.3748/wjg.v17.i33.3785
   Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242
   Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143
   Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21
   Zhang WY, 2012, DIABETES, V61, P3114, DOI 10.2337/db11-1373
NR 44
TC 63
Z9 68
U1 0
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUN 15
PY 2015
VL 6
IS 7
BP 2365
EP 2374
DI 10.1039/c5fo00397k
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA CM7TT
UT WOS:000357900100028
PM 26085110
DA 2025-04-28
ER

PT J
AU Iqbal, R
   Iqbal, SP
   Yakub, M
   Tareen, AK
   Iqbal, MP
AF Iqbal, Romaina
   Iqbal, Saleem Perwaiz
   Yakub, Mohsin
   Tareen, Asa Khan
   Iqbal, Mohammad Perwaiz
TI Major dietary patterns and risk of acute myocardial infarction in young, urban Pakistani population
SO PAKISTAN JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Acute myocardial infarction; Dietary patterns; Dietary records; Pakistani population
ID coronary-heart-disease; red meat; association; consumption; obesity
AB Objective: To investigate the role of dietary intake in the development of premature acute myocardial infarction (AMI) in a hospital-based Pakistani population in Karachi. Methods: In a case control study, 203 consecutive patients (146 males and 57 females) with their first AMI and age below 45 years were enrolled with informed consent. Similarly, 205 gender and age matched (within 3 years) healthy adults were also included as controls. Dietary intake of both cases and controls was assessed by using a simple 14-item food frequency questionnaire. Using factor analysis, 3 major dietary patterns- prudent dietary pattern, combination dietary pattern and western dietary pattern were identified. Fasting plasma/serum of both cases and controls were analyzed for homocysteine, folate, vitamin B12, blood Pb, ferritin, cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides. ANOVA and conditional logistic regression were used to predict the association of dietary patterns with AMI. Results: Consumption of prudent diet, characterized by high consumption of legumes, vegetables, wheat, chicken and fruits, is protective against the risk of premature AMI. Moderate to high consumption of combination diet, characterized by high intake of eggs, fish, fruits, juices and coffee was associated with decreased risk of AMI. No association was observed between western diet, characterized by high intake of meat, fish and tea with milk and risk of AMI. Conclusions: Consumption of a prudent dietary pattern and a combination dietary pattern is protective against the risk of AMI in a Pakistani population.
C1 [Iqbal, Romaina; Iqbal, Saleem Perwaiz] New York Inst Technol, Coll Osteopath Med, Dept Community Hlth Sci, Old Westbury, NY 11568 USA.
   [Yakub, Mohsin] New York Inst Technol, Coll Osteopath Med, Dept Biol & Biomed Sci, Old Westbury, NY 11568 USA.
   [Tareen, Asa Khan] Natl Inst Cardiovasc Dis, Karachi, Pakistan.
   [Iqbal, Romaina; Yakub, Mohsin; Iqbal, Mohammad Perwaiz] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi 74800, Pakistan.
C3 New York Institute Technology; New York Institute Technology; Aga Khan University
RP Iqbal, MP (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Stadium Rd, Karachi 74800, Pakistan.
EM perwaiz.iqbal@aku.edu
FU Pakistan Academy of Sciences/Higher Education Commission
CR Ahmed J, 2013, E MEDITERR HEALTH J, V19, P242, DOI 10.26719/2013.19.3.242
   Butt MS, 2009, J AOAC INT, V92, P1277
   Field A, 2012, DISCOVERING STATISTICS USING SPSS, V0, P0
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Grieger JA, 2012, J HUM NUTR DIET, V25, P75, DOI 10.1111/j.1365-277X.2011.01195.x
   Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029
   Holmboe-Ottesen G, 2012, FOOD NUTR RES, V56, P0, DOI 10.3402/fnr.v56i0.18891
   Hu FB, 2000, AM J CLIN NUTR, V72, P912
   Hunt JR, 2003, AM J CLIN NUTR, V78, P633S, DOI 10.1093/ajcn/78.3.633S
   Iqbal Mohammad Perwaiz, 2013, PLOS ONE, V8, Pe67981, DOI 10.1371/journal.pone.0067981
   Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716
   Jafary MH, 2007, PAK J MED SCI, V23, P485
   Javed I, 2012, PAK J MED SCI, V28, P143
   Kamath SK, 1999, AM J CLIN NUTR, V69, P621
   Lim JH, 2011, J KOREAN MED SCI, V26, P1201, DOI 10.3346/jkms.2011.26.9.1201
   Moshe G, 2013, J PEDIATR GASTR NUTR, V57, P722, DOI 10.1097/MPG.0b013e3182a80c42
   Olaya GA, 2013, AM J CLIN NUTR, V98, P983, DOI 10.3945/ajcn.112.053595
   Panwar RB, 2011, INDIAN J MED RES, V134, P26
   QUADROS E, 2000, CHEM ANAL SERIES, V0, P311
   Vyas A, 2003, J HUM NUTR DIET, V16, P327, DOI 10.1046/j.1365-277X.2003.00461.x
   Willet W, 1998, NUTR EPIDEMIOLOGY, VSecond, P0
   Yakub M, 2010, J NUTR, V140, P1261, DOI 10.3945/jn.109.120477
   Zobairi SE, 1998, AUST NZ J OBSTET GYN, V38, P188, DOI 10.1111/j.1479-828X.1998.tb02999.x
NR 23
TC 6
Z9 7
U1 0
U2 11
PU PROFESSIONAL MEDICAL PUBLICATIONS
PI SADDAR
PA PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO BOX 8766, SADDAR, KARACHI 00000, PAKISTAN
SN 1682-024X
EI 1681-715X
J9 PAK J MED SCI
JI Pak. J. Med. Sci.
PD SEP-OCT 15
PY 2015
VL 31
IS 5
BP 1213
EP 1218
DI 10.12669/pjms.315.7690
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA CX1KU
UT WOS:000365455900038
PM 26649016
DA 2025-04-28
ER

PT J
AU Hua, YN
   Ren, SY
   Guo, R
   Rogers, O
   Nair, RP
   Bagchi, D
   Swaroop, A
   Nair, S
AF Hua, Yinan
   Ren, Sidney Y.
   Guo, Rui
   Rogers, Olivia
   Nair, Rama P.
   Bagchi, Debasis
   Swaroop, Anand
   Nair, Sreejayan
TI Furostanolic saponins from Trigonella foenum-graecum alleviate diet-induced glucose intolerance and hepatic fat accumulation
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Fenugreek; Glucose Intolerance; Green coffee bean; Obesity
ID induced insulin-resistance; fenugreek seed extract; chlorogenic acid; glycemic control; obesity; supplementation; metaanalysis; metabolism; caffeine
AB Scope: The objective of this study was to evaluate the effect of fenugreek furostanolic saponins (Fenfuro (TM)) either alone or in combination with chlorogenic acid (GCB-70 (TM)) on insulin resistance in mice. Methods and results: Male C57BL/6J mice were subjected to a normal or high-fat diet (HFD) and were randomly assigned to receive Fenfuro (TM), GCB-70 (TM), or their combination for 24 wk. Metabolic parameters, glucose tolerance, serum triglycerides, cardiac function, and hepatic insulin signaling were evaluated using indirect open-circuit calorimetry, intraperitoneal glucose tolerance test, oil red O staining, echocardiography, and Western blotting, respectively. Intraperitoneal glucose tolerance test revealed glucose intolerance in the mice receiving HFD, which was attenuated by Fenfuro (TM). Serum triglyceride that was elevated following an HFD was reconciled by both Fenfuro (TM) and the combination. HFD compromised myocardial contractile function, which was unaffected by the treatment. Insulin-stimulated phosphorylation of Protein kinase B (AKT) in the liver was attenuated in mice receiving HFD, which was partially rescued by GCB-70 (TM). Neither treatment altered metabolic parameters or energy expenditure. Conclusion: Collectively, our data suggest that fenugreek furostanolic saponins and green coffee bean extract may have potential benefits in treating insulin resistance and related conditions.
C1 [Hua, Yinan; Ren, Sidney Y.; Guo, Rui; Rogers, Olivia; Nair, Sreejayan] Univ Wyoming, Coll Hlth Sci, Sch Pharm, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
   [Nair, Rama P.] Nutriwyo LLC, Div Res & Dev, Laramie, WY USA.
   [Bagchi, Debasis] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA.
   [Bagchi, Debasis; Swaroop, Anand] Cepham Inc, Div Res & Dev, Piscataway, NJ USA.
C3 University of Wyoming; University of Houston System; University of Houston
RP Nair, S (corresponding author), Univ Wyoming, Coll Hlth Sci, Sch Pharm, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
EM sreejay@uwyo.edu
FU Cepham Inc.
CR Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Unknown -, 2014, BIOMED RES INT, V0, P0, DOI DOI 10.1155/2014/606021
   Beam JR, 2015, NUTRITION, V31, P292, DOI 10.1016/j.nut.2014.07.012
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Egede LE, 2002, DIABETES CARE, V25, P324, DOI 10.2337/diacare.25.2.324
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Haber SL, 2013, AM J HEALTH-SYST PH, V70, P1202
   Haber SL, 2013, AM J HEALTH-SYST PH, V70, P1200
   Haber SL, 2013, AM J HEALTH-SYST PH, V70, P1196, DOI 10.2146/ajhp120523
   Hamza N, 2012, J ETHNOPHARMACOL, V142, P516, DOI 10.1016/j.jep.2012.05.028
   Handa T, 2005, BIOSCI BIOTECH BIOCH, V69, P1186, DOI 10.1271/bbb.69.1186
   Haritha C, 2013, J NAT SCI BIOL MED, V4, P207, DOI 10.4103/0976-9668.107292
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Hua YA, 2013, HYPERTENSION, V61, P1184, DOI 10.1161/HYPERTENSIONAHA.111.00947
   Hua YN, 2013, DIABETES, V62, P498, DOI 10.2337/db12-0350
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kouzi Samir A, 2015, FRONT BIOSCI (ELITE ED), V7, P94
   KULKARNI GV, 1994, J CELL SCI, V107, P1169
   Mathern JR, 2009, PHYTOTHER RES, V23, P1543, DOI 10.1002/ptr.2795
   Maurya CK, 2014, MOL CELL ENDOCRINOL, V395, P51, DOI 10.1016/j.mce.2014.07.018
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Neelakantan N, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-7
   Panzhinskiy E, 2014, J PHARMACOL EXP THER, V349, P248, DOI 10.1124/jpet.113.208728
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Rawat AK, 2014, FITOTERAPIA, V99, P307, DOI 10.1016/j.fitote.2014.10.006
   RIBES G, 1986, P SOC EXP BIOL MED, V182, P159
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   Sreejayan N, 2008, OBESITY, V16, P1331, DOI 10.1038/oby.2008.217
   Suksomboon N, 2011, J ETHNOPHARMACOL, V137, P1328, DOI 10.1016/j.jep.2011.07.059
   Swaroop A, 2014, TOXICOL MECH METHOD, V24, P495, DOI 10.3109/15376516.2014.943443
   Vijayakumar MV, 2005, BRIT J PHARMACOL, V146, P41, DOI 10.1038/sj.bjp.0706312
   Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 35
TC 15
Z9 15
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD OCT 15
PY 2015
VL 59
IS 10
BP 2094
EP 2100
DI 10.1002/mnfr.201500197
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA CT1HZ
UT WOS:000362550700020
PM 26201993
DA 2025-04-28
ER

PT J
AU Bajerska, J
   Mildner-Szkudlarz, S
   Walkowiak, J
AF Bajerska, Joanna
   Mildner-Szkudlarz, Sylwia
   Walkowiak, Jaroslaw
TI Effects of Rye Bread Enriched with Green Tea Extract on Weight Maintenance and the Characteristics of Metabolic Syndrome Following Weight Loss: A Pilot Study
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE metabolic syndrome; rye bread; functional foods; body-weight maintenance; green tea extract
ID blood-pressure; caffeine intake; polyphenols; consumption; guidelines; management; absorption; catechins; consumer
AB We examined whether the incorporation of green tea extract enriched rye bread (GTRB) into the diet can improve weight loss (WL) maintenance and control of abnormalities linked to metabolic syndrome (MS). A total of 55 obese men and women (mean age: 53.0 +/- 7.0 years, body mass index: 35.0 +/- 5.5 kg m(-2)) were recruited. The study had a single-blind randomized study design and consisted of an 8-week WL phase with low-energy calorie diet, followed by a 12-week weight maintenance (WM) phase. During the WM phase, the subjects were randomized into two groups, receiving either the control rye bread (control group) or the GTRB (intervention group). The ingestion of 280 and 360 g GTRB provided daily totals of 123.2 and 158.4 mg caffeine, and 188.3 and 242.1 mg of epigallocatechin gallate, for women and men, respectively. After the WL phase, subjects lost 7.3 +/- 3.1 kg of their baseline body weight. GTRB intake did not significantly influence the maintenance of WL, high-density lipoprotein-cholesterol, triglycerides, and glucose concentrations. Although, it resulted in significant differences (mean difference [95% confidence interval]) between the treatment groups in the maintenance of waist circumference (-1.22 cm [-2.4, -0.02; P=.04]), the results were not clinically meaningful. Nevertheless, the ingestion of GTRB led to the maintenance of lower blood pressure (BP), also the proportion of subjects fulfilling the criteria of MS after the WM phase was lower in the intervention group than in the control group. Although GTRB consumption did not improve significantly the WL maintenance, it resulted in a better control of BP.
C1 [Bajerska, Joanna; Walkowiak, Jaroslaw] Poznan Univ Life Sci, Fac Food Sci & Nutr, Dept Human Nutr & Hyg, PL-60624 Poznan, Poland.
   [Mildner-Szkudlarz, Sylwia] Poznan Univ Life Sci, Inst Food Technol Plant Origin, PL-60624 Poznan, Poland.
   [Walkowiak, Jaroslaw] Pozna Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Poznan, Poland.
C3 Poznan University of Life Sciences; Poznan University of Life Sciences
RP Bajerska, J (corresponding author), Poznan Univ Life Sci, Fac Food Sci & Nutr, Dept Human Nutr & Hyg, Wojska Polskiego 31, PL-60624 Poznan, Poland.
EM joanna.bajerska@up.poznan.pl
FU Polish Ministry of Sciences and Higher Education [NN312331635]
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Bajerska J, 2010, J FOOD NUTR RES-SLOV, V49, P104
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Fogelholm M, 2000, ARCH INTERN MED, V160, P2177, DOI 10.1001/archinte.160.14.2177
   Harsha DW, 2008, HYPERTENSION, V51, P1420, DOI 10.1161/HYPERTENSIONAHA.107.094011
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kunachowicz H, 2010, PRINCIPLES HUMAN NUT, V0, P0
   LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810, DOI 10.1093/ajcn/41.4.810
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   Ogden Cynthia L, 2012, NCHS DATA BRIEF, V0, P1
   Phelan S, 2003, AM J CLIN NUTR, V78, P1079, DOI 10.1093/ajcn/78.6.1079
   Sacks DB, 2002, CLIN CHEM, V48, P436, DOI 10.2337/dc11-9998
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Schramm DD, 2003, LIFE SCI, V73, P857, DOI 10.1016/S0024-3205(03)00373-4
   Siró I, 2008, APPETITE, V51, P456, DOI 10.1016/j.appet.2008.05.060
   STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Szponar L, 2000, PHOTOGRAPHIC ALBUM F, V0, P0
   Wang R, 2004, J AGR FOOD CHEM, V52, P8224, DOI 10.1021/jf048655x
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323
   Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534
   Yoto A, 2012, J PHYSIOL ANTHROPOL, V31, P0, DOI 10.1186/1880-6805-31-28
NR 32
TC 24
Z9 25
U1 0
U2 45
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD JUN 1
PY 2015
VL 18
IS 6
BP 698
EP 705
DI 10.1089/jmf.2014.0032
PG 8
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics
GA CQ3VI
UT WOS:000360531500012
PM 25494205
DA 2025-04-28
ER

PT J
AU Corrêa, VG
   Tureck, C
   Locateli, G
   Peralta, RM
   Koehnlein, EA
AF Correa, Vanesa Gesser
   Tureck, Camila
   Locateli, Gelvani
   Peralta, Rosane Marina
   Koehnlein, Eloa Angelica
TI Estimate of consumption of phenolic compounds by Brazilian population
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Antioxidants; Flavonoids; Food consumption; Phenolic compounds
ID major food sources; total antioxidant capacity; dietary-intake; tea consumption; cardiovascular-disease; oxidative stress; polyphenols; vegetables; cancer; fruits
AB Objective Estimate the intake of phenolic compounds by the Brazilian population. Methods To estimate the average per capita food consumption, micro data from the National Dietary Survey and from the Household Budget Survey from 2008 to 2009 was analyzed. The phenolic content in food was estimated from the base of Phenol-Explorer. It was chosen according to compatibility and variety of food items and usual method of preparation. Results The Brazilian population consumed, on average, 460.15 mg/day of total phenolic compounds, derived mainly from beverages (48.9%), especially coffee and legumes (19.5%). Since this analysis of classes of phenolics it was possible to observe an intake of 314 mg/day of phenolic acids, 138.92 mg/day of flavonoids and 7.16 mg/ day of other kinds of phenolics. Regarding the variables studied this present study shows that those men who live in the countryside and in the northeastern region of the country had a higher consumption of phenolic compounds. Besides, consumption was higher by adults and the elderly, the medium income classes, the population with incomplete and complete primary education and those with adequate nutrition and also overweight status. Conclusion The intake of phenolic compounds can be considered low, especially where consumption of fruit and vegetables is insufficient. We can conclude that coffee and black beans were the best contributors to phenolic intake.
C1 [Correa, Vanesa Gesser; Tureck, Camila; Locateli, Gelvani; Koehnlein, Eloa Angelica] Univ Fed Fronteira Sul, Curso Nutr, BR-85770000 Realeza, PR, Brazil.
   [Peralta, Rosane Marina] Univ Estadual Maringa, Curso Bioquim, Dept Bioquim, Maringa, Parana, Brazil.
C3 Universidade Federal da Fronteira Sul; Universidade Estadual de Maringa
RP Koehnlein, EA (corresponding author), Univ Fed Fronteira Sul, Curso Nutr, R Edmundo Gaievski 1000,Rodovia PR 182,Km 466, BR-85770000 Realeza, PR, Brazil.
EM eloa.koehnlein@uffs.edu.br
CR Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x
   Unknown -, 2014, GUIA ALIMENTAR POPUL, V0, P0
   Unknown -, 2011, COORD TRAB REND PESQ, V0, P0
   Unknown -, 2002, DIET NUTR PREV CHRON, V0, P0
   Unknown -, 2017, ANNEX 3-03, V0, P4
   Arab L, 2013, AM J CLIN NUTR, V98, P1651S, DOI 10.3945/ajcn.113.059345
   Arabbi PR, 2004, J AGR FOOD CHEM, V52, P1124, DOI 10.1021/jf0499525
   Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059
   Biesaga M, 2009, J CHROMATOGR A, V1216, P6620, DOI 10.1016/j.chroma.2009.07.066
   Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021
   Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244
   Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Debette S, 2008, ARTERIOSCL THROM VAS, V28, P353, DOI 10.1161/ATVBAHA.107.151928
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Hayashi M, 2009, NEUROPATHOLOGY, V29, P1, DOI 10.1111/j.1440-1789.2008.00888.x
   Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881
   Hervert-Hernández D, 2011, FOOD RES INT, V44, P1182, DOI 10.1016/j.foodres.2010.09.021
   Koehnlein EA, 2014, INT J FOOD SCI NUTR, V65, P293, DOI 10.3109/09637486.2013.879285
   Faller ALK, 2009, REV SAUDE PUBL, V43, P211, DOI 10.1590/S0034-89102009005000010
   Lee HS, 2013, J ACAD NUTR DIET, V113, P1194, DOI 10.1016/j.jand.2013.04.022
   McKay DL, 2015, FOOD CHEM, V168, P233, DOI 10.1016/j.foodchem.2014.07.062
   Mullen W, 2013, J AGR FOOD CHEM, V61, P5298, DOI 10.1021/jf4003126
   Murphy MM, 2012, J ACAD NUTR DIET, V112, P222, DOI 10.1016/j.jada.2011.08.044
   Nardini M, 2004, FOOD CHEM, V84, P137, DOI 10.1016/S0308-8146(03)00257-7
   Neveu V, 2010, DATABASE-OXFORD, V0, P0, DOI DOI 10.1093/database/bap024
   Nutritional Screening Initiative, 1992, INT MAN PROF CAR OLD, V0, P0
   Ordoñez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Pérez-Jiménez J, 2010, EUR J CLIN NUTR, V64, PS112, DOI 10.1038/ejcn.2010.221
   Pérez-Jiménez J, 2008, FOOD RES INT, V41, P274, DOI 10.1016/j.foodres.2007.12.004
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Quiñones M, 2013, PHARMACOL RES, V68, P125, DOI 10.1016/j.phrs.2012.10.018
   Rostagno MA, 2011, ANAL CHIM ACTA, V685, P204, DOI 10.1016/j.aca.2010.11.031
   Rothwell JA, 2015, MOL NUTR FOOD RES, V59, P160, DOI 10.1002/mnfr.201400494
   Sawaya AL, 1996, AM J CLIN NUTR, V63, P491, DOI 10.1093/ajcn/63.4.491
   Souza AD, 2013, REV SAUDE PUBL, V47, PS190, DOI 10.1590/S0034-89102013000700005
   Stea TH, 2008, EUR J NUTR, V47, P201, DOI 10.1007/s00394-008-0714-y
   Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092
   Tomata Y, 2012, AM J CLIN NUTR, V95, P732, DOI 10.3945/ajcn.111.023200
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Zamora-Ros R, 2013, BRIT J NUTR, V110, P1500, DOI 10.1017/S0007114513000688
   Zamora-Ros R, 2013, BRIT J NUTR, V109, P1498, DOI 10.1017/S0007114512003273
NR 48
TC 30
Z9 33
U1 0
U2 21
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
EI 
J9 REV NUTR
JI Rev. Nutr.
PD MAR-APR 15
PY 2015
VL 28
IS 2
BP 185
EP 196
DI 10.1590/1415-52732015000200007
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CG3EI
UT WOS:000353160500007
DA 2025-04-28
ER

PT J
AU Kiszko, K
   Cantor, J
   Abrams, C
   Ruddock, C
   Moltzen, K
   Devia, C
   McFarline, B
   Singh, H
   Elbel, B
AF Kiszko, Kamila
   Cantor, Jonathan
   Abrams, Courtney
   Ruddock, Charmaine
   Moltzen, Kelly
   Devia, Carlos
   McFarline, Bernice
   Singh, Hardeep
   Elbel, Brian
TI Corner Store Purchases in a Low-Income Urban Community in NYC
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Choice behavior; Diet; Food; Obesity; New York City
ID food stores; healthy foods; availability; access; environments
AB We assessed purchases made, motivations for shopping, and frequency of shopping at four New York City corner stores (bodegas). Surveys and purchase inventories (n = 779) were collected from consumers at four bodegas in Bronx, NY. We use Chi square tests to compare types of consumers, items purchased and characteristics of purchases based on how frequently the consumer shops at the specific store and the time of day the purchase was made. Most consumers shopped at the bodega because it was close to their home (52 %). The majority (68 %) reported shopping at the bodega at least once per day. The five most commonly purchased items were sugary beverages, (29.27 %), sugary snacks (22.34 %), coffee, (13.99 %), sandwiches, (13.09 %) and non-baked potato chips (12.2 %). Nearly 60 % of bodega customers reported their purchase to be healthy. Most of the participants shopped at the bodega frequently, valued its convenient location, and purchased unhealthy items. Work is needed to discover ways to encourage healthier choices at these stores.
C1 [Kiszko, Kamila; Cantor, Jonathan; Abrams, Courtney; Elbel, Brian] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA.
   [Cantor, Jonathan; Elbel, Brian] NYU, Robert F Wagner Sch Publ Serv, New York, NY 10012 USA.
   [Ruddock, Charmaine; Moltzen, Kelly; Devia, Carlos; McFarline, Bernice; Singh, Hardeep] Inst Family Hlth, Bronx Hlth REACH, New York, NY 10003 USA.
C3 New York University; New York University
RP Elbel, B (corresponding author), NYU, Sch Med, Dept Populat Hlth, 550 First Ave,VZ30 6th Floor, New York, NY 10016 USA.
EM Kamila.Kiszko@nyumc.org; Jonathan.Cantor@nyumc.org; Courtney.Abrams@nyumc.org; cruddock@institute.org; kmoltzen@institute.org; carlos.devia@gmail.com; andawiber@yahoo.com; hardeep.s.hunjan@gmail.com; brian.elbel@nyumc.org
FU Centers for Disease Control and Prevention [1U48DP001904-01]
CR Bodor JN, 2008, PUBLIC HEALTH NUTR, V11, P413, DOI 10.1017/S1368980007000493
   Borradaile KE, 2009, PEDIATRICS, V124, P1293, DOI 10.1542/peds.2009-0964
   Cannuscio CC, 2013, AM J PREV MED, V45, P606, DOI 10.1016/j.amepre.2013.06.021
   Cavanaugh E, 2013, PREV MED, V56, P149, DOI 10.1016/j.ypmed.2012.12.007
   DAngelo H, 2011, PUBLIC HEALTH NUTR, V14, P1632, DOI 10.1017/S1368980011000498
   Dannefer R, 2009, UNPUB, V0, P0
   Dannefer R, 2012, AM J PUBLIC HEALTH, V102, PE27, DOI 10.2105/AJPH.2011.300615
   Galvez MP, 2009, ACAD PEDIATR, V9, P339, DOI 10.1016/j.acap.2009.05.003
   Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567
   Gittelsohn J, 2008, J HUNGER ENVIRON NUT, V2, P33, DOI 10.1080/19320240801891438
   Gordon C, 2007, EATING WELL IN HARLEM: HOW AVAILABILE IS HEALTHY FOOD?, V0, P0
   Graham R, 2006, EATING EATING OUT EA, V0, P0
   Kaufman L, 2007, SOC SCI MED, V64, P2177, DOI 10.1016/j.socscimed.2007.02.019
   Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025
   Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1031, DOI 10.1017/S1368980009992771
   Lent MR, 2015, PUBLIC HEALTH NUTR, V18, P1706, DOI 10.1017/S1368980014001670
   Lucan SC, 2010, J URBAN HEALTH, V87, P394, DOI 10.1007/s11524-010-9453-5
   New York City Department of Health and Mental Hygiene, 2014, EPI DATA BRIEF, V44, P1
   New York City Department of Health and Mental Hygiene, 2012, EPI DATA BRIEF, V17, P1
   OMalley K, 2013, J COMMUN HEALTH, V38, P741, DOI 10.1007/s10900-013-9673-1
   Powell LM, 2007, AM J PREV MED, V33, PS301, DOI 10.1016/j.amepre.2007.07.007
   Ruff RR, 2015, AM J HLTH PROMOTION, V0, P0
   Song HJ, 2009, PUBLIC HEALTH NUTR, V12, P2060, DOI 10.1017/S1368980009005242
NR 25
TC 39
Z9 44
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD DEC 15
PY 2015
VL 40
IS 6
BP 1084
EP 1090
DI 10.1007/s10900-015-0033-1
PG 7
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational Health
GA CV0XU
UT WOS:000363978000005
PM 25910485
DA 2025-04-28
ER

